<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">92884</article-id><article-id pub-id-type="doi">10.7554/eLife.92884</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Structural Biology and Molecular Biophysics</subject></subj-group></article-categories><title-group><article-title>A novel bivalent interaction mode underlies a non-catalytic mechanism for Pin1-mediated protein kinase C regulation</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-337661"><name><surname>Chen</surname><given-names>Xiao-Ru</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2051-889X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-337662"><name><surname>Dixit</surname><given-names>Karuna</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3583-2512</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-342769"><name><surname>Yang</surname><given-names>Yuan</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9538-6369</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-337663"><name><surname>McDermott</surname><given-names>Mark I</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-337664"><name><surname>Imam</surname><given-names>Hasan Tanvir</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-179782"><name><surname>Bankaitis</surname><given-names>Vytas A</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1654-6759</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-62801"><name><surname>Igumenova</surname><given-names>Tatyana I</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3772-7484</contrib-id><email>tigumenova@tamu.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01f5ytq51</institution-id><institution>Department of Biochemistry &amp; Biophysics, Texas A&amp;M University</institution></institution-wrap><addr-line><named-content content-type="city">College Station</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01f5ytq51</institution-id><institution>Department of Cell Biology &amp; Genetics, Texas A&amp;M University</institution></institution-wrap><addr-line><named-content content-type="city">College Station</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Hong</surname><given-names>Heedeok</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05hs6h993</institution-id><institution>Michigan State University</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Cooper</surname><given-names>Jonathan A</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/007ps6h72</institution-id><institution>Fred Hutchinson Cancer Research Center</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>30</day><month>04</month><year>2024</year></pub-date><volume>13</volume><elocation-id>e92884</elocation-id><history><date date-type="received" iso-8601-date="2023-09-19"><day>19</day><month>09</month><year>2023</year></date><date date-type="accepted" iso-8601-date="2024-04-08"><day>08</day><month>04</month><year>2024</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2023-09-20"><day>20</day><month>09</month><year>2023</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2023.09.18.558341"/></event></pub-history><permissions><copyright-statement>© 2024, Chen, Dixit et al</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Chen, Dixit et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-92884-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-92884-figures-v1.pdf"/><abstract><p>Regulated hydrolysis of the phosphoinositide phosphatidylinositol(4,5)-bis-phosphate to diacylglycerol and inositol-1,4,5-P<sub>3</sub> defines a major eukaryotic pathway for translation of extracellular cues to intracellular signaling circuits. Members of the lipid-activated protein kinase C isoenzyme family (PKCs) play central roles in this signaling circuit. One of the regulatory mechanisms employed to downregulate stimulated PKC activity is via a proteasome-dependent degradation pathway that is potentiated by peptidyl-prolyl isomerase Pin1. Here, we show that contrary to prevailing models, Pin1 does not regulate conventional PKC isoforms α and βII via a canonical <italic>cis-trans</italic> isomerization of the peptidyl-prolyl bond. Rather, Pin1 acts as a PKC binding partner that controls PKC activity via sequestration of the C-terminal tail of the kinase. The high-resolution structure of full-length Pin1 complexed to the C-terminal tail of PKCβII reveals that a novel bivalent interaction mode underlies the non-catalytic mode of Pin1 action. Specifically, Pin1 adopts a conformation in which it uses the WW and PPIase domains to engage two conserved phosphorylated PKC motifs, the turn motif and hydrophobic motif, respectively. Hydrophobic motif is a non-canonical Pin1-interacting element. The structural information combined with the results of extensive binding studies and experiments in cultured cells suggest that non-catalytic mechanisms represent unappreciated modes of Pin1-mediated regulation of AGC kinases and other key enzymes/substrates.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>Pin1 peptidyl-prolyl isomerase</kwd><kwd>protein kinase C</kwd><kwd>signaling</kwd><kwd>non-catalytic mechanism</kwd><kwd>bivalent binding</kwd><kwd>protein kinase C degradation</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000057</institution-id><institution>National Institute of General Medical Sciences</institution></institution-wrap></funding-source><award-id>RO1GM108998</award-id><principal-award-recipient><name><surname>Igumenova</surname><given-names>Tatyana I</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000928</institution-id><institution>Welch Foundation</institution></institution-wrap></funding-source><award-id>A-1784</award-id><principal-award-recipient><name><surname>Igumenova</surname><given-names>Tatyana I</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000057</institution-id><institution>National Institute of General Medical Sciences</institution></institution-wrap></funding-source><award-id>R35GM131804</award-id><principal-award-recipient><name><surname>Bankaitis</surname><given-names>Vytas A</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000968</institution-id><institution>American Heart Association</institution></institution-wrap></funding-source><award-id>14PRE20380475</award-id><principal-award-recipient><name><surname>Yang</surname><given-names>Yuan</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000928</institution-id><institution>Welch Foundation</institution></institution-wrap></funding-source><award-id>BE-0017</award-id><principal-award-recipient><name><surname>Bankaitis</surname><given-names>Vytas A</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Integrated biophysical, structural, and in-cell approaches demonstrate a non-canonical and non-isomerizable binding motif-dependent mode of protein kinase C regulation by the peptidyl-prolyl isomerase Pin1 in mammalian cells.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Protein kinase C isoenzymes (PKCs) define a family of multi-modular Ser/Thr kinases that regulate cell growth, differentiation, apoptosis, and motility (<xref ref-type="bibr" rid="bib17">Clemens et al., 1992</xref>; <xref ref-type="bibr" rid="bib76">Rosse et al., 2010</xref>). PKCs occupy a key node of the phosphoinositide signaling pathway whose intracellular arms are mediated by diacylglycerol (DAG) and IP<sub>3</sub>-dependent Ca<sup>2+</sup> signaling (<xref ref-type="bibr" rid="bib64">Newton, 2010</xref>). Novel and conventional PKCs are allosterically activated upon translocation to membranes. This membrane recruitment process involves PKC interactions with DAG and, in the case of Ca<sup>2+</sup>-dependent isoforms, the anionic phospholipids phosphatidylserine and PtdIns(4,5)P<sub>2</sub> (<xref ref-type="bibr" rid="bib63">Newton and Protein kinase, 1995</xref>; <xref ref-type="bibr" rid="bib40">Johnson et al., 2000</xref>; <xref ref-type="bibr" rid="bib26">Evans et al., 2006</xref>). Dysregulated PKC activity is implicated in cancer progression (<xref ref-type="bibr" rid="bib37">Isakov, 2018</xref>; <xref ref-type="bibr" rid="bib18">Cooke et al., 2017</xref>), cardiac disease (<xref ref-type="bibr" rid="bib80">Singh et al., 2017</xref>), diabetes (<xref ref-type="bibr" rid="bib73">Rask-Madsen and King, 2005</xref>), and neurodegenerative disorders (<xref ref-type="bibr" rid="bib48">Lordén and Newton, 2021</xref>). Both gain- and loss-of function PKC mutations are associated with diseased states, as reported recently for certain cancers (<xref ref-type="bibr" rid="bib4">Antal et al., 2015b</xref>; <xref ref-type="bibr" rid="bib67">Parker et al., 2021</xref>) and neurodegenerative disorders (<xref ref-type="bibr" rid="bib2">Alfonso et al., 2016</xref>; <xref ref-type="bibr" rid="bib13">Callender et al., 2018</xref>).</p><p>Central to the question of PKC regulation is its phosphorylation state as it determines both cellular steady-state levels of the enzyme and its enzymatic activity. During the maturation process, a sequence of four ordered phosphorylation events (<xref ref-type="bibr" rid="bib7">Baffi et al., 2021</xref>) enable PKC to adopt a stable autoinhibited conformation in the cytosol. The autoinhibitory interactions between the N-terminal pseudo-substrate region and the C-terminal kinase domains are allosterically released by the interactions of second messengers with the PKC regulatory domain (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). The activated kinase can be additionally stabilized through the interactions with RACK (receptors for activated C-kinase) adaptor proteins (<xref ref-type="bibr" rid="bib56">Mochly-Rosen et al., 1991</xref>; <xref ref-type="bibr" rid="bib83">Stebbins and Mochly-Rosen, 2001</xref>) that play an important role in the subcellular localization of PKCs (<xref ref-type="bibr" rid="bib75">Ron et al., 1999</xref>). The open conformation that PKC assumes upon activation makes it susceptible to dephosphorylation by the protein phosphatase 2A (PP2A) (<xref ref-type="bibr" rid="bib82">Srivastava et al., 2002</xref>) and <underline>p</underline>leckstrin <underline>h</underline>omology domain and <underline>l</underline>eucine rich repeat <underline>p</underline>rotein <underline>p</underline>hosphatase (PHLPP) phosphatases (<xref ref-type="bibr" rid="bib30">Gao et al., 2008</xref>; <xref ref-type="bibr" rid="bib6">Baffi et al., 2019</xref>) with the result that the enzyme is rapidly degraded in the cell. This ‘activation-induced’ downregulation is one of the major mechanisms for terminating the PKC-mediated signaling response. Pin1, a peptidyl-prolyl isomerase, plays an important role in that process. It is for this reason that Pin1 was coined as the ‘molecular timer’ for PKC lifetime (<xref ref-type="bibr" rid="bib1">Abrahamsen et al., 2012</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Pin1 binds the turn motifs of α and βII PKC isoenzymes through its WW domain.</title><p>(<bold>A</bold>) Multi-modular architecture of conventional PKC isoenzymes, shown along with the amino acid sequence alignment of the C-terminal V5 domains. Turn and hydrophobic motifs are highlighted in purple and orange, respectively. (<bold>B</bold>) Notations for the V5 peptides that were selected for the NMR-detected binding experiments conducted in this study. (<bold>C</bold>) Residue-specific chemical shift perturbation (CSP) plots of Pin1 and its isolated WW domain obtained upon binding of pTMβII and pTMα. The turn motifs (TMs) interact exclusively with the WW domain. The CSP values Δ for the Pin1::pTMβII complex are color-coded and mapped on to lowest-energy solution NMR structure of apo Pin1 (PDB: 1NMV). (<bold>D</bold>) Representative binding isotherms and dissociation constants for the formation of the complexes between TMs and Pin1 and its WW domain. The source 2D <sup>15</sup>N-<sup>1</sup>H heteronuclear single-quantum coherence (HSQC) NMR spectra are given in <xref ref-type="supplementary-material" rid="supp1 supp2 supp3 supp4">Supplementary files 1–4</xref>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92884-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>NMR-detected binding of the PKCβII turn motif (pTMβII) to full-length Pin1.</title><p>The protein concentration was 100 μM, and the pTMβII concentration varied from 0 mM to 1 mM. Most of the affected N-H<sub>N</sub> resonances are in fast exchange on the NMR chemical shift timescale (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>, binding experiment #1).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92884-fig1-figsupp1-v1.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>NMR-detected binding of the PKCβII turn motif (pTMβII) to the isolated WW domain.</title><p>The protein concentration was 100 μM, and the pTMβII concentration varied from 0 mM to 1 mM. Most of the affected N-H<sub>N</sub> resonances are in fast exchange on the NMR chemical shift timescale (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>, binding experiment #2).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92884-fig1-figsupp2-v1.tif"/></fig><fig id="fig1s3" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 3.</label><caption><title>NMR-detected binding of the PKCα turn motif (pTMα) to full-length Pin1.</title><p>The protein concentration was 100 μM, and the pTMα concentration varied from 0 mM to 1.8 mM. Most of the affected N-H<sub>N</sub> resonances are in fast exchange on the NMR chemical shift timescale (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>, binding experiment #3).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92884-fig1-figsupp3-v1.tif"/></fig><fig id="fig1s4" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 4.</label><caption><title>NMR-detected binding of the PKCα turn motif (pTMα) to the isolated WW domain.</title><p>The protein concentration was 100 μM, and the pTMα concentration varied from 0 mM to 1.8 mM. Most of the affected N-H<sub>N</sub> resonances are in fast exchange on the NMR chemical shift timescale (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>, binding experiment #4).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92884-fig1-figsupp4-v1.tif"/></fig><fig id="fig1s5" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 5.</label><caption><title>Mass spectrometry data for the synthesized peptides derived from the C-terminal V5 regions of PKC isozymes.</title><p>(<bold>A–I</bold>) Mass spectra of the phosphorylated peptides used in this work. Expected molecular masses are: 1328.4 (pTMα); 1826.8 (pHMα); 3421.5 (pV5α); 2689.8 (V5βII-pTM-HM); 1288.3 (pTMβII); 1540.5 (pHMβII); 2609.8 (V5βII); 2769.8 (pV5βII); and 2689.8 (V5βII-TM-pHM).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92884-fig1-figsupp5-v1.tif"/></fig></fig-group><p>Pin1 is a peptidyl-prolyl isomerase of the parvuline family and is unique in its specificity toward pSer/pThr-Pro protein motifs (<xref ref-type="bibr" rid="bib49">Lu et al., 1996</xref>). These Ser/Thr-Pro motifs constitute ~30% of all phosphorylation sites in the proteome and their phosphorylation is catalyzed by proline-directed kinases (<xref ref-type="bibr" rid="bib84">Ubersax and Ferrell, 2007</xref>). It is through isomerization of the <italic>cis-trans</italic> pSer/pThr-Pro bond that Pin1 brings the associated conformational changes of its substrates into biologically relevant timescales. In turn, conformation-specific activities of Pin1 client proteins are essential for the regulation of many cellular processes including metabolism, cell cycle progression, apoptosis, cell motility, cell proliferation, and cell survival (<xref ref-type="bibr" rid="bib47">Liou et al., 2011</xref>). Pin1 is overexpressed/overactivated in cancers with the result that numerous oncoproteins are activated and tumor suppressor functions are deactivated (<xref ref-type="bibr" rid="bib51">Lu and Hunter, 2014</xref>; <xref ref-type="bibr" rid="bib101">Zhou and Lu, 2016</xref>; <xref ref-type="bibr" rid="bib98">Zannini et al., 2019</xref>; <xref ref-type="bibr" rid="bib15">Chen and Igumenova, 2023</xref>). It is because Pin1 stimulates oncogenic pathways that Pin1 inhibitors show great promise in the development of new cancer therapies (<xref ref-type="bibr" rid="bib58">Moore and Potter, 2013</xref>; <xref ref-type="bibr" rid="bib71">Pinch et al., 2020</xref>; <xref ref-type="bibr" rid="bib91">Wei et al., 2015</xref>; <xref ref-type="bibr" rid="bib14">Campaner et al., 2017</xref>; <xref ref-type="bibr" rid="bib21">Dubiella et al., 2021</xref>; <xref ref-type="bibr" rid="bib42">Koikawa et al., 2021</xref>; <xref ref-type="bibr" rid="bib43">Kozono et al., 2018</xref>).</p><p>Pin1 consists of two domains – the WW and PPIase modules (<xref ref-type="bibr" rid="bib72">Ranganathan et al., 1997</xref>). The interplay between these domains is relevant to Pin1 catalytic function as it ensures the adaptability of Pin1 to a variety of phosphorylated substrates. Both Pin1 domains possess structural elements capable of interacting with pSer/pThr-Pro motifs, but only the isomerase domain has a catalytic role in the peptidyl-prolyl bond isomerization. The WW domain exhibits an affinity for Pin1 substrates that is ~10-fold greater than that of the PPIase domain (<xref ref-type="bibr" rid="bib45">Lee and Liou, 2018</xref>), and the WW domain is thought to either facilitate substrate recruitment to the PPIase active site and/or preferentially stabilize binding of a particular substrate isomer (<xref ref-type="bibr" rid="bib50">Lu et al., 2002</xref>; <xref ref-type="bibr" rid="bib100">Zhou et al., 1999</xref>; <xref ref-type="bibr" rid="bib85">Verdecia et al., 2000</xref>). The linker connecting the two domains confers significant flexibility to the Pin1 structure, and the conformational ensemble of Pin1 in solution is comprised of an ~70:30 ratio of ‘compact’ to ‘extended’ conformers (<xref ref-type="bibr" rid="bib12">Born et al., 2021</xref>). Thus, Pin1 dynamics at both inter- and intra-domain levels play essential roles in the allosteric behavior of the enzyme (<xref ref-type="bibr" rid="bib69">Peng, 2015</xref>; <xref ref-type="bibr" rid="bib33">Guo et al., 2015</xref>).</p><p>The current model of PKC regulation by Pin1 is based on extensive cell biological evidence. It posits that Pin1 catalyzes a <italic>cis-trans</italic> isomerization of the C-terminus of the conventional (or Ca<sup>2+</sup>-dependent) PKC isoforms α and βII (<xref ref-type="bibr" rid="bib1">Abrahamsen et al., 2012</xref>). Herein, we report that, contrary to the prevailing model of Pin1 action, Pin1’s role in PKC α and βII regulation is a non-catalytic one. Instead, Pin1 acts as a PKC binding partner that sequesters two conserved phosphorylated PKC motifs in the disordered C-terminal tail (C-term) of the kinase. Our structure of the Pin1-C-term PKCβII complex reveals a novel bivalent interaction mode that has not been previously observed for Pin1, and is the first structure of the full-length Pin1 complexed to a ligand that engages both domains. Our structural and biophysical data provide the molecular basis of non-catalytic Pin1 action that is also supported by the results of activity assays and experiments in the cellular context.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>The turn motif of the α and βII PKC isoenzymes preferentially binds to the WW domain of Pin1</title><p>The key feature of the current model for Pin1-mediated PKC regulation is the Pin1-catalyzed <italic>cis-trans</italic> isomerization of the turn motif (TM) (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). TM is a conserved feature among many AGC kinases that presents a phosphorylatable Ser or Thr residue in the C-terminal domains of these enzymes (<xref ref-type="bibr" rid="bib68">Pearce et al., 2010</xref>). Phosphorylation of the TM is part of the PKC maturation process, and it is essential for enzyme stability (<xref ref-type="bibr" rid="bib64">Newton, 2010</xref>; <xref ref-type="bibr" rid="bib29">Gao and Newton, 2002</xref>). In conventional PKC isoforms (α, βI/II, γ), the TM is followed by a proline residue and this pThr-Pro motif is proposed to be the isomerizable Pin1 target (<xref ref-type="bibr" rid="bib100">Zhou et al., 1999</xref>; <xref ref-type="fig" rid="fig1">Figure 1A</xref>). Therefore, the first step toward understanding how Pin1 regulates PKC was to determine the interaction mode between Pin1 and TM. To that end, NMR-detected binding experiments were conducted using uniformly <sup>15</sup>N-enriched ([U-<sup>15</sup>N]) WW domain and full-length Pin1, and two synthetic peptides (pTMα and pTMβII) that correspond to the phosphorylated TMs of the α and βII PKC isoforms, respectively (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). Addition of increasing concentrations of pTMα and pTMβII resulted in drastic shifts in the 2D <sup>15</sup>N-<sup>1</sup>H heteronuclear single-quantum coherence (HSQC) spectra of [U-<sup>15</sup>N] Pin1 and WW (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplements 1</xref>–<xref ref-type="fig" rid="fig1s4">4</xref>). The residue-specific chemical shift perturbation (CSP) values were calculated for pairs of spectra corresponding to the maximum concentrations of pTM in each titration series <italic>vs</italic>. apo Pin1. The four CSP plots of <xref ref-type="fig" rid="fig1">Figure 1C</xref> clearly demonstrate that the pTM binding site resides on the WW domain, and that the interaction mode is not significantly influenced by the presence of the PPIase domain in full-length Pin1. The fast exchange regime of the pTM-protein interactions enabled us to construct binding curves for all resolved residues with CSPs larger than the mean (see ”Construction and analysis of the chemical shift-based binding curves” in the Methods section for details on the selection criteria and fitting procedures). The curves fit well globally with a single-site binding model (<xref ref-type="fig" rid="fig1">Figure 1D</xref>, <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>). The reported global K<sub>d</sub> values fall into the micromolar range typical for WW-substrate affinities (<xref ref-type="bibr" rid="bib85">Verdecia et al., 2000</xref>; <xref ref-type="bibr" rid="bib11">Born et al., 2019</xref>; <xref ref-type="bibr" rid="bib92">Wilson et al., 2013</xref>). The similarities of the global K<sub>d</sub> values between WW and full-length Pin1 (<xref ref-type="fig" rid="fig1">Figure 1D</xref>) further support the conclusion that the PPIase domain does not significantly affect the pTM-WW interactions, and that the TMs of the α and βII PKC isoforms bind preferentially to the Pin1 WW domain.</p></sec><sec id="s2-2"><title>Pin1 does not catalyze the <italic>cis-trans</italic> isomerization of TM in α and βII PKC isoenzymes</title><p>The lack of high-affinity interactions of the PPIase domain with substrate does not preclude a catalytic mode of action for Pin1 as demonstrated previously for several Pin1 substrates (<xref ref-type="bibr" rid="bib88">Wang et al., 2015a</xref>). We therefore tested the ability of Pin1 to isomerize the TM. These experiments monitored activity against the isolated TM and in the context of a larger C-terminal region that harbors a second phosphorylated motif found in most AGC kinases – the hydrophobic motif (HM). HMs in PKC isoforms are described by the sequence FXXF(S/T)(F/Y) where the underlined Ser/Thr is constitutively phosphorylated as part of the kinase maturation process (<xref ref-type="bibr" rid="bib64">Newton, 2010</xref>; <xref ref-type="bibr" rid="bib22">Edwards and Newton, 1997</xref>). HM is located downstream of the TM with 14 amino acid residues separating the two motifs. Cell biological studies suggest that the HM is involved in PKC interactions with Pin1 (<xref ref-type="bibr" rid="bib1">Abrahamsen et al., 2012</xref>). However, the functional role of the HM is unclear as it does not fit the definition of a canonical Pin1 substrate due to the absence of a Pro residue that follows pSer/Thr. In these and all subsequent experiments, we used two synthetic double-phosphorylated peptides (pV5α and pV5βII; <xref ref-type="fig" rid="fig1">Figure 1B</xref>) to model the C-term PKC regions that contain both phosphorylated HM and TM.</p><p>Pin1 catalytic activity is readily measured using the <sup>1</sup>H-<sup>1</sup>H exchange spectroscopy (EXSY) of substrates in the presence of catalytic amounts of the enzyme (<xref ref-type="bibr" rid="bib81">Smet et al., 2005</xref>; <xref ref-type="bibr" rid="bib39">Jinasena et al., 2019</xref>; <xref ref-type="bibr" rid="bib55">Mercedes-Camacho et al., 2013</xref>). EXSY experiments are applicable to characterization of chemical exchange processes with the exchange rates between 0.1 s<sup>–1</sup> and 100 s<sup>–1</sup> (<xref ref-type="bibr" rid="bib66">Palmer et al., 2001</xref>; <xref ref-type="bibr" rid="bib41">Kawale and Burmann, 2023</xref>). Pin1 brings the slow <italic>cis-trans</italic> isomerization process of pSer/Thr-Pro bonds into biologically relevant timescales by enhancing the isomerization rate ~10<sup>3</sup>- to 10<sup>4</sup>-fold. This rate enhancement gives rise to characteristic cross-peaks in the 2D <sup>1</sup>H-<sup>1</sup>H EXSY NMR spectra. To our surprise, addition of catalytic amounts of Pin1 to either isolated pTMβII or to the entire phosphorylated pV5βII region failed to generate cross-peaks between the amide <sup>1</sup>H resonances of pThr641 in the <italic>trans</italic>(t) and <italic>cis</italic>(c) conformations of the pThr641(–1)-Pro642(0) bond in the pThr641(–1)-Pro642(0)-Pro643(+1) segment (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). We intentionally used a long mixing time (0.5 s) to enable the detection of slow processes. Yet, no evidence of significant rate enhancement was observed, suggesting that even upon addition of Pin1 the exchange rate between the isomers remains slower than 0.1 s<sup>–1</sup>.</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Pin1 does not appreciably catalyze isomerization of the turn motif in α and βII PKC isoenzymes due to presence of proline at the +1 position.</title><p>No exchange cross-peaks characteristic of Pin1-catalyzed pThr-Pro <italic>cis-trans</italic> isomerization are present in the spectra of turn motif (TM) regions from the PKC βII (<bold>A</bold>) and α (<bold>B</bold>) isoforms. This is demonstrated for both, isolated TM and the pV5 regions that harbor both HM and TM. Non-specific catalysis by Pin1 is evident in the appearance of exchange cross-peaks for the <sup>1</sup>H<sub>N</sub> of Gln634 in <italic>cis</italic> and <italic>trans</italic> conformations of the Gln634-Pro635 segment (<bold>B</bold>). Replacement of Pro640 with Ala at the (+1) position of pTMα results in significant rate enhancement with the k<sub>EX</sub> value of 29.6 s<sup>–1</sup> (<bold>C</bold>). Thr at the (+1) position similarly enhances the rate of isomerization, as demonstrated for a short five-residue LpTPPD peptide common to the TM regions of α, βII, and γ PKCs (<bold>D</bold>). The reference spectra collected with same parameters in the absence of Pin1 are shown in blue. The concentration of the V5 region peptides was 1–2 mM, with Pin1 added at catalytic amounts of 50 μM. The mixing times for all spectra are 0.5 s. The NMR spectra show the expansion of the <sup>1</sup>H-<sup>1</sup>H amide region.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92884-fig2-v1.tif"/></fig><p>The lack of appreciable enhancement of the isomerization rate was similarly obtained for the pThr638(–1)-Pro639(0)-Pro640(+1) segment of the pTMα and pV5α regions (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). Of note, we were able to detect Pin1-catalyzed <italic>cis-trans</italic> isomerization of the peptidyl-prolyl bond between Gln634 and Pro635 in pTMα. This reaction was manifested by the appearance of cross-peaks between the amide <sup>1</sup>H<sub>N</sub> of Gln634 in the <italic>cis</italic> and <italic>trans</italic> conformations (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). Although Gln634-Pro635 is not a canonical Pin1 substrate, the catalytic action of Pin1 brings the reaction rate into a detectable range with k<sub>EX</sub> of ~1 s<sup>–1</sup>, where k<sub>EX</sub> is the sum of the forward and reverse kinetic rate constants of the isomerization reaction, k<sub>tc</sub> and k<sub>ct</sub>. The Gln634-Pro635 data serve as direct evidence that weak interactions of the TM region with the PPIase domain are sufficient for Pin1 to appreciably catalyze the <italic>cis-trans</italic> isomerization of the non-canonical Gln-Pro substrate but not the pThr-Pro segment of the TM. For both PKC α and βII isoforms, the HM has no detectable effect on Pin1 catalytic activity against these substrates.</p></sec><sec id="s2-3"><title>The proline residue at the +1 position prohibits Pin1-mediated <italic>cis-trans</italic> isomerization of TM in α and βII PKC isoenzymes</title><p>We hypothesized that the proline at position +1 rendered the pTMα and pTMβII motifs poor substrates for PPIase-catalyzed isomerization. Thus, we generated the P640A variant of pTMα by replacing Pro at +1 position with Ala. Pin1-catalyzed isomerization of the pThr638-Pro639 bond in the P640A variant is readily detectable as reported by the appearance of distinct cross-peaks between the <italic>cis</italic> and <italic>trans</italic> conformers (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). The k<sub>EX</sub> value of 29.6 s<sup>–1</sup> obtained from the time dependence of the cross-peak intensities (see “<sup>1</sup>H-<sup>1</sup>H exchange spectroscopy” in the Methods section) is typical for the Pin1 substrates. Similarly, replacement of Pro at the (+1) position with Thr in the short LpTPPD peptide common to the TM regions of α, βII, and γ PKC isoforms also resulted in significant enhancement of the <italic>cis-trans</italic> isomerization rate (k<sub>EX</sub> value of 46.2 s<sup>–1</sup>; <xref ref-type="fig" rid="fig2">Figure 2D</xref>). We conclude that Pro at the (+1) position of TMs is incompatible with these motifs serving as efficient substrates for isomerization by Pin1.</p><p>Our collective data further suggest that, contrary to prevailing models, Pin1 does not control downregulation of PKCα and βII isoforms by catalyzing isomerization of the PKC tail. Rather, Pin1 does so via a non-catalytic mechanism. The novelty of our findings prompted us to more thoroughly investigate the biophysical and structural basis of Pin1 interactions with the C-terminal domains of α and βII PKC isoforms. We focused on three aspects: (i) identifying the role of the HM, (ii) defining the binding mode, and (iii) establishing the effect of the C-terminal domain phosphorylation state on interactions with Pin1. To those ends, we conducted a total of 19 NMR-detected binding experiments between Pin1 and the relevant regions of the C-term domains of PKC α and βII isoforms with different phosphorylation states (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). All information regarding the notations, sequences, and affinities is given in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>. The Pin1 domains are identified with the subscript ‘iso’ and ‘Pin1’ in their isolated forms and full-length Pin1 contexts, respectively.</p></sec><sec id="s2-4"><title>HM of PKC binds to Pin1 via two independent sites</title><p>The HM (PKC α/βII) sequence FEGFpSF/Y does not fit the canonical definition of a Pin1 substrate, and its role in the PKC-Pin1 interactions is unknown. Addition of the phosphorylated HM regions, pHMα and pHMβII, to [U-<sup>15</sup>N] full-length Pin1 resulted in large CSPs of the amide N-H<sub>N</sub> cross-peaks for many Pin1 residues, thereby providing direct and site-specific evidence for the Pin1-HM interactions (<xref ref-type="fig" rid="fig3">Figure 3A</xref> and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A and B</xref>). We were surprised to find that residues in both Pin1 domains were significantly affected, suggesting the existence of more than one pHM binding site in Pin1 (<xref ref-type="fig" rid="fig3">Figure 3A</xref> and <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2A</xref>). To identify which Pin1 domain harbors the HM binding site(s), we titrated isolated [U-<sup>15</sup>N] WW and PPIase domains with pHMβII and α (<xref ref-type="fig" rid="fig3">Figure 3B</xref> and <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2B</xref>). The CSP patterns of full-length Pin1 and the sum of isolated domains are essentially identical. These data indicate that Pin1 contains two sites that bind the phosphorylated HM: one residing in the WW domain and the other in the PPIase domain (<xref ref-type="fig" rid="fig3">Figure 3A and B</xref> and <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Hydrophobic motif interacts with Pin1 via two independent sites.</title><p>Comparison of the chemical shift perturbation (CSP) plots obtained at maximum concentrations of pHMβII versus ligand-free proteins for (<bold>A</bold>) full-length Pin1 and (<bold>B</bold>) isolated WW and PPIase domains. The similarity of the CSP patterns in (<bold>A</bold>) and (<bold>B</bold>) indicates that pHM has two independent binding sites in Pin1, one per domain. (<bold>C</bold>) Expansion of the <sup>15</sup>N-<sup>1</sup>H chemical shift correlation spectra of Trp34 in the WW domain and Ser115 in the PPIase domain showing the fast-exchange regime of pHM binding. Full spectra are given in <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>. (<bold>D</bold>) Representative pHMβII (purple) and pHMα (black) binding curves for the Pin1 residues that belong to the WW and PPIase domains. Solid lines are the global fits to a model with two independent binding sites. (<bold>E</bold>) The unphosphorylated turn motif (TM) region upstream of the hydrophobic motif (HM) has no influence on the HM interaction mode with Pin1. Experimental conditions for all α and βII experiments are given in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>, experimental IDs # 5–10, 12, and 13.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92884-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>NMR-detected binding of hydrophobic motifs from PKCβII (<bold>A</bold>, pHMβII) and α (<bold>B</bold>, pHMα) to full-length Pin1.</title><p>The protein concentration was 100 μM, and the pHM concentration varied from 0 mM to 1.35 mM (pHMβII), and from 0 mM to 1.8 mM (pHMα). Most of the affected N-H<sub>N</sub> resonances are in fast exchange on the NMR chemical shift timescale (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>, binding experiments #7 and #10).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92884-fig3-figsupp1-v1.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>Pin1 binds hydrophobic motif of PKCα (pHMα) via two independent sites.</title><p>Comparison of the chemical shift perturbation (CSP) plots obtained at maximum concentrations of pHMα used in binding experiments versus ligand-free proteins for (<bold>A</bold>) full-length Pin1 and (<bold>B</bold>) isolated WW and PPIase domains. The similarity of the CSP patterns in (<bold>A</bold>) and (<bold>B</bold>) indicates that Pin1 has two pHM binding sites, one per domain. The protein concentration was 100 μM. Other details are given in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref> for the binding experiments #5, 6, and 7.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92884-fig3-figsupp2-v1.tif"/></fig></fig-group><p>The fast-exchange regime of pHM binding to Pin1 (<xref ref-type="fig" rid="fig3">Figure 3C</xref>) enabled us to construct the binding curves for all responsive residues and fit them globally using the two-site binding model (“Construction and analysis of the chemical shift-based binding curves” in the Methods section). The fitting produced domain-specific K<sub>d</sub> values within full-length Pin1 (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). The pHMα motif has comparable affinities to both domains (725 μM to WW<sub>Pin1</sub> and 701 μM to PPIase<sub>Pin1</sub>, <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>), whereas the pHMβII motif has a 3.5-fold greater affinity for PPIase<sub>Pin1</sub> than it does for WW<sub>Pin1</sub> (K<sub>d</sub> values of 75 μM and 257 μM, respectively; <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>). To determine if the presence of the upstream unphosphorylated TM influences pHM-Pin1 interactions, we tested the binding of the V5α-TM-pHM and V5βII-TM-pHM regions to full-length Pin1. The NMR spectra and the measured K<sub>d</sub> values are identical to those for the pHM regions only (<xref ref-type="fig" rid="fig3">Figure 3E</xref>). Thus, unphosphorylated TM has little effect on the HM interactions with Pin1. The collective data demonstrate that, despite not being a canonical substrate, the phosphorylated HM of PKC isoenzymes can interact with Pin1 via two independent binding sites that reside on the WW and PPIase domains, respectively.</p></sec><sec id="s2-5"><title>Pin1 engages in unidirectional high-affinity bivalent interactions with the PKC C-terminus</title><p>Both HM and TM are phosphorylated in mature PKC. Addition of the pV5βII and pV5α regions that harbor both phosphorylated motifs to full-length Pin1 produced large CSP values in both Pin1 domains (<xref ref-type="fig" rid="fig4">Figure 4A</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplements 1</xref> and <xref ref-type="fig" rid="fig4s2">2A</xref>). The CSP plot of full-length Pin1 complexed to pV5βII(α) matches the sum of the CSP plots obtained for the isolated WW domain complexed to pTMβII(α), and the isolated PPIase domain complexed to pHMβII(α) (<xref ref-type="fig" rid="fig4">Figure 4A and B</xref>; <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplements 1</xref> and <xref ref-type="fig" rid="fig4s2">2</xref>). These data provide unambiguous evidence that full-length Pin1 engages in bivalent interactions with the PKC C-terminal tail where WW binds the TM and PPIase binds the HM. The directionality of these interactions is imposed by the binding preferences of the TM. As the TM primarily interacts with the WW domain (<xref ref-type="fig" rid="fig1">Figure 1C</xref>), the only site available for HM binding resides on the PPIase domain. Neither motif is an isomerizable Pin1 substrate.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Unidirectional bivalent binding mode of the C-terminal PKCβII region to Pin1.</title><p>(<bold>A, B</bold>) Comparison of the chemical shift perturbation (CSP) plots of Pin1 obtained at maximum concentrations of pV5βII (<bold>A</bold>) and those of isolated domains, WW<sub>iso</sub> and PPIase<sub>iso</sub>, at maximum concentrations of pTMβII and pHMβII (<bold>B</bold>), respectively. The similarity of CSP patterns in (<bold>A</bold>) and (<bold>B</bold>) indicates that the C-term region of PKCβII binds to Pin1 in a unidirectional bivalent mode. (<bold>C</bold>) The turn motif (TM) and hydrophobic motif (HM) binding sites reside on the WW and PPIase domains, respectively. The protein concentration is 100 μM. Other details are given in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>, binding experiment IDs #9, 15, and 18. (<bold>D</bold>) K<sub>d</sub> values for the monovalent interactions of the HM and TM with isolated Pin1 domains and full-length Pin1 are contrasted with the K<sub>d</sub> value for the bivalent Pin1-pV5βII interactions. ~10-fold enhancement for the pTM binding to the WW domain and ~90-fold enhancement of the pHM binding to the PPIase domain are attributed to bivalency. The K<sub>d</sub> values used for this plot were obtained in the NMR-detected binding experiments. The K<sub>d</sub> value for pV5βII binding to the catalytically deficient C113S Pin1 variant (black bar, 3.4 μM) exceeds the wild-type value by ~2-fold.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92884-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>NMR-detected binding of the fully phosphorylated C-term regions pV5βII (<bold>A</bold>) and pV5α (<bold>B</bold>) to full-length Pin1.</title><p>The protein concentration was 100 μM, and the pV5 concentration varied from 0 μM to 375 μM in case of pV5βII, and from 0 μM to 1530 μM in case of pV5α. The binding kinetics is in the intermediate-to-fast (pV5βII) and fast (pV5α) exchange regimes (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>, binding experiments #14 and #15).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92884-fig4-figsupp1-v1.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>Unidirectional bivalent binding mode of the C-terminal PKCα region to Pin1.</title><p>Comparison of the chemical shift perturbation (CSP) plots of Pin1 obtained at maximum concentrations of pV5α (<bold>A</bold>) and those of isolated domains, WW<sub>iso</sub> and PPIase<sub>iso</sub>, at maximum concentrations of pTMα and pHMα (<bold>B</bold>), respectively. The similarity of CSP patterns in (<bold>A</bold>) and (<bold>B</bold>) indicates that the C-term region of PKCα binds to Pin1 in a unidirectional bivalent mode. The turn motif (TM) and hydrophobic motif (HM) binding sites reside on the WW and PPIase domains, respectively. The protein concentration was 100 μM. Other details are given in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>, binding experiments #4, 6, and 14.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92884-fig4-figsupp2-v1.tif"/></fig><fig id="fig4s3" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 3.</label><caption><title>The C-term region of PKCβII binds to the catalytically deficient C113S Pin1 variant.</title><p>(<bold>A</bold>) The C113S Pin1 spectrum (red) shows minimum chemical shift perturbations compared to that of the wild-type (WT) Pin1 (black). (<bold>B</bold>) The C-term region pV5βII binds to C113S Pin1, evidenced by the chemical shift changes upon addition of increasing amounts of pV5βII. The chemical exchange regime is identical to that observed for the WT Pin1 in <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>. The protein concentration was 100 μM, and the pV5βII concentration varies from 0 μM to 350 μM (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>, binding experiment ID #19).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92884-fig4-figsupp3-v1.tif"/></fig><fig id="fig4s4" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 4.</label><caption><title>Unidirectional bivalent binding mode of the C-terminal PKCβII region to C113S Pin1.</title><p>The chemical shift perturbation (CSP) plot was constructed using the chemical shifts of the apo and pV5βII-bound C113S Pin1. The similarity of CSP patterns between the pV5βII-complexed wild-type (<xref ref-type="fig" rid="fig4">Figure 4A</xref> of the main manuscript) and C113S Pin1 indicates that the binding mode of the PKCβII C-term region does not change as a result of the mutation. The protein concentration in the C113S Pin1 experiments was 100 μM and the maximum concentration of pV5βII was 350 μM (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>, binding experiment #19).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92884-fig4-figsupp4-v1.tif"/></fig><fig id="fig4s5" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 5.</label><caption><title>Thermodynamic benefits of bivalent of Pin1-C-term PKCα interactions.</title><p>K<sub>d</sub> values for the monovalent interactions of the hydrophobic and turn motifs with isolated Pin1 domains and full-length Pin1 are contrasted with the K<sub>d</sub> value for the bivalent Pin1-pV5α interactions. ~3-fold enhancement for the pTM binding to the WW domain and ~60-fold enhancement of the pHM binding to the PPIase domain are attributed to bivalency. The K<sub>d</sub> values used for this plot were obtained in the NMR-detected binding experiments #3, 4, 6, 7, and 14 (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92884-fig4-figsupp5-v1.tif"/></fig></fig-group><p>Since the Pin1-pV5βII interactions fall into the intermediate-to-fast binding regime, NMR lineshape analysis was applied to obtain the K<sub>d</sub> value of 1.5 μM (“Determination of binding affinities using lineshape analysis” in the Methods section, <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>). These interactions are only moderately affected by the C113S mutation that reduces Pin1 catalytic activity ~40-fold (<xref ref-type="bibr" rid="bib10">Behrsin et al., 2007</xref>). The catalytically deficient C113S Pin1 variant shows a clear bivalent interaction mode with pV5βII (<xref ref-type="fig" rid="fig4s3">Figure 4—figure supplements 3</xref> and <xref ref-type="fig" rid="fig4s4">4</xref>). Compared to the wild-type (WT) Pin1, C113S has only ~2-fold weaker affinity to pV5βII (K<sub>d</sub> value of 3.4 μM, <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>). The low micromolar K<sub>d</sub> values obtained for WT Pin1 and the C113S variant reflect the thermodynamic advantage that the bivalent interaction mode imparts on the interactions with the C-term tail.</p><p>We illustrate the thermodynamic effect of bivalency using the binding curves of two representative residues (Ser115 and Phe125) in three distinct system compositions (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). The affinity of monovalent PPIase-pHMβII interactions does not appreciably depend on whether pTMβII is pre-bound to the WW domain: the corresponding K<sub>d</sub> values are 133 μM and 117 μM, respectively (<xref ref-type="fig" rid="fig4">Figure 4C</xref>, <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>). Moreover, the K<sub>d</sub> values for the monovalent pHMβII-WW and pTMβII-PPIase interactions show little dependence on whether the isolated Pin1 domains or full-length Pin1 were used in the binding experiments (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). However, when both motifs are presented to full-length Pin1 on the same polypeptide chain, we observe an ~90-fold enhancement in affinity (K<sub>d</sub> = 1.5 μM). These general findings hold for the Pin1-pV5α interactions (<xref ref-type="fig" rid="fig4s5">Figure 4—figure supplement 5</xref>). In aggregate, these data provide a thermodynamic view of bivalent interactions between Pin1 and the C-term PKC tail, and attribute the respective ~10(3)-fold and ~90(60)-fold enhancements of pTMβII(α) and pHMβII(α) binding to Pin1 to bivalency.</p></sec><sec id="s2-6"><title>Phosphorylation of the conserved motifs determines the Pin1-C-term interaction mode</title><p>The action of phosphatases on the HM and TM generates monophosphorylated and dephosphorylated PKC species that are detected in Pin1 pull-down assays (<xref ref-type="bibr" rid="bib1">Abrahamsen et al., 2012</xref>). To establish how these C-term modifications affect the Pin1 binding mode, we examined the interactions of Pin1 with the α and βII C-term regions where either TM (V5-pTM-HM), HM (V5-TM-pHM), or neither (V5) were phosphorylated. Since clear spectroscopic signatures are available from our data on the PKC motif interactions with full-length Pin1 and its domains (<xref ref-type="fig" rid="fig1">Figures 1C</xref>, <xref ref-type="fig" rid="fig3">3A, B</xref>, <xref ref-type="fig" rid="fig4">4A ,B</xref>), they can be used to identify the interaction modes of different V5 species. We illustrate this point using two monophosphorylated regions of the βII isoforms bound to full-length Pin1 (<xref ref-type="fig" rid="fig5">Figure 5A–D</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Phosphorylation state of the conserved C-term motifs defines the C-term interaction mode with Pin1.</title><p>(<bold>A</bold>) Chemical shift perturbation (CSP) pattern of full-length Pin1 due to interactions with the monophosphorylated V5βII-pTM-HM region. The concentrations of Pin1 and V5βII-pTM-HM are 100 μM and 0.46 mM, respectively. (<bold>B</bold>) Chemical shift correlation plots between the Pin1::pV5βII and Pin1::V5βII-pTM-HM complexes, plotted separately for the WW (green) and the PPIase (blue) domains. pTM interacts exclusively with the WW domain and thereby imposes a unidirectional bivalent mode. The differences in the PPIase CSPs are due to the differences in the HM phosphorylation state between pV5βII and V5βII-pTM-HM. (<bold>C</bold>) CSP pattern of full-length Pin1 due to interactions with the monophosphorylated V5βII-TM-pHM region. The concentrations of Pin1 and V5βII-TM-pHM are 100 μM and 1.64 mM, respectively. (<bold>D</bold>) Chemical shift correlation plots between the Pin1::pHMβII and Pin1::V5βII-TM-pHM complexes, plotted separately for the WW (green) and the PPIase (blue) domains. High similarity of chemical shifts indicates that pHMβII and V5βII-TM-pHM binding modes are identical. (<bold>E–H</bold>) CSPs of full-length Pin1 due to interactions with the C-term PKC regions mapped onto the extended NMR structure of apo Pin1 (1nmv). The similarity of the Pin1 CSP patterns due to α and βII C-term binding suggest similar Pin1 interaction modes with PKCβII and PKCα isoforms. Phosphorylation of TM imposes a unidirectional bivalent mode irrespective of the phosphorylation state of the HM (<bold>E, F</bold>). Phosphorylation of HM directs HM to its binding sites on the WW and PPIase domains but does not impose a bivalent interaction mode (<bold>G</bold>). (<bold>H</bold>) Pin1 interactions with unphosphorylated C-term are only detectable for the C-term of PKCβII. (<bold>I</bold>) Dissociation constants of the Pin1::C-term(βII) complexes illustrating the enhancement of binding affinity due to phosphorylation. The data for the V5-TM-pHM binding to WW and PPIase are color-coded green and blue, respectively. The protein concentration is 100 μM. Other details are given in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>, binding experiment IDs #11, 13, 15, and 16. (<bold>J</bold>) 2D [<sup>15</sup>N-<sup>1</sup>H] heteronuclear single-quantum coherence (HSQC) spectra of the arginine sidechains in apo Pin1 (black) and Pin1::pV5βII complex (maroon). Cross-peaks that are exchanged-broadened in apo Pin1 but reappear upon pV5βII binding belong to the Arg residues in the phosphate binding sites of WW (green) and PPIase (blue). TM, turn motif; HM, hydrophobic motif.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92884-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Pin1 chemical shift perturbation (CSP) plots of Pin1 obtained at maximum concentrations of V5βII-TM-HM (<bold>A</bold>), V5α-pTM-HM (<bold>B</bold>), V5α-TM-pHM (<bold>C</bold>), and V5α-TM-HM (<bold>D</bold>).</title><p>The protein concentration was 100 μM. Other details are given in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>. TM, turn motif; HM, hydrophobic motif.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92884-fig5-figsupp1-v1.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 2.</label><caption><title>Representative inter-molecular <sup>1</sup>H-<sup>1</sup>H NOEs between the pTM-WW<sub>Pin1</sub> (<bold>A</bold>) and pHM-PPIase<sub>Pin1</sub> (<bold>B</bold>).</title><p>The assignment labels are color-coded according to the Pin1 domain/C-terminal PKCβII region. (<bold>C</bold>) NMR ensemble of the Pin1::pV5βII complex (PDB ID 8SG2) reveals a novel Pin1 substrate-binding mode. 20 lowest-energy structures of the Pin1::pV5βII ensemble superimposed using either the PPIase domain (left panel) or WW domain (right panel).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92884-fig5-figsupp2-v1.tif"/></fig></fig-group><p>The V5-pTM-HM binding to the full-length Pin1 produced a CSP pattern in the WW domain that is identical to that of the isolated pTM (compare <xref ref-type="fig" rid="fig5">Figures 5A</xref> and <xref ref-type="fig" rid="fig1">1B</xref>) and to that of the pV5βII region (<xref ref-type="fig" rid="fig5">Figure 5B</xref>, WW<sub>Pin1</sub> correlation plot). Since pTM binding to WW<sub>Pin1</sub> does not cause any CSPs in PPIase<sub>Pin1</sub> (<xref ref-type="fig" rid="fig1">Figure 1C</xref>), the CSPs in the PPIase<sub>Pin1</sub> upon V5-pTM-HM binding could only be caused by the interactions with the unphosphorylated HM. The PPIase<sub>Pin1</sub> chemical shift correlation plot of <xref ref-type="fig" rid="fig5">Figure 5B</xref> reflects the influence of the HM phosphate group on the backbone chemical shifts of the isomerase domain. In conclusion, phosphorylated TM imposes a unidirectional bivalent binding mode by employing its high-affinity interaction with WW<sub>Pin1</sub> to direct the unphosphorylated HM to the binding site on PPIase<sub>Pin1</sub>.</p><p>The C-term region monophosphorylated at HM (V5-TM-pHM) produced a CSP pattern (<xref ref-type="fig" rid="fig5">Figure 5C</xref>) that is essentially identical to that of the isolated pHM binding to full-length Pin1. This is illustrated by the chemical shift correlation plots constructed for WW<sub>Pin1</sub> and PPIase<sub>Pin1</sub> (<xref ref-type="fig" rid="fig5">Figure 5D</xref>). Since the unphosphorylated TM does not appreciably interact with WW<sub>Pin1</sub>, it is unable to impose the unidirectional bivalent binding mode, and the phosphorylated HM is free to occupy both the WW- and PPIase-localized binding sites. We conclude that for the V5-TM-pHM region, the mode of interaction with Pin1 is monovalent and lacks directionality.</p><p>Using these types of analysis, we identified the binding modes of the V5 regions of α and βII isoforms (<xref ref-type="fig" rid="fig5">Figure 5E–H</xref>). The chemical shift data (<xref ref-type="fig" rid="fig5">Figure 5A and C</xref>; <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>) are mapped onto the extended conformation of Pin1 and the binding modes are illustrated with cartoon representations. Of note, the unphosphorylated C-term region interacts with Pin1 weakly. The CSPs are extremely small for the α isoform but are sufficiently large for βII to arrive at a K<sub>d</sub> value of ~960 μM (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>). Based on our data, we conclude that the phosphorylation status of TM determines the valency of the Pin1-PKC C-term interaction mode.</p><p>The K<sub>d</sub> values determined for all C-term regions enabled us to estimate the thermodynamic gain associated with the phosphorylation of TM and HM in the context of bivalent interactions (<xref ref-type="fig" rid="fig5">Figure 5I</xref> and <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>). The affinity enhancement due to the TM phosphate is 62-fold, which corresponds to ΔΔG°<sub>pTM</sub> of –2.4 kcal/mol. The affinity enhancement due to the HM phosphate is 14-fold, which corresponds to ΔΔG°<sub>pHM</sub> of –1.6 kcal/mol. Both ΔΔG° values are within the range reported for the formation of the phosphate-mediated salt bridges in proteins (<xref ref-type="bibr" rid="bib25">Errington and Doig, 2005</xref>). Summing up the contributions from the two phosphate groups produces the overall ΔΔG° of –4.0 kcal/mol, or ~900-fold enhancement of the Pin1 affinity to the phosphorylated C-term of PKCβII.</p><p>The phosphate groups occupy the canonical phosphate binding sites of the Pin1 domains. We reach this conclusion by comparing the <sup>15</sup>N-<sup>1</sup>H HSQC spectra of Arg sidechains in the apo and pV5βII-complexed Pin1 (<xref ref-type="fig" rid="fig5">Figure 5J</xref>). Based on the structural data obtained previously for monovalent substrates (<xref ref-type="bibr" rid="bib85">Verdecia et al., 2000</xref>; <xref ref-type="bibr" rid="bib35">Hu et al., 2017</xref>), Arg17<sub>WW</sub> and the Arg68-Arg69<sub>PPIase</sub> motif of the PPIase catalytic loop form salt bridges with the phosphate groups. While these three residues are exchange-broadened in apo Pin1 due to dynamics, their cross-peaks reappear upon pV5βII binding – consistent with their direct interactions with these phosphate groups (<xref ref-type="fig" rid="fig5">Figure 5J</xref>). To describe the bivalent interaction mode and identify the role of individual PKC and Pin1 residues, we determined the high-resolution structure of the complex.</p></sec><sec id="s2-7"><title>Structural basis of the Pin1-PKCβII C-term bivalent recognition mode</title><p>While both α and βII isoforms show similar bivalency patterns in their Pin1 interaction modes (<xref ref-type="fig" rid="fig5">Figure 5A–D</xref>), the 8-fold higher binding affinity of pV5βII to Pin1 informed the choice of the Pin1-pV5βII complex for structural work. Since exhaustive screening of crystallization conditions failed to yield crystals suitable for X-ray diffraction, we pursued a solution NMR-based approach. The NMR structural ensemble of the Pin1-pV5βII complex was calculated with CYANA using <sup>1</sup>H-<sup>1</sup>H NOEs (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2A and B</xref>), hydrogen bond, and torsional angle restraints, and refined in explicit solvent using XPLOR-NIH (“NMR structure calculation and refinement” in the Methods section). The Pin1-pV5βII interface is defined by 75 inter-molecular NOEs whose assignment required the use of specifically labeled amino acids incorporated into the peptide substrate; a total of nine different Pin1 complexes were prepared to ensure sufficient data redundancy (<xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>). The overall ensemble has a backbone and all-heavy-atom RMSDs of 0.9 Å and 1.2 Å for the ordered regions, respectively (<xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref> and <xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2C</xref>). Of note, the linker region connecting the two domains retains its flexibility in the complex and confers some variability onto the relative position of the WW and PPIase domains, as is evident from the ensemble representation of <xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2C</xref>.</p><p>The complex exhibits novel structural features that distinguish it from all other structures of Pin1 complexes known to date. These features are highlighted in <xref ref-type="fig" rid="fig6">Figure 6</xref> using the lowest-energy structure of the ensemble. First, the Pin1 substrate-binding mode is unusual in that pV5βII traverses the entire protein and interacts with both domains in a bivalent arrangement. The terminal pV5βII anchoring points are the two phosphorylated motifs, the pSer660 of the HM that binds to the PPIase domain and the pThr641 of the TM that binds to the WW domain (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). In addition, the pV5βII region in between the two phosphorylated motifs forms an extensive network of interactions with both WW and PPIase domains (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplements 1</xref> and <xref ref-type="fig" rid="fig6s2">2</xref>). The second noteworthy aspect of the structure is the extensive conformational change that Pin1 undergoes upon pV5βII binding. The WW and PPIase domains are brought into proximity primarily via interactions with the N-terminal pV5βII region. This compact conformation of pV5βII-complexed Pin1 is distinct from the ‘closed’ conformation observed in available crystal structures of monovalent Pin1 complexes (<xref ref-type="fig" rid="fig6">Figure 6B</xref>). The major differences are: (i) the ~70° rotation of the WW domain relative to the PPIase module; and (ii) the repositioning of the α4 helix and the α4-β2 loop of the PPIase domain to accommodate pV5βII. The linker region connecting the WW and PPIase domains retains its flexibility and is not involved in pV5βII interactions.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Structure of the Pin1::pV5βII complex reveals the bivalent recognition mode.</title><p>(<bold>A</bold>) The lowest-energy NMR structure showing the pV5βII backbone (tan) forms an extensive binding interface with the WW (green) and PPIase (blue) domains of the full-length Pin1. pV5βII is broken into four segments, S1-S4, to facilitate the structural analysis. The phosphorylated Ser of the hydrophobic motif (HM) and Thr of the turn motif (TM) are shown in van der Waals representation. (<bold>B</bold>) Overlay of the crystal structure of the Pin1-AlaPro complex (1pin) and the NMR structure of the Pin1-pV5βII complex (8SG2, this work), illustrating the 70° rotation of the WW domain, along with the displacement of the α4 helix and the α4-β2 loop. (<bold>C</bold>) The ‘pTM anchor’ segment is positioned at the interface between WW and PPIase domains. The phosphate group of pThr641 forms a salt bridge with Arg17. (<bold>D</bold>) The ‘turn’ segment is stabilized by intramolecular hydrogen bonds and is wedged between the WW and PPIase domains. (<bold>E</bold>) The ‘groove’ segment is threaded between the α4 helix and the β3-β4 hairpin of PPIase. (<bold>F</bold>) The ‘pHM anchor’ segment occupies the catalytic site of the PPIase domain. Residues forming the site are color-coded according to amphiphilicity. The phosphate group of pSer660 forms salt bridges with the Arg68 and Arg69 residues of the catalytic loop. Hydrogen bonds and salt bridges are shown with black dashed lines.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92884-fig6-v1.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>2D LigPlot<sup>+</sup> diagram of representative Pin1 interactions with residues 639–650 (‘pTM anchor’ and ‘turn’) of pV5βII.</title><p>The lowest-energy structure of the Pin1::pV5βII complex was used to generate the diagram. The contact cutoff for hydrophobic contacts is 4.0 Å. The turn motif is highlighted in yellow.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92884-fig6-figsupp1-v1.tif"/></fig><fig id="fig6s2" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 2.</label><caption><title>2D LigPlot<sup>+</sup> diagram of representative Pin1 interactions with residues 651–661 (‘groove’ and ‘pHM anchor’ segments) of pV5βII.</title><p>The lowest-energy structure of the Pin1::pV5βII complex was used to generate the diagram. The contact cutoff for hydrophobic contacts is 4.0 Å. The hydrophobic motif is highlighted in gray.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92884-fig6-figsupp2-v1.tif"/></fig><fig id="fig6s3" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 3.</label><caption><title>The C-terminal tail in the structure of the PKCβII catalytic domain (PDB ID 2I0E).</title><p>(<bold>A</bold>) The C-terminal V5 domain (cyan) has elevated B-factors and peripherally interacts with the N-lobe of the catalytic domain (gray). (<bold>B</bold>) The intra-V5 R649-D646 salt bridge and the Q653(N-H<sub>N</sub>)-(O=C)I651 H-bond that are also present in the Pin1-bound pV5βII are labeled. The S1-S4 segment notation that we used to analyze the Pin1::pV5βII complex is shown in the context of the catalytic domain structure.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92884-fig6-figsupp3-v1.tif"/></fig><fig id="fig6s4" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 4.</label><caption><title>The C-terminal part of pV5βII is threaded through the PPIase groove.</title><p>Space-filling representation showing the threading of pV5βII through the PPIase domain and its anchoring by the phosphate group of pS660. The ‘turn’ segment is shown in licorice representation. The figures were prepared using the lowest-energy Pin1::pV5βII structure.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92884-fig6-figsupp4-v1.tif"/></fig><fig id="fig6s5" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 5.</label><caption><title>Comparison of the binding poses between the D-peptide, a potent unnatural peptide inhibitor of Pin1, and the ‘pHM anchor’ segment of pV5βII.</title><p>Crystal structure of the monovalent Pin1::D-peptide complex (<bold>A</bold>) and the lowest-energy NMR structure of the bivalent Pin1::pV5βII complex (<bold>B</bold>). The phosphate group interacting with the catalytic loop is highlighted with a green circle. (<bold>C</bold>) The binding poses of the ‘pHM anchor’ (dark yellow) and the D-peptide (cyan) in the catalytic site of Pin1. The Gln sidechain of the D-peptide occupies the space that is taken up by the Pin1 Gln131 sidechain in the Pin1::pV5βII complex.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92884-fig6-figsupp5-v1.tif"/></fig></fig-group></sec><sec id="s2-8"><title>Interface of the pTM anchor and turn regions of PKCβII C-term with Pin1</title><p>To facilitate structural analysis of the Pin1-pV5βII interface, we separated pV5βII into four segments: the ‘pTM anchor’ (639–643, S1), the ‘turn’ (644–650, S2), the ‘groove’ (651–655, S3), and the ‘pHM anchor’ (656–661, S4) (<xref ref-type="fig" rid="fig6">Figure 6A</xref>, <xref ref-type="video" rid="video1">Video 1</xref>). The five-residue ‘pTM anchor’ harboring the pThr641-Pro642-Pro643 segment is positioned at the interface between the WW and PPIase domains (<xref ref-type="fig" rid="fig6">Figure 6C</xref>). Its backbone runs almost parallel to the α1 helix of the PPIase domain. The key interactions are the salt bridge between the Thr641 phosphate and guanidinium groups of Arg17<sub>WW</sub>, and the hydrophobic contacts of the pThr641 methyl group and Pro642 pyrrolidine ring with the sidechains of Trp34<sub>WW</sub>, Asn90<sub>PPIase</sub>, Ile93<sub>PPIase</sub>, and Gln94<sub>PPIase</sub>. In addition, the NHε group of the Trp34<sub>WW</sub> forms a hydrogen bond with the carbonyl oxygen of pThr641. These interactions are present in 65–100% of the Pin1-pV5βII ensemble structures.</p><media mimetype="video" mime-subtype="mp4" xlink:href="elife-92884-video1.mp4" id="video1"><label>Video 1.</label><caption><title>Visualization of the lowest energy structure of the Pin1::pV5βII NMR ensemble.</title></caption></media><p>The Pro643-Asp644 segment reorients the backbone such that it runs along the β1 strand of the WW domain. This marks the beginning of the seven-residue ‘turn’ segment (<xref ref-type="fig" rid="fig6">Figure 6D</xref>) that completes the inter-domain arm of pV5βII and is responsible for the realignment of the PPIase-WW domain interface. Prior structural work on Pin1 identified residues 137–141<sub>PPIase</sub>, 148–149<sub>PPIase</sub>, and 28–32<sub>WW</sub> as being involved in the dynamic inter-domain interface (<xref ref-type="bibr" rid="bib11">Born et al., 2019</xref>; <xref ref-type="bibr" rid="bib92">Wilson et al., 2013</xref>). In the Pin1-pV5βII complex, many residues from this subset are now engaged in interactions with ‘turn’ segment pV5βII (<xref ref-type="fig" rid="fig6">Figure 6D</xref> and <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>). The turn itself is stabilized by intra-pV5βII hydrogen bonds and salt bridges. Arg649 plays a particularly prominent role in that regard as it participates in both types of interactions. The intra-molecular salt bridge formed by the Arg649 and Glu646 sidechains (present in 75% of the ensemble structures) is unique to the βII isoform (<xref ref-type="fig" rid="fig6s3">Figure 6—figure supplement 3</xref>) because these Arg and Glu residues are replaced by hydrophobic Leu and Ala/Met residues in other conventional PKC isoforms (<xref ref-type="fig" rid="fig6">Figure 6D</xref> and <xref ref-type="fig" rid="fig1">Figure 1A</xref>). The contributions of Arg sidechain-mediated interactions are likely responsible for the higher affinity of pV5βII for Pin1 relative to the affinity of pV5α.</p></sec><sec id="s2-9"><title>Interface of the groove and pHM anchor regions of PKCβII C-term with Pin1</title><p>The turn is followed by the five-residue pV5βII ‘groove’ segment that is rich in polar residues and interacts exclusively with the PPIase domain. The groove segment threads through a deep groove in the Pin1 PPIase domain formed by helix α4 and the β-sheet comprised of strands β3, β4, and β1 (<xref ref-type="fig" rid="fig6">Figure 6E</xref> and <xref ref-type="fig" rid="fig6s4">Figure 6—figure supplement 4</xref>). This configuration drives the repositioning of helix α4 and the α4-β2 loop relative to the structures of Pin1 complexed to the monovalent substrate (<xref ref-type="fig" rid="fig6">Figure 6B</xref>). The Pin1-pV5βII interface involves hydrophobic contacts, present in all 20 ensemble structures, of the only hydrophobic residue of this pV5βII segment (Ile651) with Pin1 residues Leu141<sub>PPIase</sub>, Ile159<sub>PPIase</sub>, and the Arg161<sub>PPIase</sub> methylenes. Among polar residues, pV5βII residues Ser654 and Glu655 are within H-bonding distance with the three Pin1 residues of the conserved parvulin tetrad (<xref ref-type="bibr" rid="bib89">Wang et al., 2015b</xref>; <xref ref-type="bibr" rid="bib60">Mueller et al., 2011</xref>; <xref ref-type="bibr" rid="bib9">Barman and Hamelberg, 2014</xref>): His59<sub>PPIase</sub> and His157<sub>PPIase</sub>, and Thr152<sub>PPIase</sub>, respectively (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2</xref>).</p><p>The last segment of pV5βII (the ‘pHM anchor’) emerges from the PPIase groove and occupies the catalytic site. This ‘anchor’ segment contains the entire PKCβII HM whose key residues (Phe656, Phe659, and pSer660) interact with the amphiphilic environment of the Pin1 catalytic site (<xref ref-type="fig" rid="fig6">Figure 6F</xref>). Specifically, the sidechains of Phe656 and Phe659 are accommodated by the hydrophobic environment formed by Met130<sub>PPIase</sub>, Phe125<sub>PPIase</sub>, and Leu122<sub>PPIase</sub>. The Phe659 aromatic ring can potentially engage in stacking interactions with His59<sub>PPIase</sub>. The pSer660 phosphate is anchored to the Pin1 catalytic loop via salt bridges with a triad of positively charged residues (Arg68<sub>PPIase</sub>, Arg69<sub>PPIase</sub>, and Lys63<sub>PPIase</sub>). Those interactions, present in all 20 ensemble structures, rigidify the loop as is evident from the reappearance of Arg68<sub>PPIase</sub> and Arg69 <sub>PPIase</sub> resonances in the NMR spectra upon complex formation (<xref ref-type="fig" rid="fig5">Figure 5J</xref>). Phe661, the third Phe of the HM, is not involved in any persistent interactions with the Pin1 PPIase module.</p><p>We then compared the binding poses of pHM with that of the D-peptide – a potent unnatural peptide inhibitor of Pin1 that binds specifically to the catalytic site of the PPIase domain (<xref ref-type="bibr" rid="bib99">Zhang et al., 2007</xref>; <xref ref-type="fig" rid="fig6s5">Figure 6—figure supplement 5A and B</xref>). Structural overlay of the complexes shows that pHM and the D-peptide occupy the same PPIase region, and the positions of the ligand phosphate groups coincide (<xref ref-type="fig" rid="fig6s5">Figure 6—figure supplement 5C</xref>). Notable differences include the arrangement of the ligand hydrophobic ring moieties in the catalytic site, and the position of the Gln131<sub>PPIase</sub> sidechain relative to the ligand. Specifically, the space occupied by the Gln131<sub>PPIase</sub> sidechain in the Pin1::pV5βII complex is occupied by the Gln5 sidechain of the D-peptide in the Pin1::D-peptide complex (<xref ref-type="fig" rid="fig6s5">Figure 6—figure supplement 5C</xref>). Gln131 is the C-terminal residue of the α4 helix that undergoes the most significant rearrangement upon the formation of the bivalent Pin1::pV5βII complex (<xref ref-type="fig" rid="fig6">Figure 6B</xref>).</p></sec><sec id="s2-10"><title>Pin1 null HEK293T cells exhibit elevated steady-state levels of PKCα</title><p>The structural data revealed: (i) a bivalent mode of Pin1 interactions with the C-term tail of PKCβII, (ii) that the phosphate groups occupy the canonical binding sites of the Pin1 WW and PPIase domains, and (iii) that the intervening residues can form an extensive network of interactions with the residues of both Pin1 domains. Moreover, the similarities of the NMR CSP patterns between pV5βII and pV5α binding to Pin1 report that the bivalent interaction mode is shared by both the α and βII PKC isoforms. To interrogate our biophysical and structural conclusions regarding Pin1 function in a cellular context, we developed a system for assessing Pin1-mediated PKCα regulation without the contribution of endogenous Pin1 activity in a HEK293T cell model. HEK293T cells were chosen because these cells are efficiently transfected and therefore broadly used in such experiments. PKCα was chosen for these analyses because we were able to detect endogenous PKCα by immunoblotting in HEK293T cells, whereas PKCβII overexpression was required for detection in this cell line.</p><p>Previous studies reported Pin1 downregulates PKC levels in serum-starved cells stimulated with PDBu (<xref ref-type="bibr" rid="bib1">Abrahamsen et al., 2012</xref>). Consistent with this general concept, efficient (~80%) siRNA-mediated knockdown of Pin1 expression resulted in an ~45% elevation in steady-state PKCα levels in cells cultured in the presence of serum. That is, cells stimulated by natural agonists under more physiological conditions than those stimulated by exogenous agonist PDBu under serum starvation (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1A</xref>). This relationship was further corroborated by CRISPR screens that produced Pin1 null HEK293T cell lines (“Isolation of a clonally-derived Pin1 null cell line” in the Methods section; <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1B</xref>). Clonally derived cells recovered from the CRISPR challenge exhibited a wide range of Pin1 expression levels, and immunoblotting confirmed an inverse correlation between endogenous Pin1 and steady-state PKCα levels (<xref ref-type="fig" rid="fig7">Figure 7A</xref>; R=–0.92, p&lt;0.0005). The linearity of this relationship suggests Pin1 is a limiting component in downregulation of PKCα levels.</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Regulation of PKCα homeostasis by Pin1 in HEK293T cells.</title><p>(<bold>A</bold>) PKCα protein levels at steady-state are inversely proportional to Pin1 levels. HEK293T cells were transfected with CRISPR/Cas9 plasmids encoding Pin1 guide RNAs and clonal lines were generated. Lysates of the clonally derived cell lines were resolved by SDS-PAGE, transferred to nitrocellulose, and immunoblots developed to visualize PKCα, Pin1, and actin. Blot profiles are shown at top. Bottom panel relates steady-state PKCα protein levels to Pin1 steady-state levels. Actin was used to normalize the PKCα and Pin1 profiles for each cell line and the PKCα/actin ratio was set as 1.0 for parental wild-type (WT) Pin1 cells. Clone 3 (C3) expressed no detectable Pin1 antigen and was selected for further study. (<bold>B</bold>) Pin1 null HEK293T cells exhibit elevated steady-state PKCα protein levels when cells are incubated under serum-free (upper panel; 2.3 ± 0.2; n=7; p&lt;0.0001, two-tailed t-test) and serum-replete conditions (lower panel; 2.3 ± 0.3; n=12; p&lt;0.0002, two-tailed t-test). Actin was used to normalize the PKCα and Pin1 immunoblot profiles for each cell line and the PKCα/actin ratios were set as 1.0 for parental WT Pin1 cells. (<bold>C</bold>) PKCα regulation by Pin1 derivatives with defined biochemical defects. Left panels: At top are shown representative PKCα, Pin1, and actin immunoblot profiles for WT HEK293T cells, Pin1 KO cells (C3), and Pin1 KO cells stably expressing the indicated mutant Pin1 proteins defective in PKCα binding. At bottom are shown representative PKCα. Pin1 and actin immunoblot profiles for WT HEK293T cells, Pin1 KO cells (C3), and Pin1 KO cells stably expressing the ‘catalytic-dead’ Pin1<sup>C113S</sup> mutant. In both panels the asterisk denotes endogenous Pin1 as the ectopically expressed Pin1 proteins are 3.6 kDa larger in molecular mass due to the myc and DDK epitopes with which these are tagged at their C-termini (Pin1-TRTRPL<underline>EQKLISEEDL</underline>AANDILDYK<underline>DDDDK</underline>V). Right panel: Quantification of PKCα steady-state levels in Pin1 null cells (control) and Pin1 null cells reconstituted for expression of the indicated mutant Pin1 proteins as indicated at bottom. For quantification, actin was used to normalize the PKCα and Pin1 profiles for each cell line and the PKCα/actin ratios were set as 1.0 for control Pin1 KO cells. Data represent the averages of five independent biological replicates ± standard deviation. Values were related to Pin1 KO control using an unpaired two-tailed t-test (* p&lt;0.05; **p&lt;0.01). The uncropped immunoblots are provided as source data.</p><p><supplementary-material id="fig7sdata1"><label>Figure 7—source data 1.</label><caption><title>Original uncropped immunoblots for data in <xref ref-type="fig" rid="fig7">Figure 7A</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92884-fig7-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig7sdata2"><label>Figure 7—source data 2.</label><caption><title>Original uncropped immunoblots for data in <xref ref-type="fig" rid="fig7">Figure 7C</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92884-fig7-data2-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92884-fig7-v1.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 1.</label><caption><title>PKCα levels in cells with reduced Pin1 function.</title><p>(<bold>A</bold>) HEK293T cells were transfected with mock or Pin1 siRNA as indicated at top, incubated for 72 hr in serum-replete medium, and cell lysates were prepared and analyzed by immunoblotting. Immunoblot profiles for Pin1, PKCα, and actin are shown. Actin provides a normalizing signal. Pin1 knockdown (~90%) resulted in a significant elevation of PKCα levels. The uncropped immunoblots are provided as source data. (<bold>B</bold>) Diagram outlining the workflow for generating clonally derived Pin1 null HEK293T cells using CRISPR/Cas9. (<bold>C</bold>) At top is illustrated the Pin1 gene organization with codons present in each exon shown in parentheses. Domain organization of the Pin1 protein is shown at bottom. Middle panel shows the exon coding sequences for Pin1. The start and stop codons are highlighted (underlined, bold) as are the CRISPR/Cas9 targeting sequences in exon 2 (bold). Bottom panel shows the open reading frames of each of the three <italic>Pin1</italic> null alleles identified in clone C3. The natural start codon and the CRISPR/Cas9 targeting sequences in exon 2 are highlighted in bold. The short open reading frame extensions that lie downstream of each frameshift allele are underlined and the nonsense codons that terminate translation are indicated in bold. (<bold>D</bold>) The diameters (µm) of trypsinized wild-type or Pin1 KO HEK293T cells were determined using a Countess automated cell counter. 1-5 x10<sup>4</sup> cells were counted in each of 14 independent biological replicates and data are presented as average diameters ± standard deviation. Values were related to Pin1 WT control using an unpaired two-tailed t-test (no significant difference). (<bold>E</bold>) Cell areas (µm<sup>2</sup>) of trypsinized wild-type or Pin1 KO HEK293T cells were determined by flow cytometry. 1 x10<sup>4</sup> cells were analyzed in each of 3 independent biological replicates. Data are presented as average cell areas ± standard deviation. Values were related to Pin1 WT control using an unpaired two-tailed t-test (no significant difference). (<bold>F</bold>) Viabilities of trypsinized wild-type or Pin1 KO HEK293T cells were assessed by trypan blue staining coupled to imaging with a Countess automated cell counter. 1-5 x10<sup>4</sup> cells were counted in each of 10 independent biological replicates, data are expressed as average percentages of viable cells ± standard deviation, and values were related to Pin1 WT control using an unpaired two-tailed t-test (no significant difference). (<bold>G</bold>) Growth rates of wild-type and Pin1 KO HEK293T cells were followed in a 96 hr window with an initial count of 1×10<sup>5</sup> cells (n=3). Similar data showing no difference between wild-type and KO cell growth rates were also observed when the initial count was reduced to 5×10<sup>4</sup> cells (data not shown).</p><p><supplementary-material id="fig7s1sdata1"><label>Figure 7—figure supplement 1—source data 1.</label><caption><title>Original uncropped immunoblots for data in <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1A</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92884-fig7-figsupp1-data1-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92884-fig7-figsupp1-v1.tif"/></fig></fig-group><p>The CRISPR approach produced three HEK293T clones with little or no detectable Pin1 antigen, and those lines exhibited the highest steady-state levels of PKCα. Clone 3 represented a particularly attractive candidate for a Pin1 null cell line as it was devoid of detectable Pin1 antigen. This was confirmed by DNA sequencing. HEK293T cells carry four copies of the Pin1 gene (<xref ref-type="bibr" rid="bib46">Lin et al., 2014</xref>), and DNA sequence analyses indicated clone 3 harbored three frameshift alleles. All three alleles altered the targeted exon 2 that encodes the Pin1 PPIase domain and included: (i) a 5 bp deletion that interrupts the Pin1 amino acid sequence after Thr79, (ii) an 8 bp insertion that interrupted the Pin1 sequence after Arg80, and (iii) a 10 bp deletion that disrupts the Pin1 amino acid sequence after Lys77 (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1C</xref>). The resulting translation products were prematurely terminated after addition of another 22, 10, and 7 residues, respectively. Although PKCα steady-state levels were upregulated approximately 2-fold in clone 3 relative to parental WT HEK293T cells under both serum-free and serum-replete conditions (<xref ref-type="fig" rid="fig7">Figure 7B</xref>; 2.3 ± 0.2- and 2.3 ± 0.3-fold, respectively), the Pin1 null cells were not phenotypically perturbed. Their dimensions (diameter, surface area), viabilities, and proliferation rates were indistinguishable from those of the parental cells (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1D–G</xref>). Thus, the elevation in steady-state PKCα levels identified a baseline Pin1 loss-of-function phenotype.</p></sec><sec id="s2-11"><title>Differential effects of Pin1 mutant expression on PKCα homeostasis in cultured cells</title><p>To assess the effects of Pin1 mutants on steady-state PKCα expression without the contribution of endogenous Pin1 activity, stable transgenic cell lines individually expressing epitope-tagged versions of WT Pin1; substrate-binding mutants: Pin1<sup>W34A</sup>, Pin1<sup>R68A,R69A</sup>, Pin1<sup>W34A,R68A,R69A</sup>; or the catalytic-deficient Pin1<sup>C113S</sup> were derived from clone 3 cells. As shown in <xref ref-type="fig" rid="fig7">Figure 7C</xref> (top left panel), WT Pin1 and all three of the Pin1 substrate-binding mutants were overexpressed some 4- to 10-fold relative to endogenous Pin1 levels in these stable transgenic lines. Assessment of steady-state PKCα levels in the reconstituted cell lines showed that WT Pin1 expression significantly reduced PKCα steady-state levels relative to the Pin1 null condition (<xref ref-type="fig" rid="fig7">Figure 7C</xref>, right panel). By contrast, reconstituted expression of neither Pin1<sup>W34A</sup>, Pin1<sup>R68A,R69A</sup>, nor of Pin1<sup>W34A,R68A,R69A</sup> restored Pin1 function (<xref ref-type="fig" rid="fig7">Figure 7C</xref>, right panel). As expected, the differences in the triple mutant data in comparison to the Pin1 null mutant data were not statistically significant (p=0.07). However, even though the data did not reach a threshold of statistical significance, PKCα levels in the Pin1<sup>W34A,R68A,R69A</sup>-expressing cells were consistently higher than those in Pin1 null cells. One speculation is the triple mutant imposes dominant negative effects on some limiting factor in PKCα degradation that are revealed in the Pin1 null background. More work is required to resolve this issue.</p><p>Interestingly, we were unable to produce stable cell lines that overexpressed the Pin1<sup>C113S</sup> ‘catalytic-dead’ mutant to the same levels achieved for WT Pin1 and the three substrate-binding mutants. Reconstituted Pin1<sup>C113S</sup> expression was consistently elevated only some 3-fold relative to endogenous Pin1 levels (<xref ref-type="fig" rid="fig7">Figure 7C</xref>, bottom left panel). Yet, this relatively modest level of Pin1<sup>C113S</sup> expression was as effective as WT Pin1 expression in reducing steady-state PKCα levels in otherwise Pin1 null HEK293T cells (<xref ref-type="fig" rid="fig7">Figure 7C</xref>, right panel). These collective results support a physiologically relevant mechanism for Pin1-mediated regulation of PKCα that requires a bivalent interaction mode of Pin1 with PKCα, but operates independently of the Pin1 prolyl-isomerase catalytic activity.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>How Pin1 regulates the activities of its many cellular substrates is of intense interest in contemporary biomedical science. This interest follows not only from the fact that the many targets of Pin1 regulation themselves play important cellular functions, but also that dysregulation of the Pin1 activity underlies the principal basis for multiple pathological disorders in humans. Pin1 has been the focus of many previous studies and it is generally accepted that prolyl <italic>cis-trans</italic> isomerase activity is its obligate functional feature. Yet, our understanding of how Pin1 engages its various substrates and regulates their activities remains incomplete. In this work, we provide a comprehensive biophysical, structural, and cell biological description for how Pin1 recognizes/binds its PKCα and PKCβII substrates, and report the key features required for Pin1-mediated regulation of PKC degradation. Contrary to current dogma, we demonstrate a non-catalytic role for Pin1 in the regulation of PKC stability. We further show the underlying mechanism involves a bivalent interaction mode that has not been previously observed in any reported structures of Pin1 complexes. These discoveries not only expand the potential mechanisms by which Pin1 regulates the activities of its client substrates, but also hold interesting implications for the design of therapeutically effective Pin1 inhibitors.</p><sec id="s3-1"><title>Proline at position +1 disqualifies Ser/Thr-Pro Pin1 binding motifs as isomerizable substrates</title><p>Previous experimental data suggested that Pin1-binding motifs with Pro at position +1 are disfavored substrates because of their failure to bind the catalytic PPIase domain of Pin1 (<xref ref-type="bibr" rid="bib36">Innes et al., 2013</xref>). Our results provide direct experimental support for that conclusion, as both pTMα and pTMβII motifs bind with high affinities to the Pin1 WW domain but lack high-affinity interactions with the PPIase domain. In addition, EXSY experiments clearly show that Pin1 is unable to catalyze the <italic>cis-trans</italic> isomerization of the pThr-Pro motifs of PKCα and PKCβII. The unsuitability of these motifs as Pin1 substrates is due solely to the presence of Pro at the +1 position as evidenced by our demonstrations that replacement of this Pro residue restores their activities as substrates for isomerization by Pin1. Of note, the inability of Pin1 to catalyze <italic>cis-trans</italic> isomerization was previously observed for the pT<sup>231</sup>PP site in the Tau protein (<xref ref-type="bibr" rid="bib81">Smet et al., 2005</xref>; <xref ref-type="bibr" rid="bib23">Eichner et al., 2016</xref>). Interestingly, this observation prompted the speculation that Tau is not a genuine target for regulation by Pin1 – a speculation that our data indicate requires reconsideration (see below).</p><p>Why is Pro at position +1 incompatible with Pin1-catalyzed <italic>cis-trans</italic> isomerization of what is otherwise a signature substrate motif? Computational studies predict unfavorable overall binding free energies for Pin1 engagement with the transition state and the <italic>cis</italic>-conformations of the pTPP substrates (<xref ref-type="bibr" rid="bib57">Momin et al., 2018</xref>). A definitive answer as to why Pro(+1)-containing motifs are incompatible with Pin1 catalysis remains elusive as there is currently no consensus on the precise catalytic mechanism of Pin1. The most recent ‘twisted-amide’ catalysis model (<xref ref-type="bibr" rid="bib55">Mercedes-Camacho et al., 2013</xref>) envisions a transition state where distortion of the substrate is stabilized by the H-bond between the C=O of the substrate Pro at position (0) and the backbone -NH of Pin1 residue Gln131. As formation and stabilization of the transition state relies on a dynamic network of H-bonds involving conserved residues in the Pin1 active site (<xref ref-type="bibr" rid="bib60">Mueller et al., 2011</xref>; <xref ref-type="bibr" rid="bib9">Barman and Hamelberg, 2014</xref>; <xref ref-type="bibr" rid="bib94">Xu et al., 2014</xref>), Pro at position +1 might impose geometric constraints on the substrate where formation or stabilization of the amide twist is disfavored.</p><p>The demonstration that Pin1 S/TPP binding motifs are not isomerizable has interesting implications. A survey of AGC kinases reveals that these motifs are surprisingly common in this important class of enzymes. Moreover, as is the case for the PKC kinases, S/TPP motifs are present in the TM regions for both Akt and PKN kinases (<xref ref-type="fig" rid="fig8">Figure 8A</xref>). These arrangements suggest that Pin1 binding to non-isomerizable substrates through its WW domain defines an unappreciated, yet broadly deployed, regulatory strategy that operates independently of Pin1 <italic>cis-trans</italic> isomerase activity. This point is discussed in further detail below.</p><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>Non-catalytic role for Pin1.</title><p>(<bold>A</bold>) Non-isomerizable pSer/Thr-Pro-Pro turn motifs separated by &lt;25 residues from the hydrophobic motifs are present in the C-term tails of other AGC kinases, such as AKT and PKN. (<bold>B</bold>) A possible model for Pin1-mediated downregulation of PKCα and βII isoforms. In the compact autoinhibited state, the pseudosubstrate (PS) blocks the catalytic site of the kinase and the C-terminal tail is not accessible. PKC activation involves Ca<sup>2+</sup>-dependent recruitment to the membranes where the regulatory domains, C1 through C2, bind diacylglycerol (DAG), phosphatidylserine (PtdSer), and phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P<sub>2</sub>) and thereby trigger the release of autoinhibitory interactions. The activated open PKC conformation exposes the C-terminal V5 domain that is then engaged by Pin1 via bivalent binding to the phosphorylated turn motif (TM) and hydrophobic motif (HM). Pin1 might facilitate the recruitment of phosphatases to PKC by stabilizing the PKC open form. This promotes dephosphorylation of the C-term motifs and subsequent ubiquitination and degradation of the kinase.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92884-fig8-v1.tif"/></fig></sec><sec id="s3-2"><title>The Pin1-PKC interface is described by a novel bivalent interaction mode</title><p>Our NMR structure and NMR-detected binding experiments demonstrate that Pin1 interacts with the C-terminal tails of PKCα and PKCβII in a bivalent mode. To our knowledge, this is the first structure of the full-length Pin1 complexed to the substrate that engages both Pin1 domains. The Pin1 WW domain binds the TM, a canonical Pin1 pThr-Pro recognition motif, whereas the Pin1 PPIase domain engages the HM, a non-canonical substrate that lacks Pro after the pSer residue. The specificity of TM binding exhibited by the WW domain imposes a unidirectionality to the Pin1-PKC interaction by directing the HM to the PPIase domain. This bivalent binding mode results in Pin1 adopting a mostly compact conformation, with the ‘pTM anchor’ positioned at the interface between two Pin1 domains. Based on our structure, the linker length separating two phosphorylated Ser/Thr in bivalent Pin1 substrates is projected to be an important factor. In the PKCβII V5 domain, the phosphorylated TM and HM sites are separated by 18 amino acids. This length allows the simultaneous binding of the two sites by Pin1 without causing conformational strain on Pin1 itself. It is of interest to consider these results in light of what has been observed in the interaction of the yeast Pin1 homolog Ess1 with the RNA polymerase II C-terminal tail (<xref ref-type="bibr" rid="bib62">Namitz et al., 2021</xref>). The Ess1 linker that joins the WW and PPase domains is a rather rigid element, and CTD repeats exceeding 27 amino acid residues are required to separate the two phosphorylated Ess1-binding sites for bivalent interactions (<xref ref-type="bibr" rid="bib62">Namitz et al., 2021</xref>). By contrast, the cognate Pin1 linker is unstructured, and its flexibility might afford Pin1 the potential to interact with a broader range of substrates. Moreover, the retention of linker flexibility in the Pin1::pV5βII complex suggests that the complexed Pin1 can potentially adopt ‘extended’ states that would not be readily detectable by the ensemble-averaged methods such as solution NMR.</p><p>Bivalent interactions afford significant advantages to biologically relevant protein-protein interactions as these are capable of increasing binding affinity and specificity, and inducing the appropriate conformational rearrangements in binding partners (<xref ref-type="bibr" rid="bib53">Mammen et al., 1998</xref>; <xref ref-type="bibr" rid="bib24">Erlendsson and Teilum, 2020</xref>). It is in this manner that the two substrate-binding domains of Pin1 govern its ability to engage in bivalent binding interactions that enhance the binding affinity and specificity to multi-phosphorylated client proteins (<xref ref-type="bibr" rid="bib19">Daum et al., 2007</xref>; <xref ref-type="bibr" rid="bib74">Rogals et al., 2016</xref>). Several Pin1 substrates that contain neighboring canonical pSer/Thr-Pro motifs in their unstructured regions have been characterized: IRAK1 kinase (<xref ref-type="bibr" rid="bib74">Rogals et al., 2016</xref>), Cdc25c (<xref ref-type="bibr" rid="bib36">Innes et al., 2013</xref>), Tau (<xref ref-type="bibr" rid="bib23">Eichner et al., 2016</xref>), and STAT3 (<xref ref-type="bibr" rid="bib52">Lufei et al., 2007</xref>). Of those, the IRAK1-derived peptide was the only reported case of bivalent binding to Pin1 based on the NMR CSP data analysis, and this interaction involved two isomerizable pSer/Thr-Pro motifs (<xref ref-type="bibr" rid="bib74">Rogals et al., 2016</xref>). Our Pin1::pV5βII complex structure represents the first natural bivalent substrate-bound Pin1 structure. The two phosphate groups occupy the substrate-binding site of the WW and PPIase domains, and the intervening residues stabilize the domain interface and bring the two domains into proximity. The linker that connects the Pin1 WW and PPIase domains maintains its flexibility and does not participate in interactions with the PKCβII C-terminal tail. The structure of this complex provides a guide for interpreting the potential binding modes of other Pin1 substrates that contain multiple pSer/Thr-Pro and non-canonical Pin1 motifs. For example, cyclin E contains both canonical pThr<sup>380</sup>-Pro<sup>381</sup> and non-canonical pSer<sup>384</sup>-Gly<sup>385</sup> motifs (<xref ref-type="bibr" rid="bib96">Yeh et al., 2006</xref>). The pSer<sup>384</sup>-Gly<sup>385</sup> motif serves as an important determinant of cyclin E interactions with Pin1 and its Pin1-mediated downregulation.</p></sec><sec id="s3-3"><title>Pin1 regulates PKC levels via a non-canonical non-catalytic mechanism</title><p>With regard to Pin1-mediated regulation of PKC, we note the linear relationship between Pin1 and PKCα steady-state levels up to the point of physiological levels of Pin1 expression – as documented in analyses of the clones derived from the CRISPR screen (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). However, additional elevations in Pin1 expression did not result in further reductions in PKCα steady-state levels as evidenced by the Pin1 reconstitution experiments. Our interpretation of the data is that physiological expression of Pin1 in HEK293T cells is normally the limiting factor in the stimulated PKCα degradation pathway. When Pin1 is expressed in excess of physiological levels however, some other component of the PKCα degradation pathway becomes limiting in those contexts. It is posited that Pin1 isomerase activity promotes ubiquitination and subsequent degradation of conventional PKC enzymes (<xref ref-type="bibr" rid="bib1">Abrahamsen et al., 2012</xref>). This proposal rests on the observation that challenge of stimulated cells with a small molecule inhibitor of Pin1 abolishes agonist-induced ubiquitination of PKC. Interpretation of those data is neither ironclad, nor are those results inconsistent with our conclusions. It remains to be established that the inhibitor does not compromise the Pin1-PKC interaction. As described above, our collective biochemical and biophysical data suggest Pin1 downregulates PKC via a mechanism independent of its prolyl <italic>cis-trans</italic> isomerization activity. Pin1 reconstitution experiments provide direct support for this concept as expression of the ‘catalytic-dead’ Pin1<sup>C113S</sup> mutant rescues the Pin1 null condition in a HEK293T cell model.</p><p>How might Pin1 operate via a non-catalytic mechanism to downregulate PKC activity? Upon activation, the membrane-associated conformation of PKC is sensitive to dephosphorylation – first at the HM site by PHLPP and subsequently at the TM site and activation loop by PP2A (<xref ref-type="bibr" rid="bib30">Gao et al., 2008</xref>; <xref ref-type="bibr" rid="bib6">Baffi et al., 2019</xref>; <xref ref-type="bibr" rid="bib34">Hansra et al., 1996</xref>; <xref ref-type="bibr" rid="bib8">Baffi and Newton, 2022</xref>). One possibility is that Pin1 discharges a scaffolding or substrate chaperoning function where it aids (directly or indirectly) in the recruitment of protein phosphatases to the Pin1-PKC complex. Indeed, interactions between Pin1 and PP2A have been detected in pulmonary eosinophils (<xref ref-type="bibr" rid="bib79">Shen et al., 2008</xref>). Such an activity, when coupled to a substrate chaperoning function, might ‘organize’ and stimulate ordered dephosphorylation of the PKC C-terminus with subsequent degradation of the kinase. A recruitment mechanism of this nature is attractive in that it provides a means for channeling activated PKC to specific protein phosphatase(s) in a temporally and spatially appropriate manner (<xref ref-type="fig" rid="fig8">Figure 8B</xref>). Alternatively, sequestration of the HM site by Pin1 might prevent the formation of the autoinhibitory state (<xref ref-type="bibr" rid="bib95">Yang et al., 2018</xref>; <xref ref-type="bibr" rid="bib3">Antal et al., 2015a</xref>) and thereby ‘trap’ PKC in an open ‘activated’ conformation. This activated conformer would be particularly susceptible to the action of phosphatases that trigger its ultimate degradation. The significance of phosphorylated HM in maintaining the stability of AGC kinases is well documented (<xref ref-type="bibr" rid="bib6">Baffi et al., 2019</xref>; <xref ref-type="bibr" rid="bib8">Baffi and Newton, 2022</xref>; <xref ref-type="bibr" rid="bib59">Mora et al., 2004</xref>).</p><p>It is tempting to speculate that non-catalytic functions for peptidyl-prolyl isomerases are more broadly represented in this group of enzymes. Pin1 and <italic>Escherichia coli</italic> trigger factor (TF) are both peptidyl-prolyl <italic>cis-trans</italic> isomerases – although Pin1 is a member of the Parvulin family of peptidyl-prolyl isomerases whereas TF is a member of the FK506-binding protein class. The enzymatic activity of TF is dispensable for its function as a protein folding chaperone (<xref ref-type="bibr" rid="bib44">Kramer et al., 2004</xref>). A TF<sup>F198A</sup> mutant competent for client protein binding, but defective in peptidyl-prolyl <italic>cis-trans</italic> isomerization activity, remains active as a folding-promoting chaperone in vivo (<xref ref-type="bibr" rid="bib44">Kramer et al., 2004</xref>). Regardless, our data indicate one can no longer confidently infer whether a protein is a target of Pin1 regulation solely based on whether or not the putative substrate presents isomerizable pSer/Thr-Pro motifs.</p></sec><sec id="s3-4"><title>Implications for therapeutic interventions targeting Pin1</title><p>The oncogenic properties associated with dysregulation of Pin1 activities identify the isomerase as an attractive target for the development of new therapeutic approaches for cancer treatment (<xref ref-type="bibr" rid="bib101">Zhou and Lu, 2016</xref>; <xref ref-type="bibr" rid="bib93">Wu et al., 2022</xref>; <xref ref-type="bibr" rid="bib16">Chuang et al., 2021</xref>). Unfortunately, although numerous small molecule Pin1 inhibitors have been identified (<xref ref-type="bibr" rid="bib58">Moore and Potter, 2013</xref>; <xref ref-type="bibr" rid="bib97">Yu et al., 2020</xref>), these have been plagued by serious off-target toxicities. Resolution of this issue presents a significant obstacle to productive development of the Pin1-targeted drug pipeline (<xref ref-type="bibr" rid="bib58">Moore and Potter, 2013</xref>; <xref ref-type="bibr" rid="bib27">Fila et al., 2008</xref>; <xref ref-type="bibr" rid="bib61">Nam et al., 2001</xref>). In that regard, the screens used to identify Pin1 inhibitors typically rely on readouts of catalytic activity. The data we report herein suggest alternative strategies. That is, screens for ligands that target the bivalent interaction mode rather than the Pin1 catalytic activity. Such strategies hold the potential for enhancing inhibitor specificity and affinity and thereby reducing the toxicities associated with off-target effects. The structure of the Pin1::pV5βII complex now offers a precise template for guiding the design and development of bivalent inhibitors that simultaneously bind to both the Pin1 WW and PPIase domains.</p></sec></sec><sec id="s4" sec-type="methods"><title>Methods</title><sec id="s4-1"><title>Protein expression and purification</title><p>A total of three Pin1 protein constructs were used in this study. The following genes with a codon-optimized DNA sequence were cloned into a pET-SUMO vector (Invitrogen): full-length Pin1 (residues 1–163), the WW domain (residues 1–50), and the PPIase domain (residues 50–163). Pin1 and isolated domains were heterologously expressed in <italic>E. coli</italic> BL21(DE3) and BL21(DE3)pLysS strains, respectively. For the natural abundance protein preparation, cells were grown in Luria broth (LB) to an OD<sub>600</sub> of 0.6 prior to induction of protein expression with 0.5 mM IPTG. The cells were grown for additional 4–5 hr at 37°C. For the expression of isotopically enriched proteins, we used an LB to M9 minimal media resuspension method (<xref ref-type="bibr" rid="bib54">Marley et al., 2001</xref>). To generate uniformly <sup>15</sup>N-enriched (U-[<sup>15</sup>N]) or <sup>15</sup>N, <sup>13</sup>C-enriched (U-[<sup>15</sup>N,<sup>13</sup>C]) protein samples, the M9 media contained either 1 g/l of <sup>15</sup>NH<sub>4</sub>Cl and 3 g/l of natural-abundance D-glucose, or 1 g/l of <sup>15</sup>NH<sub>4</sub>Cl and 3 g/l of <sup>13</sup>C-D-glucose, respectively. The expression of isotopically enriched Pin1 in BL21(DE3) cells was induced for 15 hr at 15°C. The expression of isotopically enriched individual domains in BL21(DE3) pLysS strain was induced for 5 hr at 37°C.</p><p>The cells were harvested by centrifugation (4000 rpm, 30 min) at 4°C. Cell pellets were resuspended in a buffer containing 20 mM Tris-HCl (pH 7.5), 0.5 M NaCl, 5 mM imidazole, and 10 mM β-mercaptoethanol. The 6×His-tagged SUMO fusion proteins were purified using a HisTrap HP Ni<sup>2+</sup> affinity column (GE Healthcare Life Sciences). The fractions containing fusion protein were pooled and exchanged into a SUMO protease cleavage buffer (20 mM Tris-HCl at pH 8.0, 0.15 M NaCl) using a HiPrep 26/10 column (GE Healthcare Life Sciences). The cleavage reaction was initiated by adding 6×His-tagged SUMO protease to a final concentration of ~8 μg/ml to the protein solution. After 30 min at room temperature, the reaction mixture was loaded onto to the second HisTrap HP Ni<sup>2+</sup> affinity column to purify the desired protein from the 6×His-tagged SUMO and 6×His-tagged SUMO protease.</p><p>Purified proteins (Pin1, WW, or PPIase) were buffer-exchanged into an NMR buffer using either 5 kDa or 3 kDa MWCO centrifugal concentrators (Vivaspin, Sartorius). The NMR buffer contained 10 mM d<sub>4</sub>-imidazole at pH 6.6, 100 mM KCl, 1 mM TCEP, 8% D<sub>2</sub>O, and 0.02% NaN<sub>3</sub>. The purity was assessed with SDS-PAGE conducted on samples with serial dilutions. Protein concentrations were determined by measuring the absorbance at 280 nm and using the following extinction coefficients: 20970 M<sup>–1</sup> cm<sup>–1</sup> (Pin1), 13980 M<sup>–1</sup>cm<sup>–1</sup> (WW), and 6990 M<sup>–1</sup> cm<sup>–1</sup> (PPIase). The molecular masses of purified proteins were determined by MALDI-TOF mass spectrometry.</p></sec><sec id="s4-2"><title>Synthesis and purification of the C-terminal PKC peptides</title><p>All 18 peptides used in this study were derived from the C-terminal V5 regions of either βII, α, or βI PKC isoenzymes (<italic>Homo sapiens</italic>) and synthesized commercially (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). The modifications included acetylation and amidation at the N- and C-termini, respectively, to avoid the influence of positive and negative charges terminal charges on binding and catalysis. All natural abundance peptides were purchased as crude mixtures and subsequently HPLC-purified on a C18 column (Waters). The buffers used for purification were 5 mM NH<sub>4</sub>HCO<sub>3</sub> in 100% water (buffer A) and 5 mM NH<sub>4</sub>HCO<sub>3</sub> in 82% acetonitrile/18% H<sub>2</sub>O (buffer B). A linear gradient of buffer B ranging from 0% to 20–40%, depending on the peptide, was applied during the elution step. The molecular weight and purity of the peptides were verified using ESI and MALDI-TOF mass spectrometry (<xref ref-type="fig" rid="fig1s5">Figure 1—figure supplement 5</xref>). Isotopically enriched peptides, #14 and #15 in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>, were purchased in already purified form and used as is. For the binding experiments (vide infra), stock solutions of peptides were prepared by dissolving the lyophilized powders in ddH<sub>2</sub>O. The pH was adjusted to 6.6 either with NH<sub>4</sub>OH or HCl. The peptide concentration was determined using the absorbance at 205 nm; for the phosphorylated peptides, phosphate assay was additionally used (<xref ref-type="bibr" rid="bib28">Fogg and Wilkinson, 1958</xref>).</p></sec><sec id="s4-3"><title>Quantitative analysis of Pin1 interactions with the C-terminal PKC regions</title><p>NMR-detected binding experiments were conducted by adding aliquots of concentrated peptide stock solutions to the [U-<sup>15</sup>N] protein (Pin1, WW, or PPIase) samples, and recording [<sup>15</sup>N,<sup>1</sup>H] HSQC spectra for each peptide concentration point. The spectra were collected at 25°C on Bruker Avance III spectrometers operating at the <sup>1</sup>H Larmor frequencies of 600 MHz or 500 MHz. The concentration of protein samples was between 90 μM and 100 μM. A total of 19 binding experiments were conducted; the parameters are summarized in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>. The binding data were analyzed in three ways, as described in the following subsections.</p><sec id="s4-3-1"><title>CSP analysis</title><p>The CSP analysis involved the calculation of the N-H<sub>N</sub> cross-peak displacement between the two proteins states, apo Pin1 and Pin1 in the presence of peptide at some specific concentration used in the binding experiments. The combined CSP value, Δ, was calculated in a residue-specific manner using the following equation:<disp-formula id="equ1"><label>(1)</label><mml:math id="m1"><mml:mrow><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo>=</mml:mo><mml:msqrt><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi mathvariant="normal">Δ</mml:mi><mml:mspace width="thinmathspace"/><mml:msub><mml:mi>δ</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">H</mml:mi></mml:mrow></mml:mrow></mml:msub><mml:msup><mml:mo stretchy="false">)</mml:mo><mml:mn>2</mml:mn></mml:msup></mml:mrow><mml:mo>+</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mn>0.152</mml:mn><mml:mo>×</mml:mo><mml:mi mathvariant="normal">Δ</mml:mi><mml:mspace width="thinmathspace"/><mml:msub><mml:mi>δ</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">N</mml:mi></mml:mrow></mml:mrow></mml:msub><mml:msup><mml:mo stretchy="false">)</mml:mo><mml:mn>2</mml:mn></mml:msup></mml:msqrt></mml:mstyle></mml:mrow></mml:math></disp-formula></p></sec><sec id="s4-3-2"><title>Construction and analysis of the chemical shift-based binding curves</title><p>The residues for analysis were selected according to the following criteria: (i) their CSP Δ exceeds the mean; (ii) they fall into the fast-exchange regime; and (iii) their cross-peaks are resolved. These sets of residues (ranging in numbers from 14 to 44) are listed in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref> for each Pin1/WW/PPIase-peptide ligand pair. A total of 459 binding curves were constructed by plotting Δ values against total peptide concentration. Quantitative analysis was carried out by globally fitting the binding curves for each Pin1/WW/PPIase-peptide pair. Two binding models were used: single-site binding and two independent sites binding where appropriate. The experimental data fit well with the chosen models, indicating that Δ values of the selected residues report directly on binding rather than indirect allosteric/dynamic effects. All K<sub>d</sub> values reported in this manuscript were obtained from the global fits.</p></sec><sec id="s4-3-3"><title>Single-site binding model</title><p>In this model, the following equation was used for fitting the data is <xref ref-type="bibr" rid="bib5">Auguin et al., 2004</xref>; <xref ref-type="bibr" rid="bib70">Phizicky and Fields, 1995</xref>:<disp-formula id="equ2"><label>(2)</label><mml:math id="m2"><mml:mrow><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mi mathvariant="normal">Δ</mml:mi><mml:mo>=</mml:mo><mml:msub><mml:mi mathvariant="normal">Δ</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">x</mml:mi></mml:mrow></mml:mrow></mml:msub><mml:mfrac><mml:mrow><mml:msub><mml:mi mathvariant="normal">P</mml:mi><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi mathvariant="normal">L</mml:mi><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi mathvariant="normal">K</mml:mi><mml:mrow><mml:mi mathvariant="normal">d</mml:mi></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:msqrt><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi mathvariant="normal">P</mml:mi><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi mathvariant="normal">L</mml:mi><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi mathvariant="normal">K</mml:mi><mml:mrow><mml:mi mathvariant="normal">d</mml:mi></mml:mrow></mml:msub><mml:msup><mml:mo stretchy="false">)</mml:mo><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo>−</mml:mo><mml:mn>4</mml:mn><mml:msub><mml:mi mathvariant="normal">P</mml:mi><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:msub><mml:mi mathvariant="normal">L</mml:mi><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:msqrt></mml:mrow><mml:mrow><mml:mn>2</mml:mn><mml:msub><mml:mi mathvariant="normal">P</mml:mi><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mstyle></mml:mrow></mml:math></disp-formula></p><p>where K<sub>d</sub> is the dissociation constant, Δ<sub>max</sub> is the chemical shift changes at complete saturation, and P<sub>0</sub> and L<sub>0</sub> are total protein and ligand concentrations, respectively.</p></sec><sec id="s4-3-4"><title>Two-site binding model (independent sites)</title><p>According to our NMR data, the binding sites of the pHM on the Pin1 domains are independent, i.e., the binding to second site does not depend on whether or not first site is populated, and vice versa. The formalism outlined below is adapted from <xref ref-type="bibr" rid="bib87">Wang, 1990</xref>. There are two binding equilibria that describe the process:<disp-formula id="equ3"><label>(3)</label><mml:math id="m3"><mml:mrow><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mo>+</mml:mo><mml:mi mathvariant="normal">L</mml:mi><mml:mover><mml:mo>⇌</mml:mo><mml:mpadded width="+0.667em" lspace="0.278em" voffset=".15em"><mml:mrow><mml:msub><mml:mi mathvariant="normal">K</mml:mi><mml:mi mathvariant="normal">d</mml:mi></mml:msub><mml:msub><mml:mo>,</mml:mo><mml:mi mathvariant="normal">W</mml:mi></mml:msub></mml:mrow></mml:mpadded></mml:mover><mml:mrow><mml:msub><mml:mi mathvariant="normal">P</mml:mi><mml:mrow><mml:mi mathvariant="normal">W</mml:mi></mml:mrow></mml:msub><mml:mi mathvariant="normal">L</mml:mi></mml:mrow></mml:mrow></mml:mstyle></mml:mrow></mml:math></disp-formula><disp-formula id="equ4"><label>(4)</label><mml:math id="m4"><mml:mrow><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="normal">W</mml:mi></mml:msub><mml:mi mathvariant="normal">L</mml:mi><mml:mo>+</mml:mo><mml:mi mathvariant="normal">L</mml:mi></mml:mrow><mml:mover><mml:mo>⇌</mml:mo><mml:mpadded width="+0.667em" lspace="0.278em" voffset=".15em"><mml:mrow><mml:msub><mml:mi mathvariant="normal">K</mml:mi><mml:mi mathvariant="normal">d</mml:mi></mml:msub><mml:msub><mml:mo>,</mml:mo><mml:mi mathvariant="normal">I</mml:mi></mml:msub></mml:mrow></mml:mpadded></mml:mover><mml:msub><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="normal">L</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:mstyle></mml:mrow></mml:math></disp-formula></p><p>Definitions: P, full-length Pin1; L, ligand, in this case pHM; P<sub>W</sub>, Pin1 bound to L through the WW domain; P<sub>I</sub>, Pin1 bound to L through the PPIase domain; K<sub>d,I</sub>, dissociation constant for L binding to the PPIase domain; K<sub>d,W</sub>, dissociation constant for L binding to the WW domain; A<sub>W,i</sub> chemical shift difference between the apo and L-bound Pin1 for the ith residue in the WW domain; A<sub>I,i</sub> max chemical shift difference between the apo and L-bound Pin1 for the ith residue in the PPIase domain; f<sub>L,W</sub>, fractional population of L-bound sites on the WW domain of Pin1; f<sub>L,I</sub> fractional population of L-bound sites on the PPIase domain of Pin1.</p><p>The chemical shift change due to ligand binding will be proportional to the fraction of the protein complexed to ligand L through a particular domain. In our case, we can equate this to the fractional population of ligand-bound sites of the WW and PPIase domains. These fractions can be expressed in terms of corresponding K<sub>d</sub> values and free ligand concentration:<disp-formula id="equ5"><label>(5)</label><mml:math id="m5"><mml:mrow><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi mathvariant="normal">f</mml:mi><mml:mrow><mml:mi mathvariant="normal">L</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="normal">W</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:mi mathvariant="normal">L</mml:mi><mml:mo stretchy="false">]</mml:mo></mml:mrow><mml:mrow><mml:msub><mml:mi mathvariant="normal">K</mml:mi><mml:mrow><mml:mi mathvariant="normal">d</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="normal">W</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mo stretchy="false">[</mml:mo><mml:mi mathvariant="normal">L</mml:mi><mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:mfrac></mml:mrow></mml:mstyle></mml:mrow></mml:math></disp-formula><disp-formula id="equ6"><label>(6)</label><mml:math id="m6"><mml:mrow><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi mathvariant="normal">f</mml:mi><mml:mrow><mml:mi mathvariant="normal">L</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="normal">I</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:mi mathvariant="normal">L</mml:mi><mml:mo stretchy="false">]</mml:mo></mml:mrow><mml:mrow><mml:msub><mml:mi mathvariant="normal">K</mml:mi><mml:mrow><mml:mi mathvariant="normal">d</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="normal">I</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mo stretchy="false">[</mml:mo><mml:mi mathvariant="normal">L</mml:mi><mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:mfrac></mml:mrow></mml:mstyle></mml:mrow></mml:math></disp-formula></p><p>The expressions for the residue-specific chemical shift changes therefore become:<disp-formula id="equ7"><label>(7)</label><mml:math id="m7"><mml:mrow><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi mathvariant="normal">Δ</mml:mi><mml:mrow><mml:mi mathvariant="normal">W</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="normal">i</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi mathvariant="normal">A</mml:mi><mml:mrow><mml:mi mathvariant="normal">W</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="normal">i</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi mathvariant="normal">f</mml:mi><mml:mrow><mml:mi mathvariant="normal">L</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="normal">W</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi mathvariant="normal">A</mml:mi><mml:mrow><mml:mi mathvariant="normal">W</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="normal">i</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">[</mml:mo><mml:mi mathvariant="normal">L</mml:mi><mml:mo stretchy="false">]</mml:mo></mml:mrow><mml:mrow><mml:msub><mml:mi mathvariant="normal">K</mml:mi><mml:mrow><mml:mi mathvariant="normal">d</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="normal">W</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mo stretchy="false">[</mml:mo><mml:mi mathvariant="normal">L</mml:mi><mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:mfrac></mml:mrow></mml:mstyle></mml:mrow></mml:math></disp-formula><disp-formula id="equ8"><label>(8)</label><mml:math id="m8"><mml:mrow><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msub><mml:mi mathvariant="normal">Δ</mml:mi><mml:mrow><mml:mi mathvariant="normal">I</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="normal">i</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi mathvariant="normal">A</mml:mi><mml:mrow><mml:mi mathvariant="normal">I</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="normal">i</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi mathvariant="normal">f</mml:mi><mml:mrow><mml:mi mathvariant="normal">L</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="normal">I</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi mathvariant="normal">A</mml:mi><mml:mrow><mml:mi mathvariant="normal">I</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="normal">i</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">[</mml:mo><mml:mi mathvariant="normal">L</mml:mi><mml:mo stretchy="false">]</mml:mo></mml:mrow><mml:mrow><mml:msub><mml:mi mathvariant="normal">K</mml:mi><mml:mrow><mml:mi mathvariant="normal">d</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="normal">I</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mo stretchy="false">[</mml:mo><mml:mi mathvariant="normal">L</mml:mi><mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:mfrac></mml:mrow></mml:mstyle></mml:mrow></mml:math></disp-formula></p><p><xref ref-type="bibr" rid="bib87">Wang, 1990</xref>, provided the expression for [L] in terms of L<sub>0</sub> and P<sub>0</sub>:<disp-formula id="equ9"><label>(9)</label><mml:math id="m9"><mml:mrow><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:mi mathvariant="normal">L</mml:mi><mml:mo stretchy="false">]</mml:mo><mml:mo>=</mml:mo><mml:mo>−</mml:mo><mml:mfrac><mml:mi mathvariant="normal">a</mml:mi><mml:mn>3</mml:mn></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mn>2</mml:mn><mml:mn>3</mml:mn></mml:mfrac><mml:msqrt><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msup><mml:mi mathvariant="normal">a</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mo>−</mml:mo><mml:mn>3</mml:mn><mml:mi mathvariant="normal">b</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:msqrt><mml:mi>cos</mml:mi><mml:mo>⁡</mml:mo><mml:mfrac><mml:mrow><mml:mo>θ</mml:mo></mml:mrow><mml:mn>3</mml:mn></mml:mfrac></mml:mrow></mml:mstyle></mml:mrow></mml:math></disp-formula></p><p>where:<disp-formula id="equ10"><mml:math id="m10"><mml:mrow><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi mathvariant="normal">a</mml:mi><mml:mo>=</mml:mo><mml:msub><mml:mi mathvariant="normal">K</mml:mi><mml:mrow><mml:mi mathvariant="normal">d</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="normal">W</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi mathvariant="normal">K</mml:mi><mml:mrow><mml:mi mathvariant="normal">d</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="normal">I</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mn>2</mml:mn><mml:msub><mml:mi mathvariant="normal">P</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>−</mml:mo><mml:msub><mml:mi mathvariant="normal">L</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:mstyle></mml:mrow></mml:math></disp-formula><disp-formula id="equ11"><mml:math id="m11"><mml:mrow><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi mathvariant="normal">b</mml:mi><mml:mo>=</mml:mo><mml:msub><mml:mi mathvariant="normal">K</mml:mi><mml:mrow><mml:mi mathvariant="normal">d</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="normal">W</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi mathvariant="normal">K</mml:mi><mml:mrow><mml:mi mathvariant="normal">d</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="normal">I</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi mathvariant="normal">K</mml:mi><mml:mrow><mml:mi mathvariant="normal">d</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="normal">I</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi mathvariant="normal">P</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi mathvariant="normal">K</mml:mi><mml:mrow><mml:mi mathvariant="normal">d</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="normal">W</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi mathvariant="normal">P</mml:mi><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>−</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msub><mml:mi mathvariant="normal">K</mml:mi><mml:mrow><mml:mi mathvariant="normal">d</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="normal">W</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi mathvariant="normal">K</mml:mi><mml:mrow><mml:mi mathvariant="normal">d</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="normal">I</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:msub><mml:mi mathvariant="normal">L</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:mstyle></mml:mrow></mml:math></disp-formula><disp-formula id="equ12"><mml:math id="m12"><mml:mrow><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi mathvariant="normal">c</mml:mi><mml:mo>=</mml:mo><mml:mo>−</mml:mo><mml:msub><mml:mi mathvariant="normal">K</mml:mi><mml:mrow><mml:mi mathvariant="normal">d</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="normal">W</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi mathvariant="normal">K</mml:mi><mml:mrow><mml:mi mathvariant="normal">d</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="normal">I</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi mathvariant="normal">L</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:mstyle></mml:mrow></mml:math></disp-formula><disp-formula id="equ13"><mml:math id="m13"><mml:mrow><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>θ</mml:mi><mml:mo>=</mml:mo><mml:mi>arccos</mml:mi><mml:mo>⁡</mml:mo><mml:mfrac><mml:mrow><mml:mo>−</mml:mo><mml:mn>2</mml:mn><mml:msup><mml:mi mathvariant="normal">a</mml:mi><mml:mn>3</mml:mn></mml:msup><mml:mo>+</mml:mo><mml:mn>9</mml:mn><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">b</mml:mi><mml:mo>−</mml:mo><mml:mn>27</mml:mn><mml:mi mathvariant="normal">c</mml:mi></mml:mrow><mml:mroot><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msup><mml:mi mathvariant="normal">a</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mo>−</mml:mo><mml:mn>3</mml:mn><mml:mi mathvariant="normal">b</mml:mi><mml:msup><mml:mo stretchy="false">)</mml:mo><mml:mn>3</mml:mn></mml:msup></mml:mrow><mml:mn>2</mml:mn></mml:mroot></mml:mfrac><mml:mspace width="2em"/><mml:mo stretchy="false">(</mml:mo><mml:mn>0</mml:mn><mml:mo>&lt;</mml:mo><mml:mi>θ</mml:mi><mml:mo>&lt;</mml:mo><mml:mrow><mml:mo>π</mml:mo></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mstyle></mml:mrow></mml:math></disp-formula></p><p><xref ref-type="disp-formula" rid="equ7 equ8">Equations 7 and 8</xref>, with the appropriate substitution of [L] from <xref ref-type="disp-formula" rid="equ13">Equation 9</xref>, were used as fitting functions for the binding curves for the residues that belong to the WW and PPIase domains, respectively. To keep the fitting functions as simple as possible, we did not combine the <sup>1</sup>H and <sup>15</sup>N chemical shifts but used them individually to construct the experimental binding curves. The fitting was conducted using IgorPro software (Wavemetrics), with K<sub>d,W</sub> and K<sub>d,I</sub> as global parameters and Δ<sub>W,i</sub> and Δ<sub>I,i</sub> as the local ones.</p></sec><sec id="s4-3-5"><title>Determination of binding affinities using lineshape analysis</title><p>K<sub>d</sub> values that are determined from the chemical shift analysis become less accurate when the binding regime approaches the ‘tight’ limit. Therefore, for the K<sub>d</sub> values that are smaller than P<sub>0</sub>/5 (20 μM), we used the lineshape analysis to obtain the information about binding affinity. The residues were selected according to the same criteria as those for the CSP-based analyses. The lineshape analysis was conducted for a total of 241 sites (listed in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>) using the software package TITAN (<xref ref-type="bibr" rid="bib90">Waudby et al., 2016</xref>). The [<sup>1</sup>H, <sup>15</sup>N]-HSQC were processed with exponential line broadening using NMRPipe (<xref ref-type="bibr" rid="bib20">Delaglio et al., 1995</xref>). For each protein-peptide ligand pair, data were fit globally using the ‘two-state ligand-binding’ model, <inline-formula><mml:math id="inf1"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mo>+</mml:mo><mml:mi mathvariant="normal">L</mml:mi><mml:mo stretchy="false">⇄</mml:mo><mml:mi mathvariant="normal">P</mml:mi><mml:mi mathvariant="normal">L</mml:mi></mml:mrow></mml:mstyle></mml:math></inline-formula>, within TITAN. The input parameters were the total protein concentration P<sub>0</sub> (100 µM) and the total ligand concentration L<sub>0</sub>, the latter ranging from 0 to the saturating or near-saturating values. The parameters obtained from the global fits were the dissociation constant K<sub>d</sub> and the off-rate constant, k<sub>off</sub>.</p></sec></sec><sec id="s4-4"><title><sup>1</sup>H-<sup>1</sup>H exchange spectroscopy</title><p>The ability of Pin1 to catalyze the isomerization of the TM was probed using 2D EXSY (<xref ref-type="bibr" rid="bib38">Jeener et al., 1979</xref>). The NMR samples contained 50 μM natural-abundance Pin1 and V5 peptides with concentrations ranging between 1 mM and 2 mM. The EXSY experiments were conducted on the total of six peptides: pV5βII, pV5α,pTMβII, pTMα, pTMα-P640A, and SP-2 (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>).</p><p>For the -pTPP-containing V5 regions, the maximum mixing time was set to 500 ms. The mixing times t<sub>mix</sub> for pTMα-P640A were: 20, 35, 50, 75, 100, 140, 200, 280, 400, and 500 ms. The mixing times t<sub>mix</sub> for the SP-2 were: 10, 25, 30, 40, 70, 100, 150, 200, 300, 400, and 500 ms. The <italic>cis-trans</italic> isomerization of the pThr-Pro bond was monitored by following the intensity of the diagonal and cross-peaks corresponding to the <sup>1</sup>H<sub>N</sub> resonance of Thr641 and Thr638 in the βII and α peptides, respectively. The time dependence of the ratio of intensities of the cis→trans (I<sub>ct</sub>) and diagonal trans-trans peak (I<sub>tt</sub>), I<sub>ct</sub>/I<sub>tt</sub>, is given by the following equation:<disp-formula id="equ14"> <label>(10)</label><mml:math id="m14"><mml:mrow><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mfrac><mml:mrow><mml:msub><mml:mi mathvariant="normal">I</mml:mi><mml:mi mathvariant="normal">c</mml:mi></mml:msub><mml:mi mathvariant="normal">t</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mi mathvariant="normal">I</mml:mi><mml:mi mathvariant="normal">t</mml:mi></mml:msub><mml:mi mathvariant="normal">t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi mathvariant="normal">k</mml:mi><mml:mi mathvariant="normal">t</mml:mi></mml:msub><mml:mi mathvariant="normal">c</mml:mi><mml:mo stretchy="false">[</mml:mo><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:mi>exp</mml:mi><mml:mo>⁡</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mo>−</mml:mo><mml:msub><mml:mi mathvariant="normal">k</mml:mi><mml:mi mathvariant="normal">E</mml:mi></mml:msub><mml:mi mathvariant="normal">X</mml:mi><mml:msub><mml:mi mathvariant="normal">t</mml:mi><mml:mrow><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">x</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo stretchy="false">]</mml:mo></mml:mrow><mml:mrow><mml:msub><mml:mi mathvariant="normal">k</mml:mi><mml:mi mathvariant="normal">c</mml:mi></mml:msub><mml:mi mathvariant="normal">t</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mi mathvariant="normal">k</mml:mi><mml:mi mathvariant="normal">t</mml:mi></mml:msub><mml:mi mathvariant="normal">c</mml:mi><mml:mi>exp</mml:mi><mml:mo>⁡</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mo>−</mml:mo><mml:msub><mml:mi mathvariant="normal">k</mml:mi><mml:mi mathvariant="normal">E</mml:mi></mml:msub><mml:mi mathvariant="normal">X</mml:mi><mml:msub><mml:mi mathvariant="normal">t</mml:mi><mml:mrow><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">x</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mfrac></mml:mrow></mml:mstyle></mml:mrow></mml:math></disp-formula></p><p>where k<sub>ct</sub> and k<sub>tc</sub> are the forward and reverse rate constants for cis→trans isomerization reaction, k<sub>EX</sub> is the exchange rate constant that is equal to k<sub>ct</sub>+k<sub>tc</sub>, and t<sub>mix</sub> is the mixing time. <xref ref-type="disp-formula" rid="equ1">Equation (10)</xref> was used to fit the data, with k<sub>tc</sub> and k<sub>ct</sub> as the adjustable parameters. The populations of the cis- and trans-conformers of the peptidyl-prolyl pThr-Pro bond were estimated using the SP-2 peptide (LpTPTD), where the cis-cis diagonal peak is well resolved. The populations of the trans- and cis-conformers of the pThr-Pro bond were I<sub>tt</sub>/(I<sub>tt</sub>+I<sub>cc</sub>)=91% and I<sub>cc</sub>/(I<sub>tt</sub>+I<sub>cc</sub>)=9%, respectively.</p></sec><sec id="s4-5"><title>Determination of the Pin1-pV5βII complex structure using solution NMR spectroscopy</title><sec id="s4-5-1"><title>Sample preparation</title><p>We prepared a total of 10 NMR samples for the structural analysis of the Pin1-pV5βII complex. The samples are listed in <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>, along with the corresponding NMR experiments. The NMR buffer was 10 mM <sup>2</sup>H<sub>4</sub>-imidazole at pH 6.6, 100 mM KCl, 1 mM TCEP, 8% D<sub>2</sub>O, and 0.02% NaN<sub>3</sub>, except for sample #2* where 100% D<sub>2</sub>O was used. Samples #1–3 were used to collect the NMR data used for resonance assignments and structure determination. Samples #4–10 provided validation for the assignments. The validation relied on the spectral simplification through the use of single-domain constructs of Pin1 and selectively labeled pTM and pHM regions of pV5βII. All 2D and 3D NMR experiments were acquired at 25°C on the Bruker Avance III HD spectrometers operating at the <sup>1</sup>H Larmor frequency of 600 MHz or 800 MHz. The temperature was calibrated using deuterated methanol. The chemical shifts were externally referenced to DSS. The NMR data were processed with NMRPipe (<xref ref-type="bibr" rid="bib20">Delaglio et al., 1995</xref>) and analyzed with CcpNmr-Analysis program, version 2.4.2 (<xref ref-type="bibr" rid="bib86">Vranken et al., 2005</xref>).</p></sec><sec id="s4-5-2"><title>NMR structure calculation and refinement</title><p>The backbone and sidechain <sup>1</sup>H resonances of Pin1 complexed to pV5βII were assigned using standard 3D NMR methods (<xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>). Pin1-bound pV5βII <sup>1</sup>H resonances were assigned using 2D double-filtered NOESY and TOCSY experiments conducted on samples #3 and #5 (<xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>). To facilitate the assignments and overcome the problem of extensive spectral overlap, we prepared NMR samples where the pTMβII and pHMβII peptides were selectively labeled with [U-<sup>13</sup>C,<sup>15</sup>N] amino acids at specific positions (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>, peptides #14 and #15; <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>, samples #6 and #7).</p><p>The distance restraints were obtained from the height of the <sup>1</sup>H-<sup>1</sup>H cross-peaks in the NOESY spectra. The inter-molecular NOEs were obtained using 3D-<sup>15</sup>N/<sup>13</sup>C-edited <sup>13</sup>C, <sup>15</sup>N-filtered NOESY-HSQC (<xref ref-type="bibr" rid="bib65">Ogura et al., 1996</xref>; <xref ref-type="bibr" rid="bib102">Zwahlen et al., 1997</xref>) on samples #1, #2, #6, and #7; and 2D [F1/F2] <sup>13</sup>C, <sup>15</sup>N-filtered NOESY on sample #3. A total of 2812 (662 of them long-range) intra-Pin1, 241 intra-pV5βII, and 75 inter-molecular Pin1-pV5βII NOEs were used for the structure calculation (<xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>). Hydrogen bonds were identified based on the <sup>1</sup>H-<sup>2</sup>D exchange rates of amide <sup>1</sup>H atoms. Dihedral angles were predicted by the DANGLE routine within the CcpNmr program (<xref ref-type="bibr" rid="bib86">Vranken et al., 2005</xref>) using a complete set of <sup>15</sup>N, <sup>13</sup>C′, <sup>13</sup>C<sup>α</sup>, <sup>13</sup>C<sup>β</sup>, <sup>1</sup>H<sup>α</sup>, and <sup>1</sup>H<sup>N</sup> chemical shifts.</p><p>An ensemble of the Pin1-pV5βII complex structures was calculated using the torsion angle dynamics protocol in CYANA (version 3) (<xref ref-type="bibr" rid="bib32">Güntert and Buchner, 2015</xref>; <xref ref-type="bibr" rid="bib31">Güntert et al., 1997</xref>). Nine hundred random conformers were subjected to 20,000 steps of annealing. The 50 low-energy conformers that had no upper distance violations of &gt;0.2 Å or dihedral angle violations of &gt;5° were used as an input for the refinement procedure implemented in Xplor NIH, version 2.51.5 (<xref ref-type="bibr" rid="bib77">Schwieters et al., 2003</xref>; <xref ref-type="bibr" rid="bib78">Schwieters et al., 2006</xref>). The refinement was conducted in explicit solvent, using the TIP3P water model. The refined ensemble comprising 20 structures was deposited in the PDB under the accession code 8SG2.</p></sec></sec><sec id="s4-6"><title>In-cell experiments</title><sec id="s4-6-1"><title>Cell lines</title><p>All ex vivo in-cell experiments were performed with STR-authenticated HEK293T cells obtained from the American Type Culture Collection (ATCC catalog number CRL-3216) and their transgenic derivatives. Due to their distinct epithelial morphologies, these cells are not on the list of commonly misidentified cell lines maintained by the International Cell Line Authentication Committee. To maintain cell line integrity, HEK293T cells were not cultured with other cell lines to prevent cross-contamination and cultured cell morphologies were monitored throughout the project. Since both WT and mutant derivative HEK293T cell lines were used in this project, unintended cross-contamination was screened by PCR amplification of distinguishing genomic regions and subsequent DNA sequence analysis of all WT and derivative mutant clonal cell lines to confirm genotype. Cell lines were tested to ensure negative status for mycoplasma contamination using the Universal Mycoplasma Detection Kit (ATCC catalog number 30-1012K).</p></sec><sec id="s4-6-2"><title>Reagents</title><p>Chemical reagents were obtained from MilliporeSigma (Burlington, MA, USA) or Thermo Fisher Scientific (Waltham, MA, USA) unless otherwise specified. Disposable plastics, tissue culture dishes, etc. were from Genesee (El Cajon, CA, USA) or VWR (Radnor, PA, USA). Primary antibodies obtained from Cell Signaling Technology (Denvers, MA, USA) included those directed against Pin1 [3722S], beta actin [4970S], PKCα [20565], PKCβ [46809S], and GFP [2555S]. Primary anti-DDK immunoglobulin [TA50011-100] was obtained from OriGene Technologies Inc (Rockville, MD, USA). Secondary goat anti-rabbit IgG (H+L) HRP conjugated antibody was from MilliporeSigma.</p></sec><sec id="s4-6-3"><title>Generation of Pin1 mutant expression plasmids</title><p>A Myc/DDK eptiope-tagged Pin1 (NM_006221) Human Tagged ORF Clone (Cat# RC202543) was obtained from OriGene Technologies Inc. The Q5 Site-Directed Mutagenesis Kit (NEB, Ipswich, MA, USA) was used to generate the appropriate Pin1 point mutants: Pin1 W34A, R68A/ R69A, C113S, and W34A/R68A/ R69A. All site-directed mutations were verified by DNA sequence analysis.</p><p>The primer sequences for the construction of each point mutant are as follows (sites of mutation are highlighted):</p><p>W34A:</p><list list-type="simple"><list-item><p>forward primer 5’- <named-content content-type="sequence">CGCCAGCCAG<bold><underline>G</underline></bold>CCGAGCGGCCCA</named-content> -3’</p></list-item><list-item><p>reverse primer 5’- <named-content content-type="sequence">TTAGTGATGTGGTTGAAGTAGTACAC</named-content> 3’</p></list-item></list><p>R68A/R69A:</p><list list-type="simple"><list-item><p>forward primer 5’- <named-content content-type="sequence">CAGCCAGTCA<bold><underline>GCCGCC</underline></bold>CCCTCGTCCTGGCG</named-content> -3’</p></list-item><list-item><p>reverse primer 5’- <named-content content-type="sequence">TGCTTCACCAGCAGGTGC</named-content> -3’</p></list-item></list><p>C113S:</p><list list-type="simple"><list-item><p>forward primer 5’- <named-content content-type="sequence">GTTCAGCGAC<bold><underline>A</underline></bold>GCAGCTCAGCCA</named-content> -3’</p></list-item><list-item><p>reverse primer 5’- <named-content content-type="sequence">TGTGAGGCCAGAGACTCAAAG</named-content> -3’</p></list-item></list></sec><sec id="s4-6-4"><title>Cell culture and plasmid transfections</title><p>HEK293T cells were cultured in a humified incubator at 37°C and 5% CO<sub>2</sub> in high-glucose Dulbecco’s Modified Eagle Medium plus sodium pyruvate (Genesee) and supplemented with 10% FBS and penicillin (100 units/ml)/streptomycin (100 µg/ml). After trypsinization to release adherent cells, viable cell counts and cell size were determined by trypan blue staining (Invitrogen, Thermo Fisher Scientific) followed by passage through a Countess II automated cell counter (Thermo Fisher Scientific) according to the manufacturer’s instructions. Plasmid transfections were performed using Lipofectamine LTX with Plus reagent (Thermo Fisher Scientific) according to the manufacturer’s instructions. Stable expression lines were generated by transfection followed by serial selection with 2 mg/ml geneticin (Gibco).</p></sec><sec id="s4-6-5"><title>Cell lysate preparation and Pin1 immunoblotting</title><p>Expression of Pin1, its corresponding variants, and PKCα levels were monitored by immunoblotting. Cells were solubilized in lysis buffer (BB150: 50 mM Tris pH 7.6, 150 mM NaCl, 0.2% CHAPS, 10 mM EDTA) on ice and centrifuged at 21,000×<italic>g</italic> for 5 min at 4°C to remove insoluble materials. Protein in the soluble fractions was quantified using the colorimetric bicinchoninic acid assay (Pierce) and samples were prepared with 80 µg of total lysate protein in 1× Laemlli buffer (62.5 mM Tris-HCl, 2% SDS, 25% glycerol, and 0.01% bromophenol blue, pH 6.8). Samples were subsequently boiled for 5 min and resolved by SDS-PAGE using 15% acrylamide gels (120 V constant voltage for 80 min) and transferred onto 0.2 µm nitrocellulose membranes (Bio-Rad) at 350 mA (constant current) for 1 hr. Following transfer, membranes were blocked for 1 hr in 5% milk powder (wt/vol) in 20 mM Tris pH 7.6, 150 mM NaCl, 0.1% Tween 20 (TBST), and incubated at 4°C overnight with primary antibodies at a 1:1000 dilution in Tris-buffered saline (pH 7.6), 0.1% Tween 20, 5% BSA (wt/vol) with rocking. Following incubation, blots were washed three times for 10 min each in TBST and incubated with goat anti-rabbit secondary antibody coupled to horseradish peroxidase (MillliporeSigma; 1:10,000 dilution) in TBST/5% BSA for 1 hr at room temperature. Following three additional 10 min washes with TBST, blots were developed using SuperSignal West Femto Maximum Sensitivity Substrate (Thermo Fisher Scientific) and analyzed by densitometry using a Molecular Imager ChemiDoc XRS+ system (Bio-Rad Laboratories, Hercules, CA, USA). Protein levels were normalized to total protein load and verified using actin as loading control.</p></sec><sec id="s4-6-6"><title>Quantification of PKCα levels</title><p>PKCα levels were assessed in cells seeded at 1.5×10<sup>6</sup> cells per 35 mm dish 24 hr prior to analysis. Cells from three dishes were pooled per sample. Cells were seeded in complete media containing 10% FBS unless otherwise stated. Following incubation, cells were washed with phosphate-buffered saline and snap-frozen in liquid nitrogen prior to analysis.</p></sec><sec id="s4-6-7"><title>siRNA-mediated knockdown of Pin1</title><p>siRNA transfections were performed using Dharmafect (Dharmacon/Horizon) according to the manufacturer’s instructions in antibiotic free growth media. HEK293T cells were incubated with siRNA complexes overnight and complete media were exchanged the following day. Optimal Pin1 knockdown was determined to be at 72 hr post-transfection. All transfection complexes for both sets of reagents were prepared in optimum media lacking FBS or antibiotics. The ON-TARGET plus Human Pin1 (5300) siRNA-SMART pool (Dharmacon/Horizon) sequences were as follows: J-003291-10 5’-GCUCAGGCCGAGUGUACUA-3’, J-003291-11 5’-GAAGACGCCU CGUUUGCGC-3’, J-003291-12 5’-GAAGAUCACCCGGACCAAG-3’, and J-003291-13 5’-CCAC AUCACUAACGCCAGC-3’.</p></sec><sec id="s4-6-8"><title>Isolation of a clonally derived Pin1 null cell line</title><p>To generate clonal cell lines lacking Pin1 protein, HEK293T cells were sequentially transfected with two CRISPR/Cas9 plasmids driving expression of guide RNAs that specifically target exon2 of the <italic>Pin1</italic> structural gene (MilliporeSigma product numbers and targeting sequences: CRISPRD HSPD0000031439 5’-GA <named-content content-type="sequence">GAAGATCACCCGGACCA</named-content>-3’, CRISPRD HSPD0000031440 5’-<named-content content-type="sequence">TAACGCCAGCCAGTGGG</named-content> AG-3’). Transfected cells were flow-sorted on the basis of GFP fluorescence on a three-laser (405 nm, 488 nm, 640 nm) Beckman Coulter Moflo Astrios high-speed cell sorter at a rate of &lt;1000 events/s. Cell debris were gated and eliminated from the bulk sort. GFP was detected using a 664/22 nm bandpass filter, and Cas9-GFP positive cells were bulk-sorted into 1.5 ml tube using the ‘Purify mode’ routine with a drop envelope of 1–2 droplets.</p><p>Following an initial round of sorting, cells were allowed to recover, and the bulk-sorted population was re-transfected with the second CRISPR/Cas9 plasmid and re-sorted as described. Those second-round bulk-sorted cells were tested to assess overall Pin1 expression within the heterogeneous cell population by immunoblotting for Pin1 antigen. In procedures where the bulk population expressed ≤50% of WT Pin1 levels using total protein to normalize data, individual cell lines were developed from the bulk-sorted population by limiting serial dilution and expansion of single cells into clonal cell populations. Clonally derived cell lines lacking detectable Pin1 antigen were identified by immunoblotting with anti-Pin1 immunoglobulin.</p><p>Clonally derived cell lines were verified by sequencing of individual <italic>Pin1</italic> alleles. Total genomic DNA was isolated from each cell line using the GenElute Mammalian Genomic Miniprep Kits (MilliporeSigma). The <italic>Pin1</italic> coding region from exons 2 and 3 was recovered by amplifying each of these coding exons individually via polymerase chain reaction using the Phusion-Plus high-fidelity proof-reading enzyme (ThermoFisher Scientific). Primers used for amplification of each exon were as follows:</p><list list-type="simple"><list-item><p>Exon 2 -- Forward 5’-<named-content content-type="sequence">CTGGGAGCACAACCCTAGC</named-content>-3’</p></list-item><list-item><p>Reverse 5’-<named-content content-type="sequence">AGGTCATGCACTGGCGTTTT</named-content>-3</p></list-item><list-item><p>Forward 5’-<named-content content-type="sequence">GGGAGCACAACCCTAGCTG</named-content>-3</p></list-item><list-item><p>Reverse 5’-<named-content content-type="sequence">CTACAAAGGCTCACCTGGGA</named-content>-3</p></list-item><list-item><p>Exon 3 -- Forward 5’-<named-content content-type="sequence">CTGGCACTCCCATTCCGTTC</named-content>-3</p></list-item><list-item><p>Reverse 5’-<named-content content-type="sequence">CCTGCCATGTCATCTGTCCC</named-content>-3</p></list-item><list-item><p>Forward 5’-<named-content content-type="sequence">ACTCCCATTCCGTTCCATGTC</named-content>-3</p></list-item><list-item><p>Reverse 5’-<named-content content-type="sequence">CCCTGCCATGTCATCTGTCC</named-content>-3</p></list-item><list-item><p>Exon 4 -- Forward 5’-<named-content content-type="sequence">CAGGTCAGATGCAGAAGCCAT</named-content>-3</p></list-item><list-item><p>Reverse 5’-<named-content content-type="sequence">CCACGACATCTTCCCCACTAT</named-content>-3</p></list-item><list-item><p>Forward 5’-<named-content content-type="sequence">AGGTCAGATGCAGAAGCCATT</named-content>-3</p></list-item><list-item><p>Reverse 5’-<named-content content-type="sequence">GATCCCCTCCCCACGACATC</named-content>-3</p></list-item></list><p>PCR products were extended by <italic>Taq</italic> polymerase-driven poly-deoxyadenosine tailing in 30 min. Tailed PCR products were analyzed by agarose gel electrophoresis alongside products generated from a WT HEK293T cell control. Bands were excised and gel purified using a Qiaquick Gel Extraction Kit (QIAGEN). Purified DNA fragments were ligated into the pGEMt-easy plasmid (Promega) and transformed into DH5α bacteria selected on standard LB agar plates containing ampicillin (100 µg/ml), X-gal (50 µg/ml), and IPTG (1 mM). Blue/white colony screening was employed to identify those transformants harboring plasmids containing inserts (white colonies). Plasmids were prepared from individual colonies using the QIAprep Spin Miniprep Kit and individual allele sequences were obtained by DNA sequencing using the T7 primer to program the sequencing reaction.</p></sec><sec id="s4-6-9"><title>Production of stable transgenic cell lines expressing Pin1 variants</title><p>To generate cell lines expressing WT or mutant Pin1 proteins as sole sources for Pin1 activity, HEK293T Pin1 KO cells (clone C3) were transfected with WT Pin1, the W34A, R68A/R69A, W34A/R68A/R69A, or C113S transgenes tagged with the myc/DDK epitopes. The epitope tags were engineered at the Pin1 C-terminus using the following DNA sequence (myc and DDK coding sequences underlined):</p><p>5’- <named-content content-type="sequence">ACG CGT ACG CGG CCG CTC <underline>GAG CAG AAA CTC ATC TCA GAA GAG GAT CTG</underline> GCA GCA AAT GAT ATC CTG GAT TAC AAG <underline>GAT GAC GAC GAT AAG</underline> GTT TAA</named-content> -3’</p><p>Twenty-four hours post-transfection, an aliquot of the transfected cells was harvested to generate lysates from which successful transfection and protein expression were assessed by immunoblotting for Pin1 antigen. The remaining cells were cultured in high-selection media (2 mg/ml geneticin) and grown at low density, with repeated passage and frequent media changes, over a period of 3 weeks. Pin1 expression was subsequently re-examined by immunoblotting for Pin1 antigen and verified stable lines were consistently maintained under low-selection conditions (1 mg/ml geneticin).</p></sec><sec id="s4-6-10"><title>Cell area and cell viability measurements by flow cytometry</title><p>Cells were loaded into the Image Stream X Mark II imaging flow cytometer (Cytek/Amnis Freemont, CA, USA) to measure cell area and viability. Cells were analyzed at a concentration of 1×10<sup>6</sup> cells in 50 µl of FACS buffer (phosphate-buffered saline, 0.5% bovine serum albumin) supplemented with eBioscience propridium iodide (Invitrogen) to a final concentration of 2 µg/ml. All data from the Image Stream were acquired using the Inspire program (version 201.1.0.765; Cytek/Amnis Freemont, CA, USA). The acquisition parameters used were 40× objective, medium speed, 488 nm wavelength, laser power 100 mW, SSC laser power 2.81 mW. The scatter channel was set for channel 6, the bright-field channels were set to channels 1 and 9. The core stream size was set to 6 µm, and 10,000 events of focused, live, single cells were collected. The focus was determined by plotting the Gradient RMS values for channel 1 bright field in a histogram and selecting cells that possessed a gradient RMS value of ≥40. Single cells were identified in the focused cells by plotting the aspect ratio of the channel 1 bright field (y-axis) versus channel 1 bright-field area (x-axis). Single cells reside in the range of 0.6–1 in the aspect ratio and between 0 and 1×10<sup>3</sup> µm<sup>2</sup> range in the area of channel 1. Cell viability was determined by plotting the intensity of channel 5 (propidium iodide) on the y-axis versus intensity of channel 6 (side scatter). The data were analyzed using the acquisition gates and settings in the IDEAS 6.3 (Cytek/Amnis Freemont, CA, USA) data analysis software package. The median of the cell area and % viability parameters were calculated for each sample.</p></sec></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Data curation, Formal analysis, Validation, Investigation, Visualization, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Data curation, Formal analysis, Validation, Investigation, Visualization, Writing – original draft</p></fn><fn fn-type="con" id="con3"><p>Conceptualization, Formal analysis, Investigation, Visualization, Writing – review and editing</p></fn><fn fn-type="con" id="con4"><p>Formal analysis, Investigation, Visualization, Writing – review and editing</p></fn><fn fn-type="con" id="con5"><p>Investigation, Visualization</p></fn><fn fn-type="con" id="con6"><p>Formal analysis, Supervision, Funding acquisition, Methodology, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con7"><p>Conceptualization, Formal analysis, Supervision, Funding acquisition, Visualization, Methodology, Writing – original draft, Project administration, Writing – review and editing</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Properties of the 18 PKC C-terminal-derived peptides used in this study.</title><p>All peptides have acetylated N-termini and amidated C-termini. TM and HM stand for the turn and hydrophobic motifs, respectively. The phosphorylated Thr of the TM and phosphorylated Ser of the HM are shown in red. Peptides having ‘V5’ in their name contain both TM and HM. Peptides starting with ‘p’ indicate that the peptide is phosphorylated at either one or both motifs, the latter only for the ‘V5’ peptides.</p></caption><media xlink:href="elife-92884-supp1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>List of binding experiments carried out in this study, with the corresponding values of the dissociation constants K<sub>d</sub> obtained from the chemical shift binding curves and/or lineshape analysis.</title></caption><media xlink:href="elife-92884-supp2-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>List of the NMR samples and experiments for the structure determination of the complex.</title><p>Sample 2* was prepared in the buffer containing 100% D<sub>2</sub>O.</p></caption><media xlink:href="elife-92884-supp3-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp4"><label>Supplementary file 4.</label><caption><title>NMR restraints statistics for the CYANA structure calculation.</title></caption><media xlink:href="elife-92884-supp4-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-92884-mdarchecklist1-v1.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>The atomic coordinates, restraints, chemical shifts, and peak lists for the Pin1::pV5bII complex are deposited in Protein Data Bank (accession code 8SG2) and Biological Magnetic Resonance Data Bank (accession code BMRB-31080).</p><p>The following datasets were generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Dixit</surname><given-names>K</given-names></name><name><surname>Chen</surname><given-names>XR</given-names></name><name><surname>Igumenova</surname><given-names>TI</given-names></name></person-group><year iso-8601-date="2023">2023</year><data-title>A novel bivalent interaction mode underlies a non-catalytic mechanism for Pin1-mediated Protein Kinase C regulation</data-title><source>RCSB Protein Data Bank</source><pub-id pub-id-type="accession" xlink:href="https://www.rcsb.org/structure/unreleased/8SG2">8SG2</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset2"><person-group person-group-type="author"><name><surname>Dixit</surname><given-names>K</given-names></name><name><surname>Chen</surname><given-names>XR</given-names></name><name><surname>Igumenova</surname><given-names>TI</given-names></name></person-group><year iso-8601-date="2023">2023</year><data-title>Data from: A novel bivalent interaction mode underlies a non-catalytic mechanism for Pin1-mediated Protein Kinase C regulation</data-title><source>Biological Magnetic Resonance Data Bank</source><pub-id pub-id-type="accession" xlink:href="https://bmrb.io/data_library/summary/index.php?bmrbId=31080">31080</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>This work was supported by grants NIH RO1 GM108998 and Robert A Welch Foundation A-1784 to TII. YY was an American Heart Association predoctoral fellow (award no. 14PRE20380475). MIM and VAB were supported by grants NIH R35 GM131804 and award BE-0017 from the Robert A Welch Foundation to VAB. We acknowledge Gus Wright (Texas A and M Veterinary School Flow Cytometry Core) for assistance in the cell sorting component of the PIN1 gene editing experiments and with cell viability and cell area measurements. We acknowledge the Protein Chemistry Laboratory (Department of Biochemistry and Biophysics, Texas A&amp;M University) for assistance with mass spectrometry experiments.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abrahamsen</surname><given-names>H</given-names></name><name><surname>O’Neill</surname><given-names>AK</given-names></name><name><surname>Kannan</surname><given-names>N</given-names></name><name><surname>Kruse</surname><given-names>N</given-names></name><name><surname>Taylor</surname><given-names>SS</given-names></name><name><surname>Jennings</surname><given-names>PA</given-names></name><name><surname>Newton</surname><given-names>AC</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Peptidyl-prolyl isomerase Pin1 controls down-regulation of conventional protein kinase C isozymes</article-title><source>The Journal of Biological Chemistry</source><volume>287</volume><fpage>13262</fpage><lpage>13278</lpage><pub-id pub-id-type="doi">10.1074/jbc.M112.349753</pub-id><pub-id pub-id-type="pmid">22318721</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alfonso</surname><given-names>SI</given-names></name><name><surname>Callender</surname><given-names>JA</given-names></name><name><surname>Hooli</surname><given-names>B</given-names></name><name><surname>Antal</surname><given-names>CE</given-names></name><name><surname>Mullin</surname><given-names>K</given-names></name><name><surname>Sherman</surname><given-names>MA</given-names></name><name><surname>Lesné</surname><given-names>SE</given-names></name><name><surname>Leitges</surname><given-names>M</given-names></name><name><surname>Newton</surname><given-names>AC</given-names></name><name><surname>Tanzi</surname><given-names>RE</given-names></name><name><surname>Malinow</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Gain-of-function mutations in protein kinase Cα (PKCα) may promote synaptic defects in Alzheimer’s disease</article-title><source>Science Signaling</source><volume>9</volume><elocation-id>ra47</elocation-id><pub-id pub-id-type="doi">10.1126/scisignal.aaf6209</pub-id><pub-id pub-id-type="pmid">27165780</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antal</surname><given-names>CE</given-names></name><name><surname>Callender</surname><given-names>JA</given-names></name><name><surname>Kornev</surname><given-names>AP</given-names></name><name><surname>Taylor</surname><given-names>SS</given-names></name><name><surname>Newton</surname><given-names>AC</given-names></name></person-group><year iso-8601-date="2015">2015a</year><article-title>Intramolecular C2 domain-mediated autoinhibition of protein kinase C βII</article-title><source>Cell Reports</source><volume>12</volume><fpage>1252</fpage><lpage>1260</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2015.07.039</pub-id><pub-id pub-id-type="pmid">26279568</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antal</surname><given-names>CE</given-names></name><name><surname>Hudson</surname><given-names>AM</given-names></name><name><surname>Kang</surname><given-names>E</given-names></name><name><surname>Zanca</surname><given-names>C</given-names></name><name><surname>Wirth</surname><given-names>C</given-names></name><name><surname>Stephenson</surname><given-names>NL</given-names></name><name><surname>Trotter</surname><given-names>EW</given-names></name><name><surname>Gallegos</surname><given-names>LL</given-names></name><name><surname>Miller</surname><given-names>CJ</given-names></name><name><surname>Furnari</surname><given-names>FB</given-names></name><name><surname>Hunter</surname><given-names>T</given-names></name><name><surname>Brognard</surname><given-names>J</given-names></name><name><surname>Newton</surname><given-names>AC</given-names></name></person-group><year iso-8601-date="2015">2015b</year><article-title>Cancer-associated protein kinase C mutations reveal kinase’s role as tumor suppressor</article-title><source>Cell</source><volume>160</volume><fpage>489</fpage><lpage>502</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.01.001</pub-id><pub-id pub-id-type="pmid">25619690</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Auguin</surname><given-names>D</given-names></name><name><surname>Barthe</surname><given-names>P</given-names></name><name><surname>Royer</surname><given-names>C</given-names></name><name><surname>Stern</surname><given-names>MH</given-names></name><name><surname>Noguchi</surname><given-names>M</given-names></name><name><surname>Arold</surname><given-names>ST</given-names></name><name><surname>Roumestand</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Structural basis for the co-activation of protein kinase B by T-cell leukemia-1 (TCL1) family proto-oncoproteins</article-title><source>The Journal of Biological Chemistry</source><volume>279</volume><fpage>35890</fpage><lpage>35902</lpage><pub-id pub-id-type="doi">10.1074/jbc.M400364200</pub-id><pub-id pub-id-type="pmid">15169787</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baffi</surname><given-names>TR</given-names></name><name><surname>Van</surname><given-names>A-AN</given-names></name><name><surname>Zhao</surname><given-names>W</given-names></name><name><surname>Mills</surname><given-names>GB</given-names></name><name><surname>Newton</surname><given-names>AC</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Protein kinase C quality control by phosphatase phlpp1 unveils loss-of-function mechanism in cancer</article-title><source>Molecular Cell</source><volume>74</volume><fpage>378</fpage><lpage>392</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2019.02.018</pub-id><pub-id pub-id-type="pmid">30904392</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baffi</surname><given-names>TR</given-names></name><name><surname>Lordén</surname><given-names>G</given-names></name><name><surname>Wozniak</surname><given-names>JM</given-names></name><name><surname>Feichtner</surname><given-names>A</given-names></name><name><surname>Yeung</surname><given-names>W</given-names></name><name><surname>Kornev</surname><given-names>AP</given-names></name><name><surname>King</surname><given-names>CC</given-names></name><name><surname>Del Rio</surname><given-names>JC</given-names></name><name><surname>Limaye</surname><given-names>AJ</given-names></name><name><surname>Bogomolovas</surname><given-names>J</given-names></name><name><surname>Gould</surname><given-names>CM</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Kennedy</surname><given-names>EJ</given-names></name><name><surname>Kannan</surname><given-names>N</given-names></name><name><surname>Gonzalez</surname><given-names>DJ</given-names></name><name><surname>Stefan</surname><given-names>E</given-names></name><name><surname>Taylor</surname><given-names>SS</given-names></name><name><surname>Newton</surname><given-names>AC</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>mTORC2 controls the activity of PKC and Akt by phosphorylating a conserved TOR interaction motif</article-title><source>Science Signaling</source><volume>14</volume><elocation-id>eabe4509</elocation-id><pub-id pub-id-type="doi">10.1126/scisignal.abe4509</pub-id><pub-id pub-id-type="pmid">33850054</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baffi</surname><given-names>TR</given-names></name><name><surname>Newton</surname><given-names>AC</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Protein kinase C: release from quarantine by mTORC2</article-title><source>Trends in Biochemical Sciences</source><volume>47</volume><fpage>518</fpage><lpage>530</lpage><pub-id pub-id-type="doi">10.1016/j.tibs.2022.03.003</pub-id><pub-id pub-id-type="pmid">35361526</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barman</surname><given-names>A</given-names></name><name><surname>Hamelberg</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Cysteine-mediated dynamic hydrogen-bonding network in the active site of Pin1</article-title><source>Biochemistry</source><volume>53</volume><fpage>3839</fpage><lpage>3850</lpage><pub-id pub-id-type="doi">10.1021/bi5000977</pub-id><pub-id pub-id-type="pmid">24840168</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Behrsin</surname><given-names>CD</given-names></name><name><surname>Bailey</surname><given-names>ML</given-names></name><name><surname>Bateman</surname><given-names>KS</given-names></name><name><surname>Hamilton</surname><given-names>KS</given-names></name><name><surname>Wahl</surname><given-names>LM</given-names></name><name><surname>Brandl</surname><given-names>CJ</given-names></name><name><surname>Shilton</surname><given-names>BH</given-names></name><name><surname>Litchfield</surname><given-names>DW</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Functionally important residues in the peptidyl-prolyl isomerase Pin1 revealed by unigenic evolution</article-title><source>Journal of Molecular Biology</source><volume>365</volume><fpage>1143</fpage><lpage>1162</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2006.10.078</pub-id><pub-id pub-id-type="pmid">17113106</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Born</surname><given-names>A</given-names></name><name><surname>Henen</surname><given-names>MA</given-names></name><name><surname>Vögeli</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Activity and affinity of Pin1 variants</article-title><source>Molecules</source><volume>25</volume><elocation-id>36</elocation-id><pub-id pub-id-type="doi">10.3390/molecules25010036</pub-id><pub-id pub-id-type="pmid">31861908</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Born</surname><given-names>A</given-names></name><name><surname>Soetbeer</surname><given-names>J</given-names></name><name><surname>Breitgoff</surname><given-names>F</given-names></name><name><surname>Henen</surname><given-names>MA</given-names></name><name><surname>Sgourakis</surname><given-names>N</given-names></name><name><surname>Polyhach</surname><given-names>Y</given-names></name><name><surname>Nichols</surname><given-names>PJ</given-names></name><name><surname>Strotz</surname><given-names>D</given-names></name><name><surname>Jeschke</surname><given-names>G</given-names></name><name><surname>Vögeli</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Reconstruction of coupled intra- and interdomain protein motion from nuclear and electron magnetic resonance</article-title><source>Journal of the American Chemical Society</source><volume>143</volume><fpage>16055</fpage><lpage>16067</lpage><pub-id pub-id-type="doi">10.1021/jacs.1c06289</pub-id><pub-id pub-id-type="pmid">34579531</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Callender</surname><given-names>JA</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Lordén</surname><given-names>G</given-names></name><name><surname>Stephenson</surname><given-names>NL</given-names></name><name><surname>Jones</surname><given-names>AC</given-names></name><name><surname>Brognard</surname><given-names>J</given-names></name><name><surname>Newton</surname><given-names>AC</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Protein kinase Cα gain-of-function variant in Alzheimer’s disease displays enhanced catalysis by a mechanism that evades down-regulation</article-title><source>PNAS</source><volume>115</volume><fpage>E5497</fpage><lpage>E5505</lpage><pub-id pub-id-type="doi">10.1073/pnas.1805046115</pub-id><pub-id pub-id-type="pmid">29844158</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campaner</surname><given-names>E</given-names></name><name><surname>Rustighi</surname><given-names>A</given-names></name><name><surname>Zannini</surname><given-names>A</given-names></name><name><surname>Cristiani</surname><given-names>A</given-names></name><name><surname>Piazza</surname><given-names>S</given-names></name><name><surname>Ciani</surname><given-names>Y</given-names></name><name><surname>Kalid</surname><given-names>O</given-names></name><name><surname>Golan</surname><given-names>G</given-names></name><name><surname>Baloglu</surname><given-names>E</given-names></name><name><surname>Shacham</surname><given-names>S</given-names></name><name><surname>Valsasina</surname><given-names>B</given-names></name><name><surname>Cucchi</surname><given-names>U</given-names></name><name><surname>Pippione</surname><given-names>AC</given-names></name><name><surname>Lolli</surname><given-names>ML</given-names></name><name><surname>Giabbai</surname><given-names>B</given-names></name><name><surname>Storici</surname><given-names>P</given-names></name><name><surname>Carloni</surname><given-names>P</given-names></name><name><surname>Rossetti</surname><given-names>G</given-names></name><name><surname>Benvenuti</surname><given-names>F</given-names></name><name><surname>Bello</surname><given-names>E</given-names></name><name><surname>D’Incalci</surname><given-names>M</given-names></name><name><surname>Cappuzzello</surname><given-names>E</given-names></name><name><surname>Rosato</surname><given-names>A</given-names></name><name><surname>Del Sal</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A covalent PIN1 inhibitor selectively targets cancer cells by A dual mechanism of action</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>15772</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms15772</pub-id><pub-id pub-id-type="pmid">28598431</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>XR</given-names></name><name><surname>Igumenova</surname><given-names>TI</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Regulation of eukaryotic protein kinases by Pin1, a peptidyl-prolyl isomerase</article-title><source>Advances in Biological Regulation</source><volume>87</volume><elocation-id>100938</elocation-id><pub-id pub-id-type="doi">10.1016/j.jbior.2022.100938</pub-id><pub-id pub-id-type="pmid">36496344</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chuang</surname><given-names>HH</given-names></name><name><surname>Zhen</surname><given-names>YY</given-names></name><name><surname>Tsai</surname><given-names>YC</given-names></name><name><surname>Chuang</surname><given-names>CH</given-names></name><name><surname>Huang</surname><given-names>MS</given-names></name><name><surname>Hsiao</surname><given-names>M</given-names></name><name><surname>Yang</surname><given-names>CJ</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Targeting pin1 for modulation of cell motility and cancer therapy</article-title><source>Biomedicines</source><volume>9</volume><elocation-id>359</elocation-id><pub-id pub-id-type="doi">10.3390/biomedicines9040359</pub-id><pub-id pub-id-type="pmid">33807199</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clemens</surname><given-names>MJ</given-names></name><name><surname>Trayner</surname><given-names>I</given-names></name><name><surname>Menaya</surname><given-names>J</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>The role of protein kinase C isoenzymes in the regulation of cell proliferation and differentiation</article-title><source>Journal of Cell Science</source><volume>103</volume><fpage>881</fpage><lpage>887</lpage><pub-id pub-id-type="doi">10.1242/jcs.103.4.881</pub-id><pub-id pub-id-type="pmid">1487501</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooke</surname><given-names>M</given-names></name><name><surname>Magimaidas</surname><given-names>A</given-names></name><name><surname>Casado-Medrano</surname><given-names>V</given-names></name><name><surname>Kazanietz</surname><given-names>MG</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Protein kinase C in cancer: The top five unanswered questions</article-title><source>Molecular Carcinogenesis</source><volume>56</volume><fpage>1531</fpage><lpage>1542</lpage><pub-id pub-id-type="doi">10.1002/mc.22617</pub-id><pub-id pub-id-type="pmid">28112438</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daum</surname><given-names>S</given-names></name><name><surname>Lücke</surname><given-names>C</given-names></name><name><surname>Wildemann</surname><given-names>D</given-names></name><name><surname>Schiene-Fischer</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>On the benefit of bivalency in peptide ligand/pin1 interactions</article-title><source>Journal of Molecular Biology</source><volume>374</volume><fpage>147</fpage><lpage>161</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2007.09.019</pub-id><pub-id pub-id-type="pmid">17931657</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delaglio</surname><given-names>F</given-names></name><name><surname>Grzesiek</surname><given-names>S</given-names></name><name><surname>Vuister</surname><given-names>GW</given-names></name><name><surname>Zhu</surname><given-names>G</given-names></name><name><surname>Pfeifer</surname><given-names>J</given-names></name><name><surname>Bax</surname><given-names>A</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>NMRPipe: a multidimensional spectral processing system based on UNIX pipes</article-title><source>Journal of Biomolecular NMR</source><volume>6</volume><fpage>277</fpage><lpage>293</lpage><pub-id pub-id-type="doi">10.1007/BF00197809</pub-id><pub-id pub-id-type="pmid">8520220</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dubiella</surname><given-names>C</given-names></name><name><surname>Pinch</surname><given-names>BJ</given-names></name><name><surname>Koikawa</surname><given-names>K</given-names></name><name><surname>Zaidman</surname><given-names>D</given-names></name><name><surname>Poon</surname><given-names>E</given-names></name><name><surname>Manz</surname><given-names>TD</given-names></name><name><surname>Nabet</surname><given-names>B</given-names></name><name><surname>He</surname><given-names>S</given-names></name><name><surname>Resnick</surname><given-names>E</given-names></name><name><surname>Rogel</surname><given-names>A</given-names></name><name><surname>Langer</surname><given-names>EM</given-names></name><name><surname>Daniel</surname><given-names>CJ</given-names></name><name><surname>Seo</surname><given-names>HS</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Adelmant</surname><given-names>G</given-names></name><name><surname>Sharifzadeh</surname><given-names>S</given-names></name><name><surname>Ficarro</surname><given-names>SB</given-names></name><name><surname>Jamin</surname><given-names>Y</given-names></name><name><surname>Martins da Costa</surname><given-names>B</given-names></name><name><surname>Zimmerman</surname><given-names>MW</given-names></name><name><surname>Lian</surname><given-names>X</given-names></name><name><surname>Kibe</surname><given-names>S</given-names></name><name><surname>Kozono</surname><given-names>S</given-names></name><name><surname>Doctor</surname><given-names>ZM</given-names></name><name><surname>Browne</surname><given-names>CM</given-names></name><name><surname>Yang</surname><given-names>A</given-names></name><name><surname>Stoler-Barak</surname><given-names>L</given-names></name><name><surname>Shah</surname><given-names>RB</given-names></name><name><surname>Vangos</surname><given-names>NE</given-names></name><name><surname>Geffken</surname><given-names>EA</given-names></name><name><surname>Oren</surname><given-names>R</given-names></name><name><surname>Koide</surname><given-names>E</given-names></name><name><surname>Sidi</surname><given-names>S</given-names></name><name><surname>Shulman</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Marto</surname><given-names>JA</given-names></name><name><surname>Dhe-Paganon</surname><given-names>S</given-names></name><name><surname>Look</surname><given-names>T</given-names></name><name><surname>Zhou</surname><given-names>XZ</given-names></name><name><surname>Lu</surname><given-names>KP</given-names></name><name><surname>Sears</surname><given-names>RC</given-names></name><name><surname>Chesler</surname><given-names>L</given-names></name><name><surname>Gray</surname><given-names>NS</given-names></name><name><surname>London</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Sulfopin is a covalent inhibitor of Pin1 that blocks Myc-driven tumors in vivo</article-title><source>Nature Chemical Biology</source><volume>17</volume><fpage>954</fpage><lpage>963</lpage><pub-id pub-id-type="doi">10.1038/s41589-021-00786-7</pub-id><pub-id pub-id-type="pmid">33972797</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edwards</surname><given-names>AS</given-names></name><name><surname>Newton</surname><given-names>AC</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Phosphorylation at conserved carboxyl-terminal hydrophobic motif regulates the catalytic and regulatory domains of protein kinase C</article-title><source>The Journal of Biological Chemistry</source><volume>272</volume><fpage>18382</fpage><lpage>18390</lpage><pub-id pub-id-type="doi">10.1074/jbc.272.29.18382</pub-id><pub-id pub-id-type="pmid">9218480</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eichner</surname><given-names>T</given-names></name><name><surname>Kutter</surname><given-names>S</given-names></name><name><surname>Labeikovsky</surname><given-names>W</given-names></name><name><surname>Buosi</surname><given-names>V</given-names></name><name><surname>Kern</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Molecular mechanism of pin1-tau recognition and catalysis</article-title><source>Journal of Molecular Biology</source><volume>428</volume><fpage>1760</fpage><lpage>1775</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2016.03.009</pub-id><pub-id pub-id-type="pmid">26996941</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erlendsson</surname><given-names>S</given-names></name><name><surname>Teilum</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Binding revisited-avidity in cellular function and signaling</article-title><source>Frontiers in Molecular Biosciences</source><volume>7</volume><elocation-id>615565</elocation-id><pub-id pub-id-type="doi">10.3389/fmolb.2020.615565</pub-id><pub-id pub-id-type="pmid">33521057</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Errington</surname><given-names>N</given-names></name><name><surname>Doig</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>A phosphoserine-lysine salt bridge within an alpha-helical peptide, the strongest alpha-helix side-chain interaction measured to date</article-title><source>Biochemistry</source><volume>44</volume><fpage>7553</fpage><lpage>7558</lpage><pub-id pub-id-type="doi">10.1021/bi050297j</pub-id><pub-id pub-id-type="pmid">15895998</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname><given-names>JH</given-names></name><name><surname>Murray</surname><given-names>D</given-names></name><name><surname>Leslie</surname><given-names>CC</given-names></name><name><surname>Falke</surname><given-names>JJ</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Specific translocation of protein kinase Calpha to the plasma membrane requires both Ca2+ and PIP2 recognition by its C2 domain</article-title><source>Molecular Biology of the Cell</source><volume>17</volume><fpage>56</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1091/mbc.e05-06-0499</pub-id><pub-id pub-id-type="pmid">16236797</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fila</surname><given-names>C</given-names></name><name><surname>Metz</surname><given-names>C</given-names></name><name><surname>van der Sluijs</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Juglone inactivates cysteine-rich proteins required for progression through mitosis</article-title><source>The Journal of Biological Chemistry</source><volume>283</volume><fpage>21714</fpage><lpage>21724</lpage><pub-id pub-id-type="doi">10.1074/jbc.M710264200</pub-id><pub-id pub-id-type="pmid">18539601</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fogg</surname><given-names>DN</given-names></name><name><surname>Wilkinson</surname><given-names>NT</given-names></name></person-group><year iso-8601-date="1958">1958</year><article-title>The colorimetric determination of phosphorus</article-title><source>The Analyst</source><volume>83</volume><elocation-id>406</elocation-id><pub-id pub-id-type="doi">10.1039/an9588300406</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>T</given-names></name><name><surname>Newton</surname><given-names>AC</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>The turn motif is a phosphorylation switch that regulates the binding of Hsp70 to protein kinase C</article-title><source>The Journal of Biological Chemistry</source><volume>277</volume><fpage>31585</fpage><lpage>31592</lpage><pub-id pub-id-type="doi">10.1074/jbc.M204335200</pub-id><pub-id pub-id-type="pmid">12080070</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>T</given-names></name><name><surname>Brognard</surname><given-names>J</given-names></name><name><surname>Newton</surname><given-names>AC</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>The phosphatase PHLPP controls the cellular levels of protein kinase C</article-title><source>The Journal of Biological Chemistry</source><volume>283</volume><fpage>6300</fpage><lpage>6311</lpage><pub-id pub-id-type="doi">10.1074/jbc.M707319200</pub-id><pub-id pub-id-type="pmid">18162466</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Güntert</surname><given-names>P</given-names></name><name><surname>Mumenthaler</surname><given-names>C</given-names></name><name><surname>Wüthrich</surname><given-names>K</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Torsion angle dynamics for NMR structure calculation with the new program DYANA</article-title><source>Journal of Molecular Biology</source><volume>273</volume><fpage>283</fpage><lpage>298</lpage><pub-id pub-id-type="doi">10.1006/jmbi.1997.1284</pub-id><pub-id pub-id-type="pmid">9367762</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Güntert</surname><given-names>P</given-names></name><name><surname>Buchner</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Combined automated NOE assignment and structure calculation with CYANA</article-title><source>Journal of Biomolecular NMR</source><volume>62</volume><fpage>453</fpage><lpage>471</lpage><pub-id pub-id-type="doi">10.1007/s10858-015-9924-9</pub-id><pub-id pub-id-type="pmid">25801209</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>J</given-names></name><name><surname>Pang</surname><given-names>X</given-names></name><name><surname>Zhou</surname><given-names>HX</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Two pathways mediate interdomain allosteric regulation in pin1</article-title><source>Structure</source><volume>23</volume><fpage>237</fpage><lpage>247</lpage><pub-id pub-id-type="doi">10.1016/j.str.2014.11.009</pub-id><pub-id pub-id-type="pmid">25543254</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hansra</surname><given-names>G</given-names></name><name><surname>Bornancin</surname><given-names>F</given-names></name><name><surname>Whelan</surname><given-names>R</given-names></name><name><surname>Hemmings</surname><given-names>BA</given-names></name><name><surname>Parker</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>12-O-Tetradecanoylphorbol-13-acetate-induced dephosphorylation of protein kinase Calpha correlates with the presence of a membrane-associated protein phosphatase 2A heterotrimer</article-title><source>The Journal of Biological Chemistry</source><volume>271</volume><fpage>32785</fpage><lpage>32788</lpage><pub-id pub-id-type="doi">10.1074/jbc.271.51.32785</pub-id><pub-id pub-id-type="pmid">8955114</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>X</given-names></name><name><surname>Dong</surname><given-names>S-H</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Zhou</surname><given-names>XZ</given-names></name><name><surname>Chen</surname><given-names>R</given-names></name><name><surname>Nair</surname><given-names>S</given-names></name><name><surname>Lu</surname><given-names>KP</given-names></name><name><surname>Chen</surname><given-names>L-F</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Prolyl isomerase PIN1 regulates the stability, transcriptional activity and oncogenic potential of BRD4</article-title><source>Oncogene</source><volume>36</volume><fpage>5177</fpage><lpage>5188</lpage><pub-id pub-id-type="doi">10.1038/onc.2017.137</pub-id><pub-id pub-id-type="pmid">28481868</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Innes</surname><given-names>BT</given-names></name><name><surname>Bailey</surname><given-names>ML</given-names></name><name><surname>Brandl</surname><given-names>CJ</given-names></name><name><surname>Shilton</surname><given-names>BH</given-names></name><name><surname>Litchfield</surname><given-names>DW</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Non-catalytic participation of the Pin1 peptidyl-prolyl isomerase domain in target binding</article-title><source>Frontiers in Physiology</source><volume>4</volume><elocation-id>18</elocation-id><pub-id pub-id-type="doi">10.3389/fphys.2013.00018</pub-id><pub-id pub-id-type="pmid">23407864</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isakov</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Protein kinase C (PKC) isoforms in cancer, tumor promotion and tumor suppression</article-title><source>Seminars in Cancer Biology</source><volume>48</volume><fpage>36</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1016/j.semcancer.2017.04.012</pub-id><pub-id pub-id-type="pmid">28571764</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeener</surname><given-names>J</given-names></name><name><surname>Meier</surname><given-names>BH</given-names></name><name><surname>Bachmann</surname><given-names>P</given-names></name><name><surname>Ernst</surname><given-names>RR</given-names></name></person-group><year iso-8601-date="1979">1979</year><article-title>Investigation of exchange processes by two-dimensional NMR spectroscopy</article-title><source>The Journal of Chemical Physics</source><volume>71</volume><fpage>4546</fpage><lpage>4553</lpage><pub-id pub-id-type="doi">10.1063/1.438208</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jinasena</surname><given-names>D</given-names></name><name><surname>Simmons</surname><given-names>R</given-names></name><name><surname>Gyamfi</surname><given-names>H</given-names></name><name><surname>Fitzkee</surname><given-names>NC</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Molecular mechanism of the pin1-Histone H1 interaction</article-title><source>Biochemistry</source><volume>58</volume><fpage>788</fpage><lpage>798</lpage><pub-id pub-id-type="doi">10.1021/acs.biochem.8b01036</pub-id><pub-id pub-id-type="pmid">30507159</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>JE</given-names></name><name><surname>Giorgione</surname><given-names>J</given-names></name><name><surname>Newton</surname><given-names>AC</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>The C1 and C2 domains of protein kinase C are independent membrane targeting modules, with specificity for phosphatidylserine conferred by the C1 domain</article-title><source>Biochemistry</source><volume>39</volume><fpage>11360</fpage><lpage>11369</lpage><pub-id pub-id-type="doi">10.1021/bi000902c</pub-id><pub-id pub-id-type="pmid">10985781</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Kawale</surname><given-names>AA</given-names></name><name><surname>Burmann</surname><given-names>BM</given-names></name></person-group><year iso-8601-date="2023">2023</year><chapter-title>Advanced NMR spectroscopy methods to study protein structure and Dynamics</chapter-title><person-group person-group-type="editor"><name><surname>Saudagar</surname><given-names>P</given-names></name><name><surname>Tripathi</surname><given-names>T</given-names></name></person-group><source>Advanced Spectroscopic Methods to Study Biomolecular Structure and Dynamics</source><publisher-name>Elsevier</publisher-name><fpage>125</fpage><lpage>152</lpage><pub-id pub-id-type="doi">10.1016/B978-0-323-99127-8.00010-6</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koikawa</surname><given-names>K</given-names></name><name><surname>Kibe</surname><given-names>S</given-names></name><name><surname>Suizu</surname><given-names>F</given-names></name><name><surname>Sekino</surname><given-names>N</given-names></name><name><surname>Kim</surname><given-names>N</given-names></name><name><surname>Manz</surname><given-names>TD</given-names></name><name><surname>Pinch</surname><given-names>BJ</given-names></name><name><surname>Akshinthala</surname><given-names>D</given-names></name><name><surname>Verma</surname><given-names>A</given-names></name><name><surname>Gaglia</surname><given-names>G</given-names></name><name><surname>Nezu</surname><given-names>Y</given-names></name><name><surname>Ke</surname><given-names>S</given-names></name><name><surname>Qiu</surname><given-names>C</given-names></name><name><surname>Ohuchida</surname><given-names>K</given-names></name><name><surname>Oda</surname><given-names>Y</given-names></name><name><surname>Lee</surname><given-names>TH</given-names></name><name><surname>Wegiel</surname><given-names>B</given-names></name><name><surname>Clohessy</surname><given-names>JG</given-names></name><name><surname>London</surname><given-names>N</given-names></name><name><surname>Santagata</surname><given-names>S</given-names></name><name><surname>Wulf</surname><given-names>GM</given-names></name><name><surname>Hidalgo</surname><given-names>M</given-names></name><name><surname>Muthuswamy</surname><given-names>SK</given-names></name><name><surname>Nakamura</surname><given-names>M</given-names></name><name><surname>Gray</surname><given-names>NS</given-names></name><name><surname>Zhou</surname><given-names>XZ</given-names></name><name><surname>Lu</surname><given-names>KP</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapy</article-title><source>Cell</source><volume>184</volume><fpage>4753</fpage><lpage>4771</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2021.07.020</pub-id><pub-id pub-id-type="pmid">34388391</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kozono</surname><given-names>S</given-names></name><name><surname>Lin</surname><given-names>Y-M</given-names></name><name><surname>Seo</surname><given-names>H-S</given-names></name><name><surname>Pinch</surname><given-names>B</given-names></name><name><surname>Lian</surname><given-names>X</given-names></name><name><surname>Qiu</surname><given-names>C</given-names></name><name><surname>Herbert</surname><given-names>MK</given-names></name><name><surname>Chen</surname><given-names>C-H</given-names></name><name><surname>Tan</surname><given-names>L</given-names></name><name><surname>Gao</surname><given-names>ZJ</given-names></name><name><surname>Massefski</surname><given-names>W</given-names></name><name><surname>Doctor</surname><given-names>ZM</given-names></name><name><surname>Jackson</surname><given-names>BP</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Dhe-Paganon</surname><given-names>S</given-names></name><name><surname>Lu</surname><given-names>KP</given-names></name><name><surname>Zhou</surname><given-names>XZ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Arsenic targets Pin1 and cooperates with retinoic acid to inhibit cancer-driving pathways and tumor-initiating cells</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>3069</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-05402-2</pub-id><pub-id pub-id-type="pmid">30093655</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kramer</surname><given-names>G</given-names></name><name><surname>Patzelt</surname><given-names>H</given-names></name><name><surname>Rauch</surname><given-names>T</given-names></name><name><surname>Kurz</surname><given-names>TA</given-names></name><name><surname>Vorderwülbecke</surname><given-names>S</given-names></name><name><surname>Bukau</surname><given-names>B</given-names></name><name><surname>Deuerling</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Trigger factor peptidyl-prolyl cis/trans isomerase activity is not essential for the folding of cytosolic proteins in <italic>Escherichia coli</italic></article-title><source>The Journal of Biological Chemistry</source><volume>279</volume><fpage>14165</fpage><lpage>14170</lpage><pub-id pub-id-type="doi">10.1074/jbc.M313635200</pub-id><pub-id pub-id-type="pmid">14729669</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>YM</given-names></name><name><surname>Liou</surname><given-names>YC</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Gears-in-motion: the interplay of ww and ppiase domains in pin1</article-title><source>Frontiers in Oncology</source><volume>8</volume><elocation-id>469</elocation-id><pub-id pub-id-type="doi">10.3389/fonc.2018.00469</pub-id><pub-id pub-id-type="pmid">30460195</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>Y-C</given-names></name><name><surname>Boone</surname><given-names>M</given-names></name><name><surname>Meuris</surname><given-names>L</given-names></name><name><surname>Lemmens</surname><given-names>I</given-names></name><name><surname>Van Roy</surname><given-names>N</given-names></name><name><surname>Soete</surname><given-names>A</given-names></name><name><surname>Reumers</surname><given-names>J</given-names></name><name><surname>Moisse</surname><given-names>M</given-names></name><name><surname>Plaisance</surname><given-names>S</given-names></name><name><surname>Drmanac</surname><given-names>R</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Speleman</surname><given-names>F</given-names></name><name><surname>Lambrechts</surname><given-names>D</given-names></name><name><surname>Van de Peer</surname><given-names>Y</given-names></name><name><surname>Tavernier</surname><given-names>J</given-names></name><name><surname>Callewaert</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Genome dynamics of the human embryonic kidney 293 lineage in response to cell biology manipulations</article-title><source>Nature Communications</source><volume>5</volume><elocation-id>4767</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms5767</pub-id><pub-id pub-id-type="pmid">25182477</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liou</surname><given-names>YC</given-names></name><name><surname>Zhou</surname><given-names>XZ</given-names></name><name><surname>Lu</surname><given-names>KP</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Prolyl isomerase Pin1 as a molecular switch to determine the fate of phosphoproteins</article-title><source>Trends in Biochemical Sciences</source><volume>36</volume><fpage>501</fpage><lpage>514</lpage><pub-id pub-id-type="doi">10.1016/j.tibs.2011.07.001</pub-id><pub-id pub-id-type="pmid">21852138</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lordén</surname><given-names>G</given-names></name><name><surname>Newton</surname><given-names>AC</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Conventional protein kinase C in the brain: repurposing cancer drugs for neurodegenerative treatment?</article-title><source>Neuronal Signaling</source><volume>5</volume><elocation-id>S20210036</elocation-id><pub-id pub-id-type="doi">10.1042/NS20210036</pub-id><pub-id pub-id-type="pmid">34737895</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>KP</given-names></name><name><surname>Hanes</surname><given-names>SD</given-names></name><name><surname>Hunter</surname><given-names>T</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>A human peptidyl-prolyl isomerase essential for regulation of mitosis</article-title><source>Nature</source><volume>380</volume><fpage>544</fpage><lpage>547</lpage><pub-id pub-id-type="doi">10.1038/380544a0</pub-id><pub-id pub-id-type="pmid">8606777</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>KP</given-names></name><name><surname>Liou</surname><given-names>YC</given-names></name><name><surname>Zhou</surname><given-names>XZ</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Pinning down proline-directed phosphorylation signaling</article-title><source>Trends in Cell Biology</source><volume>12</volume><fpage>164</fpage><lpage>172</lpage><pub-id pub-id-type="doi">10.1016/s0962-8924(02)02253-5</pub-id><pub-id pub-id-type="pmid">11978535</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>Z</given-names></name><name><surname>Hunter</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Prolyl isomerase Pin1 in cancer</article-title><source>Cell Research</source><volume>24</volume><fpage>1033</fpage><lpage>1049</lpage><pub-id pub-id-type="doi">10.1038/cr.2014.109</pub-id><pub-id pub-id-type="pmid">25124924</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lufei</surname><given-names>C</given-names></name><name><surname>Koh</surname><given-names>TH</given-names></name><name><surname>Uchida</surname><given-names>T</given-names></name><name><surname>Cao</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Pin1 is required for the Ser727 phosphorylation-dependent Stat3 activity</article-title><source>Oncogene</source><volume>26</volume><fpage>7656</fpage><lpage>7664</lpage><pub-id pub-id-type="doi">10.1038/sj.onc.1210567</pub-id><pub-id pub-id-type="pmid">17563747</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mammen</surname><given-names>M</given-names></name><name><surname>Choi</surname><given-names>SK</given-names></name><name><surname>Whitesides</surname><given-names>GM</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Polyvalent interactions in biological systems: implications for design and use of multivalent ligands and inhibitors</article-title><source>Angewandte Chemie</source><volume>37</volume><fpage>2754</fpage><lpage>2794</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1521-3773(19981102)37:20&lt;2754::AID-ANIE2754&gt;3.0.CO;2-3</pub-id><pub-id pub-id-type="pmid">29711117</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marley</surname><given-names>J</given-names></name><name><surname>Lu</surname><given-names>M</given-names></name><name><surname>Bracken</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>A method for efficient isotopic labeling of recombinant proteins</article-title><source>Journal of Biomolecular NMR</source><volume>20</volume><fpage>71</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1023/a:1011254402785</pub-id><pub-id pub-id-type="pmid">11430757</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mercedes-Camacho</surname><given-names>AY</given-names></name><name><surname>Mullins</surname><given-names>AB</given-names></name><name><surname>Mason</surname><given-names>MD</given-names></name><name><surname>Xu</surname><given-names>GG</given-names></name><name><surname>Mahoney</surname><given-names>BJ</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Peng</surname><given-names>JW</given-names></name><name><surname>Etzkorn</surname><given-names>FA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Kinetic isotope effects support the twisted amide mechanism of Pin1 peptidyl-prolyl isomerase</article-title><source>Biochemistry</source><volume>52</volume><fpage>7707</fpage><lpage>7713</lpage><pub-id pub-id-type="doi">10.1021/bi400700b</pub-id><pub-id pub-id-type="pmid">24116866</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mochly-Rosen</surname><given-names>D</given-names></name><name><surname>Khaner</surname><given-names>H</given-names></name><name><surname>Lopez</surname><given-names>J</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Identification of intracellular receptor proteins for activated protein kinase C</article-title><source>PNAS</source><volume>88</volume><fpage>3997</fpage><lpage>4000</lpage><pub-id pub-id-type="doi">10.1073/pnas.88.9.3997</pub-id><pub-id pub-id-type="pmid">1850844</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Momin</surname><given-names>M</given-names></name><name><surname>Yao</surname><given-names>XQ</given-names></name><name><surname>Thor</surname><given-names>W</given-names></name><name><surname>Hamelberg</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Substrate sequence determines catalytic activities, domain-binding preferences, and allosteric mechanisms in pin1</article-title><source>The Journal of Physical Chemistry. B</source><volume>122</volume><fpage>6521</fpage><lpage>6527</lpage><pub-id pub-id-type="doi">10.1021/acs.jpcb.8b03819</pub-id><pub-id pub-id-type="pmid">29851476</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname><given-names>JD</given-names></name><name><surname>Potter</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Pin1 inhibitors: Pitfalls, progress and cellular pharmacology</article-title><source>Bioorganic &amp; Medicinal Chemistry Letters</source><volume>23</volume><fpage>4283</fpage><lpage>4291</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2013.05.088</pub-id><pub-id pub-id-type="pmid">23796453</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mora</surname><given-names>A</given-names></name><name><surname>Komander</surname><given-names>D</given-names></name><name><surname>van Aalten</surname><given-names>DMF</given-names></name><name><surname>Alessi</surname><given-names>DR</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>PDK1, the master regulator of AGC kinase signal transduction</article-title><source>Seminars in Cell &amp; Developmental Biology</source><volume>15</volume><fpage>161</fpage><lpage>170</lpage><pub-id pub-id-type="doi">10.1016/j.semcdb.2003.12.022</pub-id><pub-id pub-id-type="pmid">15209375</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mueller</surname><given-names>JW</given-names></name><name><surname>Link</surname><given-names>NM</given-names></name><name><surname>Matena</surname><given-names>A</given-names></name><name><surname>Hoppstock</surname><given-names>L</given-names></name><name><surname>Rüppel</surname><given-names>A</given-names></name><name><surname>Bayer</surname><given-names>P</given-names></name><name><surname>Blankenfeldt</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Crystallographic proof for an extended hydrogen-bonding network in small prolyl isomerases</article-title><source>Journal of the American Chemical Society</source><volume>133</volume><fpage>20096</fpage><lpage>20099</lpage><pub-id pub-id-type="doi">10.1021/ja2086195</pub-id><pub-id pub-id-type="pmid">22081960</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nam</surname><given-names>S</given-names></name><name><surname>Smith</surname><given-names>DM</given-names></name><name><surname>Dou</surname><given-names>QP</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo</article-title><source>Journal of Biological Chemistry</source><volume>276</volume><fpage>13322</fpage><lpage>13330</lpage><pub-id pub-id-type="doi">10.1074/jbc.M004209200</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Namitz</surname><given-names>KEW</given-names></name><name><surname>Zheng</surname><given-names>T</given-names></name><name><surname>Canning</surname><given-names>AJ</given-names></name><name><surname>Alicea-Velazquez</surname><given-names>NL</given-names></name><name><surname>Castañeda</surname><given-names>CA</given-names></name><name><surname>Cosgrove</surname><given-names>MS</given-names></name><name><surname>Hanes</surname><given-names>SD</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Structure analysis suggests Ess1 isomerizes the carboxy-terminal domain of RNA polymerase II via a bivalent anchoring mechanism</article-title><source>Communications Biology</source><volume>4</volume><elocation-id>398</elocation-id><pub-id pub-id-type="doi">10.1038/s42003-021-01906-8</pub-id><pub-id pub-id-type="pmid">33767358</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newton</surname><given-names>AC</given-names></name><name><surname>Protein kinase</surname><given-names>C</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Seeing two domains</article-title><source>Current Biology: CB</source><volume>5</volume><fpage>973</fpage><lpage>976</lpage><pub-id pub-id-type="doi">10.1016/S0960-9822(95)00191-6</pub-id><pub-id pub-id-type="pmid">8542286</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newton</surname><given-names>AC</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Protein kinase C: poised to signal</article-title><source>American Journal of Physiology. Endocrinology and Metabolism</source><volume>298</volume><fpage>E395</fpage><lpage>E402</lpage><pub-id pub-id-type="doi">10.1152/ajpendo.00477.2009</pub-id><pub-id pub-id-type="pmid">19934406</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogura</surname><given-names>K</given-names></name><name><surname>Terasawa</surname><given-names>H</given-names></name><name><surname>Inagaki</surname><given-names>F</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>An improved double-tuned and isotope-filtered pulse scheme based on a pulsed field gradient and a wide-band inversion shaped pulse</article-title><source>Journal of Biomolecular NMR</source><volume>8</volume><fpage>492</fpage><lpage>498</lpage><pub-id pub-id-type="doi">10.1007/BF00228150</pub-id><pub-id pub-id-type="pmid">20859780</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palmer</surname><given-names>AG</given-names></name><name><surname>Kroenke</surname><given-names>CD</given-names></name><name><surname>Loria</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Nuclear magnetic resonance methods for quantifying microsecond-to-millisecond motions in biological macromolecules</article-title><source>Methods in Enzymology</source><volume>339</volume><fpage>204</fpage><lpage>238</lpage><pub-id pub-id-type="doi">10.1016/S0076-6879(01)39315-1</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parker</surname><given-names>PJ</given-names></name><name><surname>Brown</surname><given-names>SJ</given-names></name><name><surname>Calleja</surname><given-names>V</given-names></name><name><surname>Chakravarty</surname><given-names>P</given-names></name><name><surname>Cobbaut</surname><given-names>M</given-names></name><name><surname>Linch</surname><given-names>M</given-names></name><name><surname>Marshall</surname><given-names>JJT</given-names></name><name><surname>Martini</surname><given-names>S</given-names></name><name><surname>McDonald</surname><given-names>NQ</given-names></name><name><surname>Soliman</surname><given-names>T</given-names></name><name><surname>Watson</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Equivocal, explicit and emergent actions of PKC isoforms in cancer</article-title><source>Nature Reviews. Cancer</source><volume>21</volume><fpage>51</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1038/s41568-020-00310-4</pub-id><pub-id pub-id-type="pmid">33177705</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pearce</surname><given-names>LR</given-names></name><name><surname>Komander</surname><given-names>D</given-names></name><name><surname>Alessi</surname><given-names>DR</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The nuts and bolts of AGC protein kinases</article-title><source>Nature Reviews. Molecular Cell Biology</source><volume>11</volume><fpage>9</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1038/nrm2822</pub-id><pub-id pub-id-type="pmid">20027184</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>JW</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Investigating dynamic interdomain allostery in Pin1</article-title><source>Biophysical Reviews</source><volume>7</volume><fpage>239</fpage><lpage>249</lpage><pub-id pub-id-type="doi">10.1007/s12551-015-0171-9</pub-id><pub-id pub-id-type="pmid">26495045</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phizicky</surname><given-names>EM</given-names></name><name><surname>Fields</surname><given-names>S</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Protein-protein interactions: methods for detection and analysis</article-title><source>Microbiological Reviews</source><volume>59</volume><fpage>94</fpage><lpage>123</lpage><pub-id pub-id-type="doi">10.1128/mr.59.1.94-123.1995</pub-id><pub-id pub-id-type="pmid">7708014</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinch</surname><given-names>BJ</given-names></name><name><surname>Doctor</surname><given-names>ZM</given-names></name><name><surname>Nabet</surname><given-names>B</given-names></name><name><surname>Browne</surname><given-names>CM</given-names></name><name><surname>Seo</surname><given-names>H-S</given-names></name><name><surname>Mohardt</surname><given-names>ML</given-names></name><name><surname>Kozono</surname><given-names>S</given-names></name><name><surname>Lian</surname><given-names>X</given-names></name><name><surname>Manz</surname><given-names>TD</given-names></name><name><surname>Chun</surname><given-names>Y</given-names></name><name><surname>Kibe</surname><given-names>S</given-names></name><name><surname>Zaidman</surname><given-names>D</given-names></name><name><surname>Daitchman</surname><given-names>D</given-names></name><name><surname>Yeoh</surname><given-names>ZC</given-names></name><name><surname>Vangos</surname><given-names>NE</given-names></name><name><surname>Geffken</surname><given-names>EA</given-names></name><name><surname>Tan</surname><given-names>L</given-names></name><name><surname>Ficarro</surname><given-names>SB</given-names></name><name><surname>London</surname><given-names>N</given-names></name><name><surname>Marto</surname><given-names>JA</given-names></name><name><surname>Buratowski</surname><given-names>S</given-names></name><name><surname>Dhe-Paganon</surname><given-names>S</given-names></name><name><surname>Zhou</surname><given-names>XZ</given-names></name><name><surname>Lu</surname><given-names>KP</given-names></name><name><surname>Gray</surname><given-names>NS</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Identification of a potent and selective covalent Pin1 inhibitor</article-title><source>Nature Chemical Biology</source><volume>16</volume><fpage>979</fpage><lpage>987</lpage><pub-id pub-id-type="doi">10.1038/s41589-020-0550-9</pub-id><pub-id pub-id-type="pmid">32483379</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ranganathan</surname><given-names>R</given-names></name><name><surname>Lu</surname><given-names>KP</given-names></name><name><surname>Hunter</surname><given-names>T</given-names></name><name><surname>Noel</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Structural and functional analysis of the mitotic rotamase Pin1 suggests substrate recognition is phosphorylation dependent</article-title><source>Cell</source><volume>89</volume><fpage>875</fpage><lpage>886</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(00)80273-1</pub-id><pub-id pub-id-type="pmid">9200606</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rask-Madsen</surname><given-names>C</given-names></name><name><surname>King</surname><given-names>GL</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Proatherosclerotic mechanisms involving protein kinase C in diabetes and insulin resistance</article-title><source>Arteriosclerosis, Thrombosis, and Vascular Biology</source><volume>25</volume><fpage>487</fpage><lpage>496</lpage><pub-id pub-id-type="doi">10.1161/01.ATV.0000155325.41507.e0</pub-id><pub-id pub-id-type="pmid">15637306</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogals</surname><given-names>MJ</given-names></name><name><surname>Greenwood</surname><given-names>AI</given-names></name><name><surname>Kwon</surname><given-names>J</given-names></name><name><surname>Lu</surname><given-names>KP</given-names></name><name><surname>Nicholson</surname><given-names>LK</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Neighboring phosphoSer‐Pro motifs in the undefined domain of IRAK 1 impart bivalent advantage for Pin1 binding</article-title><source>The FEBS Journal</source><volume>283</volume><fpage>4528</fpage><lpage>4548</lpage><pub-id pub-id-type="doi">10.1111/febs.13943</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ron</surname><given-names>D</given-names></name><name><surname>Jiang</surname><given-names>Z</given-names></name><name><surname>Yao</surname><given-names>L</given-names></name><name><surname>Vagts</surname><given-names>A</given-names></name><name><surname>Diamond</surname><given-names>I</given-names></name><name><surname>Gordon</surname><given-names>A</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Coordinated movement of RACK1 with activated betaIIPKC</article-title><source>The Journal of Biological Chemistry</source><volume>274</volume><fpage>27039</fpage><lpage>27046</lpage><pub-id pub-id-type="doi">10.1074/jbc.274.38.27039</pub-id><pub-id pub-id-type="pmid">10480917</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosse</surname><given-names>C</given-names></name><name><surname>Linch</surname><given-names>M</given-names></name><name><surname>Kermorgant</surname><given-names>S</given-names></name><name><surname>Cameron</surname><given-names>AJM</given-names></name><name><surname>Boeckeler</surname><given-names>K</given-names></name><name><surname>Parker</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>PKC and the control of localized signal dynamics</article-title><source>Nature Reviews. Molecular Cell Biology</source><volume>11</volume><fpage>103</fpage><lpage>112</lpage><pub-id pub-id-type="doi">10.1038/nrm2847</pub-id><pub-id pub-id-type="pmid">20094051</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwieters</surname><given-names>CD</given-names></name><name><surname>Kuszewski</surname><given-names>JJ</given-names></name><name><surname>Tjandra</surname><given-names>N</given-names></name><name><surname>Clore</surname><given-names>GM</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>The Xplor-NIH NMR molecular structure determination package</article-title><source>Journal of Magnetic Resonance</source><volume>160</volume><fpage>65</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1016/s1090-7807(02)00014-9</pub-id><pub-id pub-id-type="pmid">12565051</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwieters</surname><given-names>C</given-names></name><name><surname>Kuszewski</surname><given-names>J</given-names></name><name><surname>Mariusclore</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Using Xplor–NIH for NMR molecular structure determination</article-title><source>Progress in Nuclear Magnetic Resonance Spectroscopy</source><volume>48</volume><fpage>47</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1016/j.pnmrs.2005.10.001</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>Z-J</given-names></name><name><surname>Esnault</surname><given-names>S</given-names></name><name><surname>Rosenthal</surname><given-names>LA</given-names></name><name><surname>Szakaly</surname><given-names>RJ</given-names></name><name><surname>Sorkness</surname><given-names>RL</given-names></name><name><surname>Westmark</surname><given-names>PR</given-names></name><name><surname>Sandor</surname><given-names>M</given-names></name><name><surname>Malter</surname><given-names>JS</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Pin1 regulates TGF-beta1 production by activated human and murine eosinophils and contributes to allergic lung fibrosis</article-title><source>The Journal of Clinical Investigation</source><volume>118</volume><fpage>479</fpage><lpage>490</lpage><pub-id pub-id-type="doi">10.1172/JCI32789</pub-id><pub-id pub-id-type="pmid">18188456</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>RM</given-names></name><name><surname>Cummings</surname><given-names>E</given-names></name><name><surname>Pantos</surname><given-names>C</given-names></name><name><surname>Singh</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Protein kinase C and cardiac dysfunction: a review</article-title><source>Heart Failure Reviews</source><volume>22</volume><fpage>843</fpage><lpage>859</lpage><pub-id pub-id-type="doi">10.1007/s10741-017-9634-3</pub-id><pub-id pub-id-type="pmid">28702857</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smet</surname><given-names>C</given-names></name><name><surname>Wieruszeski</surname><given-names>J-M</given-names></name><name><surname>Buée</surname><given-names>L</given-names></name><name><surname>Landrieu</surname><given-names>I</given-names></name><name><surname>Lippens</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Regulation of Pin1 peptidyl-prolyl cis/trans isomerase activity by its WW binding module on a multi-phosphorylated peptide of Tau protein</article-title><source>FEBS Letters</source><volume>579</volume><fpage>4159</fpage><lpage>4164</lpage><pub-id pub-id-type="doi">10.1016/j.febslet.2005.06.048</pub-id><pub-id pub-id-type="pmid">16024016</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srivastava</surname><given-names>J</given-names></name><name><surname>Goris</surname><given-names>J</given-names></name><name><surname>Dilworth</surname><given-names>SM</given-names></name><name><surname>Parker</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Dephosphorylation of PKCdelta by protein phosphatase 2Ac and its inhibition by nucleotides</article-title><source>FEBS Letters</source><volume>516</volume><fpage>265</fpage><lpage>269</lpage><pub-id pub-id-type="doi">10.1016/s0014-5793(02)02500-0</pub-id><pub-id pub-id-type="pmid">11959144</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stebbins</surname><given-names>EG</given-names></name><name><surname>Mochly-Rosen</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Binding specificity for RACK1 resides in the V5 region of beta II protein kinase C</article-title><source>The Journal of Biological Chemistry</source><volume>276</volume><fpage>29644</fpage><lpage>29650</lpage><pub-id pub-id-type="doi">10.1074/jbc.M101044200</pub-id><pub-id pub-id-type="pmid">11387319</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ubersax</surname><given-names>JA</given-names></name><name><surname>Ferrell</surname><given-names>JE</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Mechanisms of specificity in protein phosphorylation</article-title><source>Nature Reviews. Molecular Cell Biology</source><volume>8</volume><fpage>530</fpage><lpage>541</lpage><pub-id pub-id-type="doi">10.1038/nrm2203</pub-id><pub-id pub-id-type="pmid">17585314</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verdecia</surname><given-names>MA</given-names></name><name><surname>Bowman</surname><given-names>ME</given-names></name><name><surname>Lu</surname><given-names>KP</given-names></name><name><surname>Hunter</surname><given-names>T</given-names></name><name><surname>Noel</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Structural basis for phosphoserine-proline recognition by group IV WW domains</article-title><source>Nature Structural Biology</source><volume>7</volume><fpage>639</fpage><lpage>643</lpage><pub-id pub-id-type="doi">10.1038/77929</pub-id><pub-id pub-id-type="pmid">10932246</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vranken</surname><given-names>WF</given-names></name><name><surname>Boucher</surname><given-names>W</given-names></name><name><surname>Stevens</surname><given-names>TJ</given-names></name><name><surname>Fogh</surname><given-names>RH</given-names></name><name><surname>Pajon</surname><given-names>A</given-names></name><name><surname>Llinas</surname><given-names>M</given-names></name><name><surname>Ulrich</surname><given-names>EL</given-names></name><name><surname>Markley</surname><given-names>JL</given-names></name><name><surname>Ionides</surname><given-names>J</given-names></name><name><surname>Laue</surname><given-names>ED</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>The CCPN data model for NMR spectroscopy: development of a software pipeline</article-title><source>Proteins</source><volume>59</volume><fpage>687</fpage><lpage>696</lpage><pub-id pub-id-type="doi">10.1002/prot.20449</pub-id><pub-id pub-id-type="pmid">15815974</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>ZX</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Some applications of statistical mechanics in enzymology 1. Elementary principle</article-title><source>Journal of Theoretical Biology</source><volume>143</volume><fpage>445</fpage><lpage>453</lpage><pub-id pub-id-type="doi">10.1016/S0022-5193(05)80021-9</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Mahoney</surname><given-names>BJ</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Zintsmaster</surname><given-names>JS</given-names></name><name><surname>Peng</surname><given-names>JW</given-names></name></person-group><year iso-8601-date="2015">2015a</year><article-title>Negative regulation of peptidyl-prolyl isomerase activity by interdomain contact in human pin1</article-title><source>Structure</source><volume>23</volume><fpage>2224</fpage><lpage>2233</lpage><pub-id pub-id-type="doi">10.1016/j.str.2015.08.019</pub-id><pub-id pub-id-type="pmid">26602185</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Tochio</surname><given-names>N</given-names></name><name><surname>Kawasaki</surname><given-names>R</given-names></name><name><surname>Tamari</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>N</given-names></name><name><surname>Uewaki</surname><given-names>J-I</given-names></name><name><surname>Utsunomiya-Tate</surname><given-names>N</given-names></name><name><surname>Tate</surname><given-names>S-I</given-names></name></person-group><year iso-8601-date="2015">2015b</year><article-title>Allosteric breakage of the hydrogen bond within the dual-histidine motif in the active site of human Pin1 PPIase</article-title><source>Biochemistry</source><volume>54</volume><fpage>5242</fpage><lpage>5253</lpage><pub-id pub-id-type="doi">10.1021/acs.biochem.5b00606</pub-id><pub-id pub-id-type="pmid">26226559</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waudby</surname><given-names>CA</given-names></name><name><surname>Ramos</surname><given-names>A</given-names></name><name><surname>Cabrita</surname><given-names>LD</given-names></name><name><surname>Christodoulou</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Two-dimensional NMR lineshape analysis</article-title><source>Scientific Reports</source><volume>6</volume><elocation-id>24826</elocation-id><pub-id pub-id-type="doi">10.1038/srep24826</pub-id><pub-id pub-id-type="pmid">27109776</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>S</given-names></name><name><surname>Kozono</surname><given-names>S</given-names></name><name><surname>Kats</surname><given-names>L</given-names></name><name><surname>Nechama</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Guarnerio</surname><given-names>J</given-names></name><name><surname>Luo</surname><given-names>M</given-names></name><name><surname>You</surname><given-names>M-H</given-names></name><name><surname>Yao</surname><given-names>Y</given-names></name><name><surname>Kondo</surname><given-names>A</given-names></name><name><surname>Hu</surname><given-names>H</given-names></name><name><surname>Bozkurt</surname><given-names>G</given-names></name><name><surname>Moerke</surname><given-names>NJ</given-names></name><name><surname>Cao</surname><given-names>S</given-names></name><name><surname>Reschke</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>C-H</given-names></name><name><surname>Rego</surname><given-names>EM</given-names></name><name><surname>Lo-Coco</surname><given-names>F</given-names></name><name><surname>Cantley</surname><given-names>LC</given-names></name><name><surname>Lee</surname><given-names>TH</given-names></name><name><surname>Wu</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Pandolfi</surname><given-names>PP</given-names></name><name><surname>Zhou</surname><given-names>XZ</given-names></name><name><surname>Lu</surname><given-names>KP</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer</article-title><source>Nature Medicine</source><volume>21</volume><fpage>457</fpage><lpage>466</lpage><pub-id pub-id-type="doi">10.1038/nm.3839</pub-id><pub-id pub-id-type="pmid">25849135</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>KA</given-names></name><name><surname>Bouchard</surname><given-names>JJ</given-names></name><name><surname>Peng</surname><given-names>JW</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Interdomain interactions support interdomain communication in human Pin1</article-title><source>Biochemistry</source><volume>52</volume><fpage>6968</fpage><lpage>6981</lpage><pub-id pub-id-type="doi">10.1021/bi401057x</pub-id><pub-id pub-id-type="pmid">24020391</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>W</given-names></name><name><surname>Xue</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Zheng</surname><given-names>N</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Targeting prolyl isomerase Pin1 as a promising strategy to overcome resistance to cancer therapies</article-title><source>Pharmacological Research</source><volume>184</volume><elocation-id>106456</elocation-id><pub-id pub-id-type="doi">10.1016/j.phrs.2022.106456</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>N</given-names></name><name><surname>Tochio</surname><given-names>N</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Tamari</surname><given-names>Y</given-names></name><name><surname>Uewaki</surname><given-names>J-I</given-names></name><name><surname>Utsunomiya-Tate</surname><given-names>N</given-names></name><name><surname>Igarashi</surname><given-names>K</given-names></name><name><surname>Shiraki</surname><given-names>T</given-names></name><name><surname>Kobayashi</surname><given-names>N</given-names></name><name><surname>Tate</surname><given-names>S-I</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The C113D mutation in human Pin1 causes allosteric structural changes in the phosphate binding pocket of the PPIase domain through the tug of war in the dual-histidine motif</article-title><source>Biochemistry</source><volume>53</volume><fpage>5568</fpage><lpage>5578</lpage><pub-id pub-id-type="doi">10.1021/bi5007817</pub-id><pub-id pub-id-type="pmid">25100325</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Shu</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>P</given-names></name><name><surname>Igumenova</surname><given-names>TI</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Structural basis of protein kinase cα regulation by the C-terminal tail</article-title><source>Biophysical Journal</source><volume>114</volume><fpage>1590</fpage><lpage>1603</lpage><pub-id pub-id-type="doi">10.1016/j.bpj.2017.12.030</pub-id><pub-id pub-id-type="pmid">29642029</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yeh</surname><given-names>ES</given-names></name><name><surname>Lew</surname><given-names>BO</given-names></name><name><surname>Means</surname><given-names>AR</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>The loss of pin1 deregulates cyclin e and sensitizes mouse embryo fibroblasts to genomic instability</article-title><source>Journal of Biological Chemistry</source><volume>281</volume><fpage>241</fpage><lpage>251</lpage><pub-id pub-id-type="doi">10.1074/jbc.M505770200</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>JH</given-names></name><name><surname>Im</surname><given-names>CY</given-names></name><name><surname>Min</surname><given-names>SH</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Function of PIN1 in cancer development and its inhibitors as cancer Therapeutics</article-title><source>Frontiers in Cell and Developmental Biology</source><volume>8</volume><elocation-id>120</elocation-id><pub-id pub-id-type="doi">10.3389/fcell.2020.00120</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zannini</surname><given-names>A</given-names></name><name><surname>Rustighi</surname><given-names>A</given-names></name><name><surname>Campaner</surname><given-names>E</given-names></name><name><surname>Del Sal</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Oncogenic hijacking of the PIN1 signaling network</article-title><source>Frontiers in Oncology</source><volume>9</volume><elocation-id>94</elocation-id><pub-id pub-id-type="doi">10.3389/fonc.2019.00094</pub-id><pub-id pub-id-type="pmid">30873382</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Daum</surname><given-names>S</given-names></name><name><surname>Wildemann</surname><given-names>D</given-names></name><name><surname>Zhou</surname><given-names>XZ</given-names></name><name><surname>Verdecia</surname><given-names>MA</given-names></name><name><surname>Bowman</surname><given-names>ME</given-names></name><name><surname>Lücke</surname><given-names>C</given-names></name><name><surname>Hunter</surname><given-names>T</given-names></name><name><surname>Lu</surname><given-names>K-P</given-names></name><name><surname>Fischer</surname><given-names>G</given-names></name><name><surname>Noel</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Structural basis for high-affinity peptide inhibition of human Pin1</article-title><source>ACS Chemical Biology</source><volume>2</volume><fpage>320</fpage><lpage>328</lpage><pub-id pub-id-type="doi">10.1021/cb7000044</pub-id><pub-id pub-id-type="pmid">17518432</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>XZ</given-names></name><name><surname>Lu</surname><given-names>PJ</given-names></name><name><surname>Wulf</surname><given-names>G</given-names></name><name><surname>Lu</surname><given-names>KP</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Phosphorylation-dependent prolyl isomerization: a novel signaling regulatory mechanism</article-title><source>Cellular and Molecular Life Sciences</source><volume>56</volume><fpage>788</fpage><lpage>806</lpage><pub-id pub-id-type="doi">10.1007/s000180050026</pub-id><pub-id pub-id-type="pmid">11212339</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>XZ</given-names></name><name><surname>Lu</surname><given-names>KP</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target</article-title><source>Nature Reviews. Cancer</source><volume>16</volume><fpage>463</fpage><lpage>478</lpage><pub-id pub-id-type="doi">10.1038/nrc.2016.49</pub-id><pub-id pub-id-type="pmid">27256007</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zwahlen</surname><given-names>C</given-names></name><name><surname>Legault</surname><given-names>P</given-names></name><name><surname>Vincent</surname><given-names>SJF</given-names></name><name><surname>Greenblatt</surname><given-names>J</given-names></name><name><surname>Konrat</surname><given-names>R</given-names></name><name><surname>Kay</surname><given-names>LE</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Methods for measurement of intermolecular NOEs by multinuclear NMR spectroscopy: application to a bacteriophage λ N-Peptide/ <italic>boxB</italic> RNA complex</article-title><source>Journal of the American Chemical Society</source><volume>119</volume><fpage>6711</fpage><lpage>6721</lpage><pub-id pub-id-type="doi">10.1021/ja970224q</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.92884.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Hong</surname><given-names>Heedeok</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05hs6h993</institution-id><institution>Michigan State University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><related-object id="sa0ro1" object-id-type="id" object-id="10.1101/2023.09.18.558341" link-type="continued-by" xlink:href="https://sciety.org/articles/activity/10.1101/2023.09.18.558341"/></front-stub><body><p>Pin1 is an essential prolyl cis/trans isomerase which has attracted considerable attention as this enzyme family is implicated in cancer and neurodegenerative diseases. Here, authors provide compelling evidence that Pin1 modulates the activity of an important cell signaling kinase, Protein Kinase C by a non-catalytic mechanism. This result suggests a new mode of Pin1 action, regulating the cellular stability of the kinase via a chaperone-like activity.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.92884.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Hong</surname><given-names>Heedeok</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05hs6h993</institution-id><institution>Michigan State University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Lippens</surname><given-names>Guy</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02feahw73</institution-id><institution>CNRS</institution></institution-wrap><country>France</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2023.09.18.558341">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2023.09.18.558341v2">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;A novel bivalent interaction mode underlies a non-catalytic mechanism for Pin1-mediated Protein Kinase C regulation&quot; for consideration by <italic>eLife</italic>. We apologize the unusual delay and thank you for the patience. Your article has been reviewed by 2 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Jonathan Cooper as the Senior Editor.</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions (for the authors):</p><p>Overall, reviewers are enthusiastic about your work and provided helpful comments that can further strengthen the manuscript. They also suggested a few additional experiments. I encourage you to consider those suggestions or to justify your approaches and results. Please, provide point-by-point responses to all reviewers' comments.</p><p>1) Address the possibility that the orientation of the PPIase/WW domain interface and the conformation of the bound V5-derived peptides are dynamic rather than static.</p><p>2) Provide further explanations on the cell-based assay results, regarding the expression levels of PKC in the original WT and KO cell lines.</p><p>3) Emphasize the novelty of the Pin1-V5 peptide complex structure. Yeh et al. (JBC 2006) reports a potential noncanonical binding mode in the PIN1-cyclinE interaction.</p><p>4) Some CSP pattern may reflect allosteric or dynamic effects and only indirectly reflect binding. Also, further evidence of unidirectionality is required. NOE experiments for structure determination may help. Employing alternative methods for measuring Kd values (ITC, MST, etc.) would be worthwhile to consider.</p><p>5) A more in-depth analysis of the binding data based on the kcat/Km values will be useful to provide further insights into the Pin1-client interaction and the contribution of phosphate groups to the binding. In addition, EXSY NMR may miss some cis-trans isomerization events that can possibly occur beyond the time scale of the experiment. Please, address these points.</p><p>6) Provide mass spectrometry data of the phosphorylated peptides in the SI.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>As the structure (8SG2.pdb) is still on hold, it is harder to evaluate it in detail. I recommend the authors release it.</p><p>The connection between the structural model and the in vivo data should be strengthened.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>The following recommendations would greatly improve the quality and impact of the manuscript and certainly make it suitable for endorsement by <italic>eLife</italic>:</p><p>– Bivalent interaction: My biggest criticism is that all the data supporting the unidirectional bivalent interaction model are based only on cherry-picked residue specific Kds from NMR titrations. This can be misleading because chemical shifts may report also on allosteric or dynamic effects. The conclusions should be orthogonally supported by global Kd determination from e.g. ITC, MST, etc. The CSP patterns are not sufficient to prove unidirectionality, the mono-phosphorylated peptide could swap and bind to both sites, a FRET reporter assay or PRE experiments would decipher this.</p><p>– Enzymatic activity: The absence of enzymatic activity of Pin1 towards PKC is central to the paper and should be very carefully addressed. To me, the best hint for this is that expression of a catalytically dead mutant rescues PKC levels in Pin1 knock-out cells. However, the in vitro data are not as clear, actual rates should be quantified and an estimate of the kcat/Km should be given even if it is very low. It would be interesting to decipher the contribution of kcat and Km to the lower activity of Pin1 towards S/TPP motifs. All enzyme assays are based on EXSY NMR which is only sensitive to a narrow timescale. It would be advisable to probe other timescales using real-time NMR, and to quantify cis/trans populations based on Pro Cb-Cd 13C shifts.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.92884.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions (for the authors):</p><p>Reviewer #2 (Recommendations for the authors):</p><p>The following recommendations would greatly improve the quality and impact of the manuscript and certainly make it suitable for endorsement by eLife:</p><p>– Bivalent interaction: My biggest criticism is that all the data supporting the unidirectional bivalent interaction model are based only on cherry-picked residue specific Kds from NMR titrations. This can be misleading because chemical shifts may report also on allosteric or dynamic effects. The conclusions should be orthogonally supported by global Kd determination from e.g. ITC, MST, etc. The CSP patterns are not sufficient to prove unidirectionality, the mono-phosphorylated peptide could swap and bind to both sites, a FRET reporter assay or PRE experiments would decipher this.</p></disp-quote><p>We respectfully disagree with the reviewer’s assessment that “all the data supporting the unidirectional bivalent interaction model are based only on cherry-picked residue specific Kds from NMR titrations”.</p><p>The NMR structure of Pin1::pV5bII complex (Figure 6 and Figure 5—figure supplement 2) is the ultimate proof of the bivalent unidirectional binding mode. The structure was calculated based on the experimental restraints, including 75 inter-molecular NOEs across the Pin1-pV5bII binding interface (see Supplementary File 1). To illustrate this point, we have included several inter-molecular <sup>1</sup>H-<sup>1</sup>H strips as panels A and B of Figure 5—figure supplement 2. The CSP/Kd data of Figure 4 are entirely consistent with and fully support the unidirectional bivalent binding mode.</p><p>With respect to the monophosphorylated peptides, we provide evidence for unambiguous determination of the binding modes by adding new figure panels, Figure 5A-D. The chemical shift data and the correlation plots unambiguously show the unidirectional bivalent binding mode for the mono-phosphorylated V5-pTM-HM segment (Figure 5A-B), and a lack of bivalent unidirectional interactions for the V5-TM-pHM monophosphorylated region (Figure 5C-D). We have also added cartoon representations of the binding modes in Figure 5E-H. We hope these revisions enhance the clarity of the representation and eliminate confusion regarding the binding modes.</p><p>The reviewer suggests to conduct FRET and PRE experiments to provide additional evidence for unidirectionality (we assume this comment applies to the mono-phosphorylated V5-pTM-HM region, the data for which are now presented in Figures 5A,B,F). Indeed, we have considered these types of experiments at the initial stages of the project. However, we ruled them out because of their perturbing nature -- as applied to our system. FRET/PRE would require an introduction of at least three mutations into Pin1: mutation of two native Cys residues (one of them, Cys113, is a catalytic residue that lines the PPIase binding site) and introduction of another solvent-exposed Cys for the modification with a bulky nitroxide label or a fluorophore. Modification of the C-term PKC region raised similar concerns related to mutagenesis and introduction of bulky probes. In our assessment, the structurally non-perturbing approach implemented in the current study is superior and produces clearly interpretable data as shown in Figure 5.</p><p>Regarding “cherry-picking” of residues and K<sub>d</sub> determination:</p><p>In selecting Pin1 residues for the binding analyses we followed rigorous procedures accepted in the NMR field, and absolutely no “cherry-picking” was done. Moreover, the reported Kd values are not residue-specific but are the results of global fits (see Supplementary File 2). We also emphasize that we did not rely just on the CSP-based binding curves but also conducted lineshape analysis that includes fitting parameters such as populations of bound and unbound species. To clarify these points and emphasize that we observed no indirect effects (allosteric/dynamic), we have expanded the Methods section to provide more details on the procedures of the binding analyses on page 33 [CSP-based binding curves] and pages 35-36 [lineshape analysis].</p><p>Due to space limitations, the main figures show binding data for selected residues with global fits. All results of the binding analyses (459 experimental binding curves with fits and 241 peaks with lineshape fits, see Supplementary File 2) are available from the authors upon request. Full data or their subset can be included in the Supporting Information if the reviewer and editors deem it essential.</p><p>The reviewer suggests using orthogonal approaches such as ITC or MST. Neither ITC nor MST can provide domain-specific information for full-length Pin1, which was absolutely essential for us to be able to dissect the bivalent mode. We do not see what additional information ITC or MST can provide for our study -- unless the reviewer can point specifically to where they think our NMR-based approach is inadequate or deficient.</p><disp-quote content-type="editor-comment"><p>– Enzymatic activity: The absence of enzymatic activity of Pin1 towards PKC is central to the paper and should be very carefully addressed. To me, the best hint for this is that expression of a catalytically dead mutant rescues PKC levels in Pin1 knock-out cells. However, the in vitro data are not as clear, actual rates should be quantified and an estimate of the kcat/Km should be given even if it is very low. It would be interesting to decipher the contribution of kcat and Km to the lower activity of Pin1 towards S/TPP motifs. All enzyme assays are based on EXSY NMR which is only sensitive to a narrow timescale.</p></disp-quote><p>Regarding kcat/Km measurements: The chymotrypsin-coupled chromophore (p-nitroaniline) assay is currently the only available method to determine the kcat/Km for Pin1-catalyzed reactions. A significant limitation of the assay (pointed out by other researchers in the field, see Greenwood et al., 2011, Complete determination of the Pin1 catalytic domain thermodynamic cycle by NMR lineshape analysis. Journal of biomolecular NMR 51(1-2), 21) is that chymotrypsin only cleaves at the C-terminal region of an aromatic residue that follows a residue that is preceded by a trans peptide bond. This assay is incompatible with our system that has a double-Proline motif, leaving the <sup>1</sup>H-<sup>1</sup>H EXSY experiment the only available route to assay Pin1 catalytic activity.</p><p>Regarding EXSY experiments: EXSY NMR is sensitive to the timescale range that covers ca. 3 orders of magnitude, from 0.1 s<sup>-1</sup> to 100 s<sup>-1</sup>. We have included this statement with appropriate citations on page 7. We have also included an estimate of the exchange rate (&lt; 0.1 s<sup>-1</sup>) in our experiments on pages 7-8.</p><disp-quote content-type="editor-comment"><p>It would be advisable to probe other timescales using real-time NMR, and to quantify cis/trans populations based on Pro Cb-Cd 13C shifts.</p></disp-quote><p>Given that the equilibrium between cis- and trans- isomers is established in solution prior to the addition of Pin1, and that addition of Pin1 does not change the populations, it is not feasible to monitor this reaction using real-time NMR.</p><p>Quantifying cis-trans populations using the intensities of Cb/Cg cross-peaks requires incorporation of isotopic labels into pV5bII, as the <sup>1</sup>H-only based 2D experiments are not adequate for this purpose. Recombinant expression of isotopically enriched pV5bII is not feasible because of phosphorylation, while chemical synthesis of pV5bII with labeled amino acids is prohibitively expensive. Quantification of populations, while providing generally useful information, has no bearing on the conclusions of this work.</p></body></sub-article></article>